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ABSTRACT 
 
Micro-Biosensor Devices for Biochemical Analysis Applications 
 
by 
 
Han Zhang, Doctor of Philosophy 
Utah State University, 2019 
 
Major Professor: Dr. Anhong Zhou  
Department: Biological Engineering 
 
Traditional techniques for identification and detection of specific targets are time-
consuming, and lack portability. A biosensor defined as an analytical device consisting of 
a biological recognition element and a physicochemical transducer that converts the 
recognition to measurable signals for analytes of interest. In this dissertation, I developed 
a novel, versatile micro-biosensor system that integrates microfluidics (polymer-based 
devices or paper-based devices) and bio-sensing parts (optical sensor and electrochemical 
sensor) converting the biochemical signal to measurable pixels and electronic signals. This 
microfluidic integrated biosensor system has many advantages such as configurability 
(different combinations of parts for different applications), real-time detection, 
disposability, fast prototyping and affordability (volume could be as low as nanoliter), high 
throughput and multiplexing capability (multiple analytes); more importantly, the 
enhanced transport for controlling the flow conditions under microfluidic environment will 
remarkably increase the biosensor performance (sensitivity and selectivity). The 
microfluidics-integrated biosensor with these features offers a powerful tool with the 
attractive ability to merge biological and mechanical components into the single detection 
platform that could be an alternative to the traditional bulky equipment and instruments.  
 
This dissertation proposes a novel microfluidics-integrated biosensor platform system that 
 iv 
  
 
  
can be flexibly adapted to form individual micro-devices depending on particular 
applications. The first five technical chapters of this dissertation present five examples of 
different emerging areas with this biosensor system including drug-cancer cell screening, 
point of care (POC) diagnostics, environmental monitoring, obesity healthcare, and 
biomarker identification and detection. These micro-devices-based biosensors have great 
potential to be further developed to emerging portable sensing devices especially useful for 
the users in resource-limited settings and developing and undeveloped world. 
 
In the last chapter of the dissertation, Raman spectroscopy was employed for analysis of 
extracellular vesicles (EVs) isolated from peripheral blood mononuclear cells (PBMC) and 
trophoblast. The objective of this project was to differentiate EVs isolated from bovine 
placenta and PBMC by Raman spectroscopy. The long-term goals are to apply this non-
invasive, label-free method to distinguish EVs from the serum of pregnant and non-
pregnant cows to assess gestational status and the potential for pregnancy complications, 
which could significantly benefit animal reproduction. 
                   
(210 pages) 
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PUBLIC ABSTRACT 
 
Micro-Biosensor Devices for Biochemical Analysis Applications 
 
Han Zhang 
 
A biosensor is an analytical device integrating a biological element and a physicochemical 
transducer that convert a biological response into a measurable signal. The advantages of 
biosensors include low cost, small size, quick, sensitivity and selectivity greater than the 
conventional instruments. Biosensors have a wide range of applications ranging from 
clinical diagnostics through to environmental monitoring, agriculture industry, et al.  
 
The different types of biosensors are classified based on the sensor device as well as the 
biological material.  Biosensors can be broadly classified into (piezoelectric, etc.), 
electrochemical biosensors (potentiometric, amperometric, etc.), and optical types of 
biosensors (fiber optics, etc.). 
 
Here, we introduce a novel microfluidics-integrated biosensor platform system that can be 
flexibly adapted to form individual biosensors for different applications. In this dissertation, 
we present five examples of different emerging areas with this biosensor system including 
anti-cancer drug screening, glucose monitoring, heavy metal elements measurement, 
obesity healthcare, and waterborne pathogen DNA detection. These micro-biosensors have 
great potential to be further developed to emerging portable sensing devices especially for 
the uses in the developing and undeveloped world. At the last chapter, Raman spectroscopy 
applied to assess gestational status and the potential for pregnancy complications is 
presented and discussed. This technique could significantly benefit animal reproduction. 
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CHAPTER 1  
INTRODUCTION 
 
1.1 Rationale for Proposed Research 
 
A biosensor is generally defined as an analytical device that converts a biological 
response into a quantifiable and measurable signal via a transducer1. Every year, 
billions of US dollars have been provided to support biosensor-related studies. There is 
an urgent need in diagnostics laboratories for accurate, inexpensive and fast response 
devices. The reliability and accuracy of information on the desired biochemical 
parameters is an essential requirement for effective healthcare. Since its considerable 
advantages include smaller size, faster response, high specificity and relatively low cost, 
biosensor devices provide feasible solutions to the problems faced by the contemporary 
healthcare industry.  
 
Biosensors are analytical devices consisting of a biological recognition element and a 
transducer. The biological recognition element is for capturing analytes in test samples 
and the transducer converts the related (bio) chemical reactions to a measurable signal 
variation. The type of biosensors can be categorized into three classes in terms of the 
transducer, that is, electronic biosensors (electrical or electrochemical)2, optical 
biosensors (colorimetric, fluorescent, or Raman)3-5, and piezoelectric biosensors 
(quartz crystal microbalance)6. 
 
This dissertation mainly focuses on the design and development of optical and 
electronic biosensor devices for diagnostic and environmental monitoring applications. 
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More specific research results and findings from these topics will be introduced in the 
following chapters of the dissertation. 
 
1.2 Dissertation Outline 
 
This dissertation includes 8 chapters (Chapter 1~8).  
 
Chapter 1: This chapter is the background introduction and literature review. Since a 
more detailed background introduction is included in each technical chapter from 
chapter 2 to chapter 7, here only a brief background is presented to cover several 
important concepts in the dissertation. 
 
Chapter 2: In this chapter, we demonstrate a novel and reusable magnesium fluoride (or 
MgF2) based microfluidic device that collects native cell Raman spectra and realizes in 
situ monitoring of single cells in response to anticancer drug. Compared with traditional 
materials such as polydimethylsiloxane (PDMS) PMMA and glass, MgF2 offers 
minimal background in Raman spectroscopy measurements within typical fingerprint 
region. The performance of the proposed MgF2-based microfluidic measurement 
platform was tested by investigating anticancer drug interaction with a variety of cancer 
cell lines. Cells were cultured long-term in the device up to three days and a cell 
viability test was then conducted to evaluate the biocompatibility of microfluidic the 
device system. In addition, Raman spectroscopy was applied to examine the responses 
of cancer cells to anticancer drug exposure (24 h) at the single cell level. 
 
Chapter 3: In this chapter, we developed a 3D printed microfluidic device for the 
detection of fatty acid-induced GPR120 receptors using surface-enhanced Raman 
scattering (SERS) probes. SERS probes consist of gold nanoparticles conjugated with 
GPR120 antibody and the Raman reporter molecule mercaptobenzoic acid (MBA) was 
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applied to detect the presence of GPR120 fatty acid receptors on the surface of human 
embryonic kidney 293 cells (HEK293) after fatty acid (FA) treatment. The microfluidic 
system consisted of two parts, i.e., the concentration gradient generator (CGG) part, 
and the cell culture micro-well array. Two parts were linked together by tubing. 
HEK293 cells were cultured and induced to express GPR120 in micro-wells for 24 h 
before injection of FA and subsequently treated with SERS probes. The results showed 
a positive relation between SERS peaks and FA concentrations that agreed with our 
previously published results. The development of this method also provides a platform 
for single-cell analysis using Raman SERS in a PDMS-based microfluidic device. 
 
Chapter 4: In this chapter, we introduced two PDMS-based microfluidic 
electrochemical devices for water quality monitoring applications. The first device was 
applied to detect heavy metal Cd2+ and Pb2+ ions in water. The device consists of a 
three-electrode system on a glass substrate with a vibration motor for stirring and a 
PDMS reservoir for sample deposition. The stirring motor improves the detection limit 
and decreases deposition time. Differential pulse stripping voltammetry (DPSV) is used 
to detect Cd2+ and Pb2+ ions.  
 
The second device was designed to enable the electrochemical detection of the DNA 
sequences specific to human and other genotypes of waterborne pathogen 
Cryptosporidium. The device consists of three parts: the top polyamide (PI) layer is 
gold coated on a spot in the center of the layer for probe DNA immobilization. The 
middle layer includes PDMS channels and reservoir for sample delivery and deposition. 
The bottom layer is electrodes coated polyethylene terephthalate (PET) sheet for signal 
collection. The free bases of the DNA probe strand were hybridized with a biotin 
marked capture probe. Streptavidin-alkaline phosphatase enzyme was incubated with 
the biotin marked capture probe via biotin-streptavidin conjugation and an enzymatic 
reaction was formed for 4-aminophenyl phosphate reduction to 4-aminophenol. The 
oxidation signal was recorded using the differential pulse voltammetry (DPV) 
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electrochemical method. Because the electrode surface is clean and fresh for 
electrochemical detection, the obtained results for complementary strand analysis 
shows better sensitivity comparing with the commercial electrodes. 
 
Chapter 5: Here we introduced a novel inkjet printing method to fabricate the paper-
based analytical devices (µPADs) on Whatman® chromatography filter paper. This 
method overcomes the drawbacks previously described. Since the volume of the jetted 
ink is in a scale of nanoliters, the pattern for printing was also highly designable. The 
µPad has high stability, high sensitivity, standardized fabrication, low cost and long 
shelf-life, meaning this printing method offers great potential for clinic and POCT 
applications. The printing method is also adequate for other enzymatic reactions and 
substance detection purposes. 
 
Chapter 6: In this chapter, we introduced a smartphone-based optical platform for 
colorimetric analysis of blood glucose concentration using a paper-based device. The 
optical platform was 3D printed with black ABS plastic materials. The optical chamber 
with build-in LED lights stabilizes ambient lighting condition. The manual camera as a 
part of the Android application offers a good control of exposure time, ISO and white 
balance by enabling a quantitative manual setting. Both the optical chamber and the 
manual camera could significantly reduce the variation of gray intensity baseline on the 
same image and hence increase of readout accuracy.  In order to address the color 
uniformity issue that is encountered by traditional colorimetric device fabrication, the 
chromogen and enzymatic system were inkjet printed to construct the sensing zone of 
the µPAD using a high-resolution material printer. Since the volume of the jetted ink is 
in a scale of nanoliters, the pattern for printing was also highly designable.  
 
Chapter 7: In this work, Raman spectroscopy was employed for analysis of EVs isolated 
from PBMC and trophoblast. The dynamic light scattering (DLS), and scanning 
electron microscope (SEM) were applied to confirm the presence and the size 
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distribution of EVs after the isolation preparation. The objective of this project was to 
differentiate EVs isolated from bovine placenta and PBMC by Raman spectroscopy. 
The long-term goals are to apply this non-invasive, label-free method to distinguish 
EVs from the serum of pregnant and non-pregnant cows to assess gestational status and 
the potential for pregnancy complications. 
 
Chapter 8: A brief summary of this dissertation research was outlined and directions for 
future research were discussed. 
 
1.3 Background and Literature Review 
 
1.3.1 Applications of Raman spectroscopy and Surface-enhanced Raman 
spectroscopy (SERS) 
 
Over the last two decades, Raman spectroscopy has become an increasingly powerful 
tool for cell characterization and classification7, 8. Raman spectroscopy is a label-free 
and noninvasive technique and is also well suitable for monitoring live cells behaviors 
8. Raman spectroscopy, based on inelastic scattering, is a spectroscopic technique that 
can identify chemical compositions by characteristic fingerprints in living cells9. 
Raman spectroscopy has been applied to the area of diagnostics, tissue engineering and 
toxicological testing10, and the toxicological research of pharmaceuticals on living cells 
in vitro11. Raman spectroscopy also has been applied for real-time measurement of 
biochemical alterations in living tumor cells treated with anticancer drugs12, 13. Besides, 
confocal Raman spectroscopy is employed to trace the anticancer drug paclitaxel in 
living MCF-7 cells13. 
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Surface-enhanced Raman spectroscopy (SERS) is a surface-sensitive technique that 
enhances Raman scattering by using reporter molecules absorbed on metal 
nanostructures surface such as Ag, Au nano-particles). The enhancement factor can be 
as much as 106 to 1012, and this indicates the SERS technique could be suitable for 
single molecule detection. 
 
1.3.2 3D printing techniques 
 
3D printing is a process of fabricating three dimensional solid objects from a digital file. 
Additive processing is used to fabricate a 3D printed object. In an additive process, an 
object is created by laying down successive layers of material until the design is 
completed created. Each of the layers is a thin slice unit of the horizontal cross-section 
of the eventual object. 3D printing techniques can be classified into two types: 
stereolithographic (SLA) and fused deposition modeling (FDM). The SLA using a laser 
beam to spatially control the polymerization of light-sensitive resin in 2D dimension14. 
After the current thin layer is cured, the laser move up and cure higher layer, with this 
bottom-up approach, another layer of uncured liquid resin spreads over the top.  Fused 
deposition modeling (FDM) is the deposition of molten thermoplastic materials through 
two heated extrusion heads with a small orifice in a specific laydown pattern. Industrial 
3D printers have reached extremely high resolution, such as horizontal layer thickness 
can be as fine as 16 μm and XY plane accuracy can be as low as 20-85μm for SLA 
(Object 260 Connex3, Stratasys), and horizontal layer thickness 178 μm and achievable 
accuracy can be 241μm for FDM (Fortus 900MC, Stratasys)14. Due to the nature of the 
methods SLA normally has a higher resolution than the FDM method. 
 
1.3.3 Microfluidic device and its advantages 
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Microfluidic devices also referred to as “lab-on-a-chip (LOC)” has received much 
attention. The use of microfluidics to conduct biomedical and clinical research has a 
variety of advantages. Firstly, the fabrication of the microfluidic device is relatively 
low cost and very amenable to highly elaborate multiplexed devices. Some designs may 
be mass produced. Secondly, microfluidic bioreactors are potentially advantageous for 
cellular applications as they provide a large surface-area-to-volume ratio, so many cells 
can be produced by a low volume device15. Thirdly, because the volume of fluids within 
these devices is very small, usually from several nanoliters to several microliters, the 
reagent consumption is quite small. It helps to save expensive reagents. Microfluidic 
devices have been applied to detect bacteria, viruses and cancer cells. Some other 
biochemical assays have been a shift into a LOC format for analysis of samples such as 
whole blood, bacteria, cell suspensions or solutions16-21. 
 
1.3.4 Combined microfluidic device for single-cell Raman spectroscopy  
 
Recently, the combination of microfluidic platform and Raman spectroscopy for 
biological applications has been extensively reported for a variety of applications22-25. 
One of the major challenges for integrating microfluidic platform and Raman 
spectroscopy for cell analysis is the high noise background from polydimethylsiloxane 
(PDMS) and glass26 which are primary materials used for fabrication of the microfluidic 
device. In order to minimize the influence of such background noise, and also enhance 
the signals, surface-enhanced Raman spectroscopy (SERS) is commonly implemented 
in combination with a traditional microfluidic platform27, 28. SERS is a surface-sensitive 
technique that enhances Raman scattering by molecules adsorbed on rough metal 
surfaces or by nanostructures such as plasmonic-magnetic silica nanotubes. The 
enhancement factor can be as much as 106 to 1014 29, 30, which indicates that this 
technique is capable of detecting chemicals at the single molecular level. In 2013, SERS 
in combination with the microfluidic environment to quantitatively discriminate 
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noncancerous and cancerous cells has been reported by Hoonejani 28.  
 
1.3.5 Paper based microfluidic device for glucose detection 
 
In colorimetric glucose detection, glucose oxidase (GOx) and horseradish peroxidase 
(HRP) is a common enzyme pair used to catalyze the reaction between glucose and the 
chromogenic substrates31-34. The GOx firstly oxidizes glucose to gluconic acid and 
hydrogen peroxide (H2O2). Following, HRP catalyzes the reaction of H2O2 with 
chromogenic substrates and exhibits a blue color. The commonly used chromogenic 
substrates for HRP include Potassium iodide (KI), 3,3',5,5'-Tetramethylbenzidine 
(TMB), 3,3'-Diaminobenzidine (DAB), 2,2'-azino-bis(3-ethylbenzthiazoline-6-
sulphonic acid) (ABTS) and others35.  
 
Microfluidic paper-based analytical devices (µPADs) as a low-cost and portable 
platform for glucose assays was first proposed by the Whitesides group in 200736. Their 
device was fabricated by paper-based photo-lithography with a measurable 
concentration of analyte ranging from 0 to 500 mM. Whatman chromatography paper 
was the most commonly used lateral flow paper substrate31, 32, 37 for this µPADs device. 
The hydrophobic barriers were constructed with many techniques such as photo-
lithography, wax printing, hot embossing, and screen printing35. Following, the 
enzymes and substrates are always loaded onto the device manually. The limits of 
detection (LODs), ranging from 0.1 to 5 mM, with image data collected by a scanner 
or common digital camera is often reported in the recent publications35, 38.  
 
Although colorimetric detection provides many advantages. It also exhibits some 
drawbacks that can adversely affect the analytical performance of the μPADs. The 
washing effect36, 39, 40, poor color uniformity formed in the detection zones31, 41, 42, and 
enzyme/substrate loading overflow are three of the major problems. The washing effect 
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is caused by the washing of the reagent and enzyme from the printed position to the 
edge of the paper substrate when the sample solution travels through the patterned 
channels. Poor color uniformity and overflowing are primarily caused by unbalanced 
manual reagent loading. Recent publications have achieved noticeable improvements 
to minimize these effects32, 43-45. However, the problems still persist at the visual level. 
 
1.3.6 Electrochemical biosensor chip for discriminating DNA of microorganism  
 
Biosensor chips, especially electrochemical biosensor chips, have been developed in 
the past few decades46-50. With a combination of micro total analysis system (µ-TAS) 
and electrochemical biosensor chips, the use of µTAS to conduct biomedical and 
clinical research has a variety of advantages. Firstly, the fabrication of the microfluidic 
device is relatively low cost and very amenable to highly elaborate multiplexed devices. 
Some designs may be mass produced. Secondly, microfluidic bioreactors are 
potentially advantageous for cellular applications as they provide a large surface-area-
to-volume ratio so a large number of cells can be produced by a low volume device1. 
In addition, the reagent consumption is quite small due to the small volume of the 
device, saving expensive reagents. Summary of advantages of μ-TAS was reported by 
many recent publications50-53. The development of the µ-TAS electrochemical 
biosensor chips, which both electrochemical cell and channel networks are integrated, 
has attracted increasing attention of analysts and they have shown great potential in the 
application of point of care clinical analysis via either in vivo or in vitro measurements54. 
 
One of the most important environmental applications of electrochemical biosensor 
chips is microorganism DNA detection55, 56. For example, the µ-TAS electrochemical 
biosensor chips, as well as common electrochemical biosensors, were used to detection 
of Cryptosporidium DNA57-59, a deadly waterborne pathogen. Differential pulse 
voltammetry (DPV) and electrochemical Impedance analysis (EIS) were commonly 
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used for electrochemical detection of the DNA. The DNA probe is firstly immobilized 
onto the working electrode, then target DNA binds with probe DNA. Finally, the 
capture DNA binds to target DNA and initializes the enzymatic reaction, which 
produces an electric signal.  
 
1.3.7 Cell vesicles and identification by Raman spectroscopy    
 
In recent years, extracellular vehicles (EVs) have become a subject of intense study. 
Most body cells release different types of vesicles in extracellular environment60, 61. 
The EVs can be divided into two groups: microvesicles (MVs) and exosomes in terms 
of their origin. Microvesicles are from plasma membrane with dimensions around 150-
300 nm, and exosomes are endocytic origin with dimensions 40-150 nm which are 
relatively smaller than MVs, EVs are enriched in lipids, proteins, nucleic acid that are 
specific of the cell of origin. The function of EVs is for intercellular communication. 
The number of vesicles released from cells and their composition change according to 
the physio-pathological condition of the tissue of origin, for this reason, they are studied 
as biomarkers for identify several diseases. Raman spectroscopy as a label-free, non-
destructive, sensitive and rapid method was carried out for characterization of EVs. 
This technique provides spectra that both qualitatively and quantitatively describe the 
chemical composition of EV samples. The EVs were normally isolated from cell culture 
by several steps of centrifugation and ultracentrifugation. The Raman spectra then 
collected from EVs samples deposit on the optical window. Principal component 
analysis (PCA) of Raman spectra can be used to discriminate vesicles from different 
cell cultures62, 63. 
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CHAPTER 2  
MICROFLUIDIC CHIP FOR NON-INVASIVE ANALYSIS 
OF TUMOR CELLS INTERACTION WITH ANTI-
CANCER DRUG DOXORUBICIN BY AFM AND RAMAN 
SEPCTROSCOPY 
 
Raman spectroscopy has been playing an increasingly significant role for cell 
classification. Here we introduce a novel microfluidic chip for non-invasive Raman cell 
natural fingerprint collection. The traditional Raman spectroscopy measurement of the 
cells grown in a PDMS-based microfluidic device suffers from the background noise 
from the substrate materials of PDMS when applied to an in vitro cell assay. To 
overcome this disadvantage, the current device is designed with a middle layer of 
PDMS layer sandwiched by two MgF2 slides which minimizes the PDMS background 
signal in Raman measurements. Three cancer cell lines, including human lung cancer 
cell A549, human breast cancer cell lines MDA-MB-231 and MDA-MB-231/BRMS1, 
were cultured in this microdevice separately for a period of three days to evaluate the 
biocompatibility of the microfluidic system. In addition, atomic force microscopy 
(AFM) was used to measure Young’s modulus and adhesion force of cancer cells at the 
single cell level. The AFM results indicated our microchannel environment seems not 
to alter cell biomechanical properties. The biochemical responses of cancer cells 
exposed to anti-cancer drug doxorubicin up to 24 h were assessed by Raman 
spectroscopy. Principal component analysis (PCA) over the Raman spectra indicated 
that untreated cancer cells or treated with DOX can be distinguished. This PDMS 
microfluidic device offers a non-invasive and reusable tool for in vitro Raman 
measurement of living cells and can be potentially applied for anti-cancer drug 
screening.  
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2.1 Introduction  
Over the last two decades, Raman spectroscopy, as a label-free technique, has become 
an increasingly powerful tool for cell characterization and classification1, 2. It is a label-
free and noninvasive technique and is also well suitable for monitoring live cell 
behavior2. It is, based on inelastic scattering, a spectroscopic technique that can identify 
chemical compositions by characteristic fingerprints in living cells3. Raman 
spectroscopy has been applied to the area of diagnostics, tissue engineering and 
toxicological testing4, and the toxicological research of pharmaceuticals on living cells 
in vitro5. It also has been applied for real-time measurement of biochemical alterations 
in living tumor cells treated with anticancer drugs6, 7. Besides, confocal Raman 
spectroscopy has been employed to trace the anticancer drug paclitaxel in living MCF-
7 cancer cells7. 
 
Microfluidic devices also referred to as “lab-on-a-chip (LOC)” has received much 
attention. The use of microfluidics to conduct biomedical and clinical research has a 
variety of advantages. Firstly, the fabrication of the microfluidic device is relatively low 
cost and very amenable to highly elaborate, multiplexed devices. Some designs may be 
mass produced. Secondly, microfluidic bioreactors are potentially advantageous for 
cellular applications as they provide a large surface-area-to-volume ratio, so a large 
number of cells can be produced by a low volume device8. Thirdly, it helps to save 
expensive reagents due to the small volume of the microfluidic device. Microfluidic 
devices have been applied to detect bacteria, viruses and cancers. Some other 
biochemical assays have been shift into a LOC format for analysis of samples such as 
whole blood, bacteria, cell suspensions or solutions9-14. 
 
Recently, the combination of microfluidic platform and Raman spectroscopy for 
biological application has been extensively reported for a variety of applications15-18. 
One of the major challenges for integrating microfluidic platform and Raman 
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spectroscopy for cell analysis is the high noise background spectrum throughout the 
entire spectral range, such as polydimethylsiloxane (PDMS) and glass19. In order to 
minimize the influence of such background noise, and also enhance the signals, 
Surface-Enhanced Raman Spectroscopy (SERS) is commonly implemented in 
combination with a traditional microfluidic platform20, 21. Surface Enhanced Raman 
Spectroscopy (SERS) is a surface-sensitive technique that enhances Raman scattering 
by molecules adsorbed on rough metal surfaces or by nanostructures.  
 
Microfluidics in combination with SERS has gained respect as an analytical technique 
with attractive chemical and biological applications. Several methods has been 
investigated to enhance the Raman signal in microfluidic device, such as 
immunoassay22,23, in-solution strategy24, 25, nanoparticles embedded inside microfluidic 
channel15, 24. Nevertheless, SERS technique must introduce external nanomaterials for 
Raman signal enhancement purpose, the enhanced Raman signals only provide 
selective structural information (typically from the Raman reporter molecules) and did 
not usually reflect the original signals from cells themselves26. In addition, metal 
cytotoxicity should be considered a potential problem when applying SERS nano-
particles in living cell culture27-29. Thus, it is necessary to develop new techniques and 
approaches with new materials and designs that are capable of tracking or monitoring 
of characteristic Raman spectra from the cells themselves. 
 
Selection of an appropriate substrate for Raman measurement is another option to 
minimize the background signal. Quartz has been reported as the substrate materials2, 
17 for device detection chamber in Raman measurement, which has been shown to 
reduce background signal from the substrate materials in the spectral range of 600-1800 
cm-1. However, several characteristic Raman peaks still can be observed in this range 
when quartz used as the substrate30.  
 
In this work, we demonstrate a novel and reusable MgF2-based microfluidic device that 
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realizes in-situ monitoring of single cells in response to the anticancer drug in a non-
invasive way. Compared with quartz, MgF2 offers a minimal background in cell 
fingerprint region without any distinct background noise peak. The performance of the 
proposed MgF2-based microfluidic measurement platform was tested by investigating 
anticancer drug interaction with three model cancer cell lines including human lung 
carcinoma cell (A549), human breast cancer cell MDA-MB-231 (231), and MDA-MB-
231 cells expressing breast metastatic suppressor gene 1 (231-B), which is a gene to 
prevent metastases from spreading in the body. Cells were long-term cultured in the 
device up to three days and a viability test was then conducted to evaluate the 
biocompatibility of microfluidic device system. Additionally, AFM and Raman 
spectroscopy were applied to examine the responses of A549, 231 and 231-B cells to 
DOX exposure (24 h) at the single cell level. 
 
2.2 Materials and Methods 
2.2.1 Fabrication of the PDMS microfluidic device integrated with MgF2 substrate 
To enable Raman measurements of single cells in microfluidic chips, magnesium 
fluoride (MgF2) optical window is used. The device is composed of three layers (Figure 
2.1a): top and bottom MgF2 slices; middle polydimethylsiloxane (PDMS) (Sylgard 184 
elastomer, Dow Corning, Midland, MI) chamber layers molded from custom-patterned 
materials (University of Utah, UT). The fabrication procedure was demonstrated in 
Figure 2.1b. Firstly, PDMS were mixed in 10:1 ratio, stirred vigorously for 5 min and 
then degassed for 30 min under dynamic vacuum to remove all air bubbles. A 200 µm 
layer PDMS is spun on to the 3-inch silicon wafer at the speed of 500 rpm31 and cured 
at 60°C for 30min. After cooling, the center area (2 cm×2 cm) of the thin film is 
removed by knife plotter. The master mold is placed onto the PDMS peel-off wafer area. 
A 25G needle (B-D®) is placed on the PDMS and connects the master mold (800 µm 
height and 1000 µm width in the center area) to define the inlet and outlet ports. Then 
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cleaned PDMS precursor is poured onto the master mold and heated at 60°C for 3 h. 
After cooling, the PDMS was peeled off the mold, the inlet and outlet needles were 
replaced by new ones, then placed between two flat MgF2 (1mm thickness) glass plates 
to provide a microfluidic channel. Finally, three layers were pressurized together by 
four clamps at four corners of the holder consisting of two aluminum frame chips 
(Central Valley Machine, Logan, Utah). Figure 2.1c is the device in use and Figure 2.1d 
is a 3D structure demonstration of the designed device. 
 
 
Figure 2.1 MgF2-based device architecture and fabrication. Cross-section view of the 
fabricated microfluidic device (a); Device fabrication procedure (b); Device currently 
in use (c); Microfluidic device 3D architecture (d).  
 
2.2.2 Cell preparation 
Human lung carcinoma A549 cells passage number 4 (ATCC, USA) were maintained 
in HyClone® DME/F-12k 1:1(1X) medium supplemented with 5% fetal bovine serum 
(Gibco® by Life Technologies UT) and 1% penicillin-streptomycin (Invitrogen™) at 
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incubator (37°C with 5% CO2). Cells were passaged at 80–90% confluence using 
trypsin-EDTA (Gibco® by Life Technologies). 
 
Human breast adenocarcinoma cell lines MDA-MB-231 and MDA-MB-231/BRMS1 
were cultured in HyClone® DME/F-12 1:1(1X) medium containing 10% fetal bovine 
serum (FBS)(Gibco® by Life Technologies UT) at incubator environment (37°C with 
5% CO2) Cells were passaged at 80–90% confluency and used for experiments. No 
antibiotics or antimycotics were used during cell culture. 
 
2.2.3 Device sterilization and cell seeding 
 
The device was assembled and sterilized by autoclaving for 20 min under 121°C, after 
sterilization, ethanol was flowed through the channels at 30 µL/min for 30 min, 
followed by a phosphate-buffered saline (PBS) wash. Finally, the device was coated by 
fetal bovine serum overnight at 4°C in fridge. The channels were tested for leakage by 
flowing food dye through the microchannels. Cells were trypsinized and fully 
suspended by vertex mixer (Corning LSE) before injection to microchannels. 1 ml 
syringe (B-D®) was used for cell injection to the microfluidic device. The seeding 
density for all cell types were 5000 cells/cm2  
2.2.4 Anticancer drug doxorubicin (DOX) treatment  
Doxorubicin (DOX) powder (Sigma-Aldrich, St Louis, MO) was dissolved in PBS and 
stored at 4°C as a stock solution (100 nM) within one day prior to use. For full 
attachment, A549, 231 and 231-B cells were incubated for 24 h and 48 h respectively 
after seeding, then DOX contained medium was injected by a syringe pump at a speed 
of 500 µL/min at a IC50 concentration of 71 nM for A549 cells, 49 nM for 231 cells and 
71 nM for 231-B cells respectively32. Drugs were washed away by normal medium after 
24 h incubation before the test. The cells were then ready for measurement. 
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2.2.5 Atomic force microscopy measurement 
In order to measure the mechanical properties of cells (cell elasticity and adhesion 
force), the devices were unclamped after culture. The bottom MgF2 glass substrate was 
removed from the device and placed into 10 cm (ID) culture dish (Cole-Parmer). The 
cells were tested in FBS buffer solution and the whole measurement was accomplished 
within 2 h to approximate physiological conditions.  
 
PicoPlus contact mode AFM from (Picoplus, Agilent Technologies, USA) controlled 
by Picoview 1.18 software was applied to measure cellular samples at room temperature 
(25°C). The tip on the cantilever is of thickness between 0.55 µm-0.65 µm, and a Si3N4 
tip curvature radius is 20 nm. The spring constant of the cantilever was at 0.03-0.12 
N/m (Bruker USA) and its corresponding deflection sensitivities were 45-50 nm/V.  
For biomechanical properties measurement, force-distance curves were determined by 
software Picoview 1.18 to calculate cellular Young’s modulus and adhesion force of 
each individual cells. For each cell line, 20 cells and 15 force curves on the central area 
of different cells to avoid spurious detections. The Scanning Probe Image Processor 
(SPIP) software 6.0.13 (Image Metrology, Denmark) was used to calculate cell Young’s 
modulus and adhesion force by fitting the Sneddon variation of Hertz model. Cellular 
Poisson's ratio was 0.5 and the half cone-opening angle of tip was 36˚. The equation 
2.133 listed below was used to calculate cell Young’s modulus. 
 
𝐸𝑐𝑒𝑙𝑙 =
4𝐹(∆𝑍)(1−𝜂𝑐𝑒𝑙𝑙
2)
3(∆𝑍1.5)𝑡𝑎𝑛𝜃
          Equation 2-1 
 
Where 𝐸𝑐𝑒𝑙𝑙: Young’s modulus; F: loading force; 𝜂𝑐𝑒𝑙𝑙: passion ratio; ∆𝑍: indentation; 
𝜃 tip half cone opening angle. 
2.2.6 Raman micro-spectroscopy and data acquisition 
The Renishaw inVia Raman spectrometer connected to a Leica microscope was used 
21 
 
 
for the cell spectra collection. A 785 nm near-IR laser was equipped for Raman 
spectrometer. Silicon wafer was used for calibration before data collection (adjusted to 
520.5±0.1 cm-1 for silicon peak).   
 
Samples of A549 and 231/231-B cells were cultured in the MgF2-based PDMS 
microfluidic device for 48 h and the Raman measurement was conducted for the cells 
in culture medium. The Raman spectra were collected from range 600 cm-1 to 1800 cm-
1. The exposure time was 10 seconds for 1 accumulation at 100% laser power for all the 
cell samples. Cosmic rays in raw spectra were removed using “zap” function in 
Renishaw Wire 3.4 software. MATLAB (R2016a) Principal Component Analysis (PCA) 
was applied to qualitatively distinguish the difference between control and treatment 
groups34, 35. 
 
Raman measurements for the cells with and without exposure to DOX is shown in 
Schematic 2.1. The first Raman spectra datasets were collected from both control and 
treatment groups 24 h after cell seeding.  After that, the treatment groups and control 
groups were refreshed with DOX media and normal media, respectively. And the 
second spectra datasets were collected from both control and treatment groups 24 h 
after the medium refreshment.  
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Schematic 2.1 The experimental procedure for Raman analysis of tumor cells 
interaction with DOX. 
2.2.7 Raman data analysis 
Software Renishaw Wire 3.4 was used to remove cosmic rays in raw spectra. Since 
Raman spectra are affected by the background noise and physical properties of the cell 
samples, Mathematical processes are necessary to apply in order to reduce systematic 
noise, and also enhance the resolution of chemical compositions from target cells. In 
this study, principal component analysis (PCA)36 was performed on the spectral dataset 
with the purpose of defining a new dimensional space in which the major variance in 
the original dataset can be captured and represented by only a few principal component 
(PC) variables and hence allow the most significant variables responsible for these 
differences to be identified. PCA methods were applied to extract useful information 
from raw dataset. Firstly, PCA was applied to examine the differences between the 
groups of untreated and treated of 231, 231B and A549 cell lines after the same length 
of culture time. Then, the differences between pre and post treatment (24 h after 
treatment) of the treated group were also compared by PCA. Therefore, we compared 
the datasets from different groups (treated and untreated) at the same time point (48 h 
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after seeding) and same group (treated group) at the different time point (pre-treatment 
and 24 h post-treatment). All algorithms were implemented in MATLAB R2017b 
(Mathworks Inc., Natick, USA). 
2.2.8 Cell culture in device and viability test 
To evaluate the biocompatibility of the microfluidic device, three types of tumor cells 
(A549, 231, 231-B) were cultured in MgF2-based device individually for a period of 3 
days. The cells were injected manually to three individual devices and cultured in an 
incubator under 5% CO2 37ºC environment. Medium was refreshed every 24 h. After 
3-day culture, a viability tests were conducted to verify the cell condition of 
proliferation. The live/death dye (Invitrogen™) was injected into the device at the 
injection speed of 500 μl/min by syringe pump, and incubation for 45 min before 
removal of the dye by PBS buffer. Fluorescence images were collected by an Olympus 
IX71 inverted fluorescence microscope equipped with an Olympus DP30BW CCD 
camera. Images were collection was operated using Olympus DP-BSW Controller and 
Manager Software. Phase or bright field images were acquired with a 10X Phase lens 
(Olympus),  
 
2.3 Results and Discussion 
2.3.1 Magnesium fluoride (MgF2) substrate caused Raman laser signal attenuation 
 
Magnesium fluoride (MgF2) is introduced as a substrate material for both microfluidic 
device fabrication and cancer cell culture. The in-device cancer cell culture assay had 
been discussed in this session. There are several reasons that we use MgF2 substrate 
rather than other materials in Raman measurement; 1) MgF2 has an extremely wide 
transmission Range. Windows and lenses made of this material can be used over the 
entire range of wavelengths from about 0.2μm (vacuum ultraviolet) to around 7.0μm 
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(infrared)37. 2) Magnesium fluoride does not produce an intense background noise 
signal in the cell fingerprint area (Fig 2.2, black curve). The Raman spectrum of MgF2 
is of low counts, flat and smooth. 3) MgF2 is biocompatible for cell culture and suitable 
for cell adhesion after protein coating. 
 
Although many advantages, MgF2 substrates for microfluidic device Raman detection 
also has its drawbacks. One main challenge is signal attenuation, MgF2 substrate would 
cause an optical light intensity attenuation and Raman laser power attenuation while 
light or laser travels through MgF2 optical window or substrate. During each individual 
Raman spectrum collection, the laser passes through the MgF2 optical windows four 
times in total (twice of each on both top and bottom MgF2 window). Although the 
transmittance of MgF2 is as high as over 90% in optical light range38, the counts of 
Raman spectrum still drops significantly after multiple attenuations.  
 
Figure 2.2 shows the average Raman spectrum of A549 cells detected when cells 
cultured on MgF2 substrate (red); cultured inside of the microfluidic device (green), as 
well as the PDMS substrate background peak (blue) and the background Raman 
spectrum of MgF2 substrate (black). According to the result illustrated in Figure 2.2a, 
the pure PDMS peaks are much stronger than cells Raman peaks, even at only 10% 
laser power, the counts of the highest peak of PDMS (710 cm-1) was 5701, however, 
the highest peak for cells culture in device and on MgF2 slice were 1204 (1650 cm-1) 
and 2122 (1002 cm-1) respectively, the intensities are much lower than PDMS peaks. 
Devices are made of pure PDMS rather than our method, the PDMS background peaks 
will overwhelm the cell peaks and no native cell peaks could be found at the final mixed 
Raman spectra. Figure 2.2b is the Raman spectra of A549 cells cultured in device and 
on MgF2 slice with MgF2 background spectra subtracted. For most peaks that cells were 
cultured inside MgF2 device, the absolute peak value decayed to approximately 30% to 
50% of the traditional dish culture value (cells cultured on MgF2 slice). Peaks such as 
1002 cm-1, 1450 cm-1 and 1650 cm-1 which represent Phenylalanine, C-C skeletal in 
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protein, CH2 deformation of proteins and lipid, and (C=C) Amide I respectively39, 
declined to approximately 38.2%, 33.5% and 52.7% intensity of the value collected in 
traditional dish culture.  
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Figure 2.2 The Raman spectra of the A549 cell cultured inside the microfluidic device 
(green); and cultured on the MgF2 substrate in a dish (red) with 100% laser power; as 
well as Raman spectrum of the MgF2 substrate at 100% laser power (black); and Raman 
spectrum of the PDMS substrate at 10% laser power (blue). All spectra collected under 
63X aqueous lens with 10 s exposure time and 100% laser power (a). The Raman 
spectra of A549 cells cultured inside the microfluidic device (red); and cultured on the 
MgF2 substrate in the dish (green), both subtracted with MgF2 substrate background 
spectra, several peak intensity differences are highlighted in cyan color (b).  
2.3.2 Long-term cancer cell culture in device and live cell imaging 
 
 
Figure 2.3 Cancer cells long-term cultured in device and viability test; graphs in each 
group were obtained on the same spot. 
Cells were cultured in device for three days, to evaluate the device biocompatibility. 
Figure 2.3 illustrates the results of cells cultured in device at the time points of seeding, 
24 h, 48 h, 72 h and after staining. It can be seen that 231 and 231-B cells both grown 
and reached to confluence on day 3, while A549 cells showed a relatively slower 
proliferation rate. For all three groups, only few dead cells observed, cells remained 
high viability ratio after 72h culture. 
231 
231-B 
A549 
0 h 24 h 48 h 72 h 72 h fluorescence 
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Malignant cancer cells typically display anchorage-independent growth patterns and 
cell rounding, and normal cells show large, flat morphology40. Comparing with the 231 
and 231-B results at time points of 24h, 48h and 72h, obviously, 231 cells took a longer 
time to attach onto the substrate, under the same conditions. Moreover, 231 (malignant 
cancer cell) apparently showed a higher proportion of round cells than 231-B (benign 
cancer cell) at culture time points of 24 h and 72 h. As one kind of malignant cancer 
cell, 231 is likely to have lower adhesion force/weak attachment than that of the 231-
B. This argument had been supported in previous AFM tumor cell research40. 
 
During the 3-day culture, all three types of cells proliferate at a certain growth rate. 
Both 231 and 231-B cells reached to confluence at day 3 with extremely high viability 
rate. Apparently, the results showed our device is biocompatible for a variety of cell 
types. 
 
2.3.3 AFM measurements of nanomechanical properties of cancer cells 
 
Recently biomechanics of cancer cells, in particular, stiffness or elasticity, has been 
identified as an important factor relating to cancer cell biological function, adherence, 
motility, transformation, and invasion. It also influences significantly on the 
biophysical properties in terms of cell elasticity and adhesion. 
 
In order to determine the biomechanical response of cells (231, 231-B and A549) to 
DOX exposure and also how microfluidic environment would affect the 
nanomechanical properties of the cells, we assessed the biomechanical properties 
including Young’s modulus (cell elasticity) and cell adhesion force of all cell lines. The 
cells were under two different conditions: (1) cells grew in fabricated microfluidic 
device for 48 h before the test with normal culture media only(control); (2) cells were 
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cultured in microfluidic device with normal media for the first 24 h and treated by media 
with DOX at the IC50 concentration of individual cell types for the second 24 h. Before 
measurement, devices were disassembled and the MgF2 substrates, where cells cultured 
on, were immersed in PBS buffer. 
 
 
Figure 2.4 Young’s modulus (a, b and c) and adhesion force (d, e and f) distributions 
of A549 cells (a,d), 231 (b,e) and 231-B(c,f) cells with and without DOX exposure. 
*“Ctrl” group is cultured with normal media for 48 h and “DOX” group is 24-hour 
cultured with normal media and 24-hour cultured with DOX media. 
 
Figure 2.4 illustrates Young’s modulus (a, b and c) and adhesion force (d, e and f) 
distributions of A549 cells, 231 and 231-B cells with and without DOX exposure. For 
both malignant cells, the distribution of Young’s moduli and adhesion force turned to 
wider and lower, which means the samples in the treatment group have a larger standard 
deviation. The results may indicate these cells stayed in various biological conditions 
after DOX treatment. It may because the resistance to DOX varies significantly between 
individual cells, while before treatment cells are more alike to each other. Compared 
with A549, the 231 cells had more alteration on its distribution of control and treatment 
groups. However, for benign cell line 231-B, the treatment group has a narrower 
a b c 
d e 
f 
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distribution. This result may also suggest the A549 cell line has higher resistance to 
DOX under 24-hour IC50. We also found that in the control group, 231 tumor cells are 
more than 50% softer than benign 231-B cells with a distribution over three times 
narrower than that of benign 231-B cells (Figure 2.5). While after 24-hour DOX 
treatment, the stiffness of 231 cells increased to like the same level as untreated 231-B 
cells (Figure 2.4). 
 
 
Figure 2.5 Young's modulus (a, b) and adhesion force (c, d) distributions of 231 and 
231-B cells with and without DOX exposure. 
 
(a) (b) 
(c) (d) 
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Figure 2.6 An example of topography imaging of A549 cell (a); Comparison of (b) 
Young’s modulus and (c) adhesion force of A549 cells 231 and 231-B groups and DOX 
(70 nM, 24 h) treated groups. Laser exposure time 10seconds and power 100%. Values 
represent mean ±SD (bar) of multiple cells.  *p < 0.05, **p < 0.01 
 
Figure 2.6a shows a typical topography image of A549 cancer cells. Figure 2.6b 
illustrates the histograms of the measured Young’s modulus for all three cancer cell 
lines. In the control group, the measured cell elasticity values (mean±SD) were 
13.375±5.994 KPa (n=321, A549 cells), 6.888±2.899 KPa (n=336, 231 cells) and 
15.372±8.166 KPa (n=366, 231-B cells), respectively; and in the DOX treatment group, 
such measured values for A549, 231 and 231-B were 16.242±6.310 KPa (n=323), 
14.556±8.590 KPa (n=331) and 11.134±3.874 KPa (n=367), respectively. The 
measured Young’s moduli showed a significant difference (P<0.01) not only between 
control and treatment groups but also between different cell types. The Young’s moduli 
of both A549 and 231 cells increased after DOX treatment, which was observed in our 
previous work conducted in culture dish35. Notably, Young’s modulus of the benign 
cancer cell line (231-B) decreased after 24-hour DOX treatment. Besides, the benign 
231-B showed larger Young’s modulus than malignant 231 cells, which is consistent 
with previous work41. 
 
Figure 2.6c gives the histograms of the measured adhesion force for all three cell lines. 
The average cell adhesion values (mean±SD) for control groups, for A549, 231 and 
231-B were 0.3032±0.1605 nN (n=321), 0.4467±0.2204 nN (n=331) and 
0.6047±0.3377 nN (n=366) respectively. In DOX-treated groups, the average cell 
10µm 
(a) (b) (c) 
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adhesion values (mean±SD) for A549, 231 and 231-B were 0.3290±0.2063, nN 
(n=321), 0.7647±0.5183 nN (n=336) and 0.4621±0.2327 nN (n=367) respectively. 
Although the average adhesion force of A549 DOX-treated group is slightly higher than 
control group, the values did not show distinct alteration (P=0.505), However, the 
adhesion force of 231 and 231-B cells follow the same trend of that of Young’s modulus.  
 
Results showed that, under the described experiment condition, DOX treatment would 
lead to the increase in Young’s modulus on both A549 and 231 cells (malignant cell), 
but decrease on the 231-B cell (benign cell). Meanwhile, DOX treatment would cause 
the increase of adhesion force on 231 cells and decrease on 231-B, nevertheless, it 
would not significantly affect cellular adhesion behavior for A549 cells. In summary, 
the in-device cultured cell AFM results have the same trend with previously published 
results tested by dish culture method35. The results also indicated the microfluidic 
environment did not affect the mechanical property of the cancer cells. 
 
2.3.4 Microfluidic Raman assay of cellular biochemical changes induced by 
chemotherapy 
Since Raman intensities are linearly related to the concentrations of specific molecular 
bonds of cellular bio-components, the changes in their characteristic peak intensities 
reflect the alterations of corresponding biochemical compositions of cells. Three cell 
models (A549, 231 and 231-B) have been introduced to evaluation the fabricated 
microfluidic device for cell discrimination. For each cell type, we seeded into two 
devices (one for the control group and the other for treatment group) separately, with a 
seeding density of around 100,000 cells/ml. The first group of spectra was collected 
from the treatment group after 24-hour culture before DOX treatment. The DOX 
containing media was then injected into the device. The DOX treatment time was 24 h 
and the DOX final concentration is the IC50 concentration of the individual cells32. After 
24 h of DOX exposure, the second group of data was collected (Schematic 2.1). For 
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both groups of all three cell lines, 10-15 cells were randomly chosen for spectra 
acquisition. At each location, three samples from each cell type were obtained (that 
means there were 30 ~ 45 spectra for each cell type).  
 
 
Figure 2.7 The mean Raman spectra comparison of the three types of cancer cells with 
and without DOX treatment. * “24hC” is 24-hour negative control culture; 
“24hC+24hT” means 24-hour negative control culture+24-hour DOX treatment 
culture. 
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Figure 2.8 PCA analysis of the three types of cancer cells with and without DOX 
treatment. *designation of “C”, “T” is referred to Figure 2.6 
Figure 2.7 shows the average Raman spectra of randomly selected A549, 231 and 231-
b cells cultured in the device with and without DOX treatment.  
 
Principal component analysis (PCA) was conducted over the raw Raman spectra on the 
range (600-1800 cm-1). Figure 2.8 depicts the PCA-scores plot of PC1 vs PC2 obtained 
from our analysis. It was clearly seen that PCA results can distinguish the spectral 
differences for all cell types before and after DOX treatment. In the PCA score plot, the 
first principal component was found to incorporate 85.12%, 97.50%, 68.78%, 
81.87%,74.35% and 83.99% of the total variance for subplot “top left”, “top middle”, 
“top right”, “lower left”, “lower middle” and “lower right” respectively, and the first 
and second principal components accounted for 89.39%, 78.49%,79.46%, 98.14%, 
87.03% and 85.69% of the total variance for subplots in the same order, respectively.  
 
The label “24hC” means the Raman spectra were acquired 24 h after control media 
34 
 
 
control in device. “24hC+24hT” represents the cells were cultured for 48-hour culture 
(24-hour control culture and 24-hour treatment culture). Data groups “24hC” and “24h 
C+24hT” are both collected in the same microfluidic device. “48hC” indicates the cells 
were control-cultured for 48 h, whereas, cells were cultured and measured using 
different microfluidic devices.  
 
In subplots (“lower left”, “top middle” and “lower right”), a more dispersive 
distribution of sample points was observed in treatment group compared with that of 
control group. The DOX resistance varies in individual cells, and an uneven effect of 
DOX on individual cells may explain the dispersive distribution on control group. 
Nevertheless, most cells aligned with in the same trend. Our device for Raman detection 
was functionally proven as a non-invasive platform for cell fingerprint collection and 
cell discrimination.  
 
 
2.4 Conclusion 
We introduced a novel microfluidic device that integrates Raman measurement and in 
situ single-cell analysis. The device consists of three layers with the middle PDMS flow 
layer sandwiched by top and bottom MgF2 optical window. This device has proven its 
usefulness in the detection of cancer cells interaction with the anti-cancer drug. The 
device is reusable and biocompatible for long-term cell culture (up to 72 h.). AFM and 
Raman spectroscopy were applied to detect the responses of cancer cells exposed to 
anticancer drug DOX up to 24 h at the single cell level. The AFM cell biomechanics 
results from these cancer cells cultured in this microfluidic devices agreed well with 
our previously published results that were obtained from the same type of cells cultured 
in traditional culture dishes, suggesting that the biomechanical properties (Young’s 
modulus and adhesion force) of the cells cultured in this microfluidic device were not 
affected, compared to the cells in traditional culture dish. PCA results clearly 
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distinguished the spectral differences before and after DOX treatment cross all three 
cancer cell types. Most importantly, this device realizes the monitoring of cancer cells-
drug interactions in a microfluidic device in a non-invasive way with the capability of 
measurements in different time points during the culturing and minimizes the cross 
contamination otherwise the dish culture method often occurs. Although this device 
dissipated the Raman signal a little, it still offers a new microfluidic-based cell assay 
platform for in situ Raman spectroscopy monitoring of cells/drug interaction, and this 
device could be expanded with multiple channels for the application of potential 
multiplex and high throughput detection of anticancer drug/cancer cell interaction. 
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CHAPTER 3  
USE OF SURFACE-ENHANCED RAMAN SCATTERING 
(SERS) PROBE TO DETECT FATTY ACID RECEPTOR 
ACTIVITY IN A MICROFLUIDIC DEVICE 
 
In this chapter, 4-mercaptobenzoic acid (MBA)-Au nanorods conjugated with GPR120 
antibody were developed as a highly sensitive SERS probe and were applied to detect 
the interaction of fatty acids (FA) and their cognate receptor, GPR120, on the surface 
of Human Embryonic Kidney cells (HEK293-GPRR120) cultured in a 
polydimethylsiloxane (PDMS) microfluidic device. Importantly, the two dominant 
characteristic SERS peaks of the Raman reporter molecule MBA, 1078 cm-1 and 1581 
cm-1, do not overlap with the main Raman peaks from PDMS substrate when the 
appropriate spectral scanning range is selected, which effectively avoided the 
interference from the PDMS background signals. The proposed microfluidic device 
consisted of two parts, i.e., the concentration gradient generator (CGG) and cell culture 
well array. The CGG part was fabricated to deliver five concentrations of FA 
simultaneously. A high aspect ratio well structure was designed to address the problem 
of HEK cells vulnerable to shear flow. The results showed a positive correlation 
between the SERS peak intensity and FA concentrations. This work for the first time 
achieved the simultaneous monitoring of the Raman spectra of cells and the responses 
of the receptor in the cells upon the addition of fatty acid. The development of this 
method also provides a platform for monitoring of cell membrane receptors on single-
cell analysis using SERS in a PDMS-based microfluidic device.   
 
3.1 Introduction 
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The epidemic of obesity in the Western world has been attributed to several factors 
including, but not limited to, an increase in sedentary lifestyle, socioeconomic factors, 
and perhaps most importantly overconsumption of nutrients.  Of these nutrients, 
ingestion of a high fat diet has been implicated as playing a particularly important role 
leading to the development of dietary-induced obesity1-3.  Recent data from a variety 
of laboratories have attempted to elucidate the mechanisms underlying the recognition 
of dietary fat by the body as a means to eventually try and target pharmacologically the 
control of fat intake.  Cognate receptors for dietary fat include a class of fatty acid-
sensitive G protein-coupled receptors4, 5.  The best described of these is the long chain 
polyunsaturated fatty acid receptor, GPR120, which mediates the taste (and 
postingestive) recognition of fat6.  Mice lacking GPR120 (GPR120 knockouts) show a 
much-reduced behavioral response to fat (fatty acids) in the form of a reduced 
preference for linoleic acid and oleic acid7, 8. The identification of GPR120 in taste cells 
within the oral cavity, coupled with the ability of taste cells to respond to ligands of this 
receptor, is consistent with these receptors mediating the taste of fat3.  Development of 
imaging capabilities to characterize the response and specificity of these receptors, their 
distribution, and the characterization of the effect of ligand binding will facilitate our 
understanding of the function of this important class of receptors.   
Raman spectroscopy has proven itself as a non-invasive and sensitive detection 
technique in past few decades. The Raman spectrum provides a molecular fingerprint 
that could be used to characterize specific molecules from complex samples. The 
frequency difference between incident and emitted photons are described as the Raman 
shift, which is unique for individual molecules and is represented as “cm-1” (inverse of 
photon wavelength). The peak intensity of the Raman shift is directly proportional to 
the concentration of the molecules of interest. However, only a small fraction of light 
(~ 1 in 106 photons) is scattered at optical frequencies usually lower than the frequency 
of the incident photons (termed the “Raman effect”). As a result, Raman scattering 
suffers from low signal intensity. This problem can be overcome by using the Surface 
Enhanced Raman spectroscopy (SERS)9, 10. SERS is a surface-sensitive technique that 
enhances Raman scattering by molecules adsorbed on a rough metal surface (Au, Ag 
nano-particles) or by nanostructures (plasmonic-magnetic silica nanotubes). The 
enhancement factor can be as much as 106 to 1014. Therefore, SERS has been 
established as a powerful tool that can provide insight into the chemical components 
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and biomaterials with high sensitivity. Many excellent reviews describing SERS and 
its principles are available11-13.  
Microfluidics is currently a highly active field, particularly in the context of lab-
on-a-chip (LOC) systems. The use of microfluidics to conduct biomedical and clinical 
research has a variety of advantages. It offers automation, miniaturization, high-
throughput, nanoliter scaled sample volumes, and large surface area-to-volume ratio14, 
15. Combining Raman with microfluidics allows for accurate monitoring, analysis, and 
detection of a wide range of samples in micro-environments. So far, microfluidic 
platforms integrated with SERS for biochemical analysis have been extensively 
reported16-24. One of the major challenges of combining microfluidics and Raman 
spectroscopy is the strong background from substrates. Materials such as PDMS, glass 
and poly(methyl methacrylate) (PMMA) are widely used for the fabrication of 
microfluidics because of their favorable optical properties and ease of bonding. 
However, they are Raman active polymers, which have their own Raman scattering 
signal. Many methods were recently reported to minimize background from these 
materials. Substrate materials with low Raman background such as MgF2
25, CaF2
26 and 
quartz27 were employed as substitutes. However, the cost of these materials is high, and 
the prototyping and bonding presents another technical challenge. Integrated laser 
fibers within microfluidics are also reported as an alternative method to avoid the 
background 28. Nevertheless, the scale of the application remains limited and the 
fabrication cost high. 
 
Here we developed a 3D microfluidic device for detection of fatty acid-induced 
GPR120 receptors using SERS. The device is comprised of two connected functional 
parts: the concentration gradient generator (CGG) and micro-well cell culture array. 
Compared with conventional dish culture methods, monitoring the cell response to fatty 
acids in our microfluidic device is high-throughput and low-cost. The CGG could 
deliver five different concentrations of FA simultaneously to 25 wells, eliminating 
adaptation problems associated with repeated, sequential stimulations on individual 
cells. In addition, the entire device was several cm in length and the volume of each 
microwell was 3.14 µL, and hence fabrication cost and reagent consumption were much 
less. The MBA SERS probe was introduced to avoid problems associated with the 
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PMDS substrate background. The SERS spectra were collected to analyze the HEK cell 
GPR120 receptor response to different concentrations of FA. This method for the first 
time realizes the capability of simultaneous measurement of the representative native 
cell peaks and the time-dependent fatty acid interaction with its specific receptor in a 
microfluidic environment and also provides a platform for biochemical measurement 
using SERS in a PDMS-based device. 
3.2 Materials and Methods 
3.2.1 Materials 
4-Mercaptobenzoic acid (MBA), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC), N-hydroxysuccinimide (NHS), doxycycline hydrochloride 
(DOX), were purchased from Sigma-Aldrich (St Louis, MO). Blasticidin S HCl, 
hygromycin B, phosphate-buffered saline (PBS) and 0.5% trypsin–EDTA were 
purchased from Life Technologies (Carlsbad, CA). Polyethylene glycol (PEG) products, 
thiol PEG acid (HS–PEG–COOH, MW 5000) and methoxyl PEG-thiol (mPEG–SH, 
MW 5000), were purchased from Nanocs Inc. (USA). The monoclonal GPR120 
antibody was purchased from Santa Cruz Biotechnology Inc. (sc-99105). Fatty acid 
(linoleic acid, LA) was offered by Gilbertson laboratory, Department of Biology, Utah 
State University. Ultrapure water (18 MΩ cm−1) was used in this work. 
3.2.2 Device fabrication 
The fabrication steps for both parts are illustrated in Figure 3.1a and 3.1b. The 
concentration gradient generator was fabricated with photolithography. The channel 
height and width were designed to 50 µm and 200 µm respectively. SU-8 2025 negative 
photoresist (Microchem®) was spin coated on a 3-inch diameter silicon wafer at speed 
of 1800 rpm. The soft bake time was 3 min at 65°C and 10 min at 95°C. A transparency 
mask was printed at CAD/Art Services, Inc (Oregon, USA) for UV exposure. The post 
exposure bake time was 2 min at 65°C and 7 min at 95°C. PDMS soft lithography was 
applied to obtain the final device. PDMS was mixed in a 10:1 ratio, stirred vigorously 
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for 5 min and then degassed for 30 min under dynamic vacuum to remove all air bubbles 
and cured at 60°C for 2 h. The micro-well array part was replicated from a 3D printed 
master mold. The 3D master mold was fabricated using high-resolution acrylonitrile 
butadiene styrene (ABS), and a stereolithography (SLA) technique by 3D SYSTEM 
Inc. (CA, USA). The total channel height was 1200 µm (top flow channel 200 µm + 
bottom well 1000 µm) and the width was 1000 µm. Finally, the replicated PDMS layers 
were sealed by oxygen plasma etching at 50 W, for 30 seconds. The experimental setup 
for detection of GPR120 by SERS is shown in Figure 3.1c. 
 
 
Figure 3.1 Fabrication steps of the microfluidic device and the experimental 
measurement setup. (a) CGG part fabrication procedure. (b) Micro-well array part 
(a) (b) 
(c) 
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fabrication procedure. (c) Schematic of the experimental setup detection GPR120 
receptors using SERS. 
3.2.3 Device sterilization and cell seeding 
The cell culture well array was assembled and sterilized by autoclaving for 20 min 
under 121°C, after sterilization, ethanol was flowed through the channels at 30 μL/min 
for 30 min, followed by a PBS wash. The channels were tested for leakage by flowing 
food dye through the microchannels. Finally, the device was coated with fetal bovine 
serum overnight at 4°C in fridge. Cells were trypsinized and fully suspended by vertex 
mixer (Corning LSE) before injection to microchannels. 1 ml syringe (B-D®) was used 
for cell injection to the microfluidic device. The seeding density for all cell types were 
5000 cells/cm2 
3.2.4 Cell preparation  
Human embryonic kidney cells (HEK293) were kindly provided by International 
Flavors & Fragrances Inc. (IFF). HEK293 cell lines transfected with an inducible 
GPR120 gene (HEK293-GPR120) were used in this context. Cells were grown in 
DMEM-GlutaMAX media (Life Technologies, 10569-010) supplemented with 10% 
Tet-free fetal bovine serum (Fisher, NC0290780). Cells were cultured in a humidified 
atmosphere at 37°C with 5% CO2 and were passaged at over 75% confluence. 
Blasticidin S HCl (10 μg mL-1) and hygromycin B (100 μg mL-1) were added to cell 
culture medium specifically for maintenance of inducible GPR120 gene.  
3.2.5 Cell culture in device and fatty acid treatment 
To evaluate the biocompatibility of the microfluidic device, HEK293-GPR120 cells 
were cultured in the PDMS device for a period of 2 days. The cells were injected 
manually to microwell array culture chamber and the entire device was placed in an 
incubator after seeding in a 5% CO2, 37ºC environment. To induce expression of 
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GPR120, culture media with DOX at 0.5 μg mL−1 was used in the device for 48 h. The 
medium was refreshed every 24 h. Cell images were collected after the medium was 
replaced. After the 48-hour incubation in the device, the CGG part of the device was 
connected to well array part by tubing, the linoleic acid, and PBS buffer (1x) solution 
was injected into CGG part through two inlets using syringe pump at speed of 50 µl/min 
for 5 min. After another 5 min treatment, the antibody-conjugated gold nanorods 
(AuNRs, SERS probe) in the culture medium were injected to wash out the previous 
solution and kept in an incubator overnight to ensure the completion of GPR120 
antibody and receptor binding.     
 
3.2.6 Synthesis of SERS probe 
 
 
 
Figure 3.2 Schematic of MBA-AuNR-antibody preparation steps 
The steps for MBA-AuNR-antibody preparation are illustrated in Figure 3.2. First, 1 
mL of gold nanorod (AuNR) (Nanopartz Inc., USA) solution was mixed with MBA 
solution (1 mM, 10 μL) and incubated for 30 min. Solutions of HS–PEG–COOH (1 mg 
mL−1, 10 μL) and mPEG–SH (1 mg mL−1, 40 μL) were sequentially added to the 
nanorod solution and incubated for 2 h. Then, the resultant solution was centrifuged 
(12,000 g, 15 min) to remove excess PEG and MBA. Particles were re-suspended in 
water. Freshly prepared EDC (10 mM, 10 μL) and NHS (25 mM, 10 μL) solutions were 
mixed with the nanorod solution and allowed to react for 30 min. The resulting solution 
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was centrifuged, and particles were re-suspended in PBS. At last, the anti-GPR120 
antibody (0.2 mg mL−1, 10 μL) was added to the nanorod solution and incubated for 1 
h. Excess antibody was removed by centrifugation. Nanorods were re-suspended in 
PBS. The functionalized nanoprobe (MBA-AuNR-antibody) was stable in solution for 
several days at 4°C. 
3.2.7 Raman spectroscopy measurement 
Raman spectra were measured using a Renishaw inVia Raman spectrometer, equipped 
with a 785 nm near-IR laser, which was focused through a 50× long working distance 
lens (Leica Microsystems). The absolute value of the laser intensity was 110 mW 
(measured with LaserCheck, Coherent Inc, Oregon, USA) and the grating used was 
1200 l/mm. A silicon wafer was used for calibration before data collection (adjusted to 
520.5±0.1 cm-1 for silicon peak). HEK 293 cells were cultured in the PDMS 
microfluidic device for 48 h and the Raman measurement was conducted for the cells 
in PBS buffer. The Raman spectra were collected over the range of 950 cm-1 to 1150 
cm-1. The exposure time was 10 seconds for 1 accumulation at 100% laser power for 
all the cell samples. The system spectral resolution was 1 cm-1. Cosmic rays in raw 
spectra were removed using “zap” function in Renishaw WIRE 3.4 software. 
3.3 Results and Discussion 
3.3.1 High aspect ratio well structure evaluation 
Since the poor adhesion ability of HEK 293 cell line, the cells were easily detached 
under shear flow in the microfluidic environment. To address this issue, the high aspect 
ratio micro-well structure was 3D printed and replicated by PDMS molding. Cells 
proliferation in the deep wells could prevent the detachment of cells during media 
refreshment and fatty acid injection. The dimensions of the well unit are illustrated in 
Figure 3.3a and 3.3b. The flow rate profile within the channel and microwell was 
simulated with COMSOL Multiphysics 5.2a (COMSOL Inc., Palo Alto, USA). Three 
assumptions were made to mimic the actual flow situation, including (1) the fluid is 
Newtonian, (2) no-slip boundary condition, (3) the flow within the channel is 
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incompressible. The 3D model was initially created in AutoCAD 2016 (Autodesk Inc., 
USA) and then imported into COMSOL library. The simulation was performed using 
physical interfaces laminar flow (spf) under the stationary study model. The inlet 
velocity flow was set to 40 nl/min. The simulation results are illustrated in Figure 3.3c. 
The flow speed reduced by 30.16 times from 1.93 mm/sec to 0.064 mm/sec (Selected 
data collection points were 10µm above PDMS surface at cross-section plane A and B). 
 
 
 
 
Figure 3.3 (a) Fabricated single well working unit; (b) AutoCAD 3D model of well unit; 
(c) COMSOL simulation of the flow rate distribution of the well unit. (Data were 
collected at cross-section plane A and B 10 µm above boundary)  
3.3.2 Evaluation of CGG 
The two fabricated parts and combined devices are illustrated in Figure 3.4. The blue 
color food dye was injected into the CGG part by a syringe pump at speed of 200 µl/min 
100 µl/min and 50 µl/min for 5 min. The gradient output streams were collected with 
beakers and evaluated by spectrophotometry. The result is summarized in Figure 3.5 
and Table 3.1. The color intensities of output streams were close to the corresponding 
2mm 
1mm 
(a) 
(b) 
(c) 
A B 
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standard solutions. The flow rate at 50 µl/min showed the more accurate concentration 
distribution. The errors could be caused by many factors, such as uneven thickness of 
the photoresist on the fabricated master mold, trapped bubble in syringe, needle or 
device during the pumping, imperfect of hole punching for needle connection, and 
deviation of tubing length. Based on the spectrophotometric results, flow rate of 50 
µl/min was chosen to generate the fatty acid concentration gradient for treatment. 
 
 
Figure 3.4 Current microfluidic device setup for GPR120 receptor detection, (a) two 
parts connected by tubing, (b) concentration gradient generator at flow rate 50 µl/min, 
(c) HEK 293-GPR120 cell cultured in well array.  
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15µM 
0µM 
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(a) 
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Figure 3.5 The concentrations gradient distribution using food dye with different 
injection flow rates (200 µl/min, 100 µl/min and 50 µl/min). The “Standard” stand for 
food dye prepared to target concentration.    
Table 3-1 The relative percentage of output streams with different flow rates (n=3) 
 
3.3.2 Cell culture in device 
To evaluate the device biocompatibility, HEK 293 cells were placed in culture and 
induced by DOX in the device for two days before the LA treatment. Figure 3.6 presents 
the results of cells cultured in the microfluidic device at the time points of seeding, 24 
h and 48 h under 5× and 10× magnification. It can be seen that HEK 293-GPR120 cells 
Expected 
percentage 
Standard 200µl/min 100µl/min 50 µl/min 
0 -1.04±1.23 -1.48±1.89 -1.35±1.76 -1.71±1.95 
25 24.56±1.10 21.17±0.86 21.85±0.82 24.72±0.80 
50 52.56±1.10 52.79±0.47 51.17±0.54 51.62±0.38 
75 75.76±1.23 80.59±1.02 80.32±2.17 74.23±2.98 
100 98.56±0.95 97.16±1.08 97.79±0.77 98.06±0.35 
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grown and reached approximately 70% confluence on day 3. In addition, almost all 
cells attached to substrate (Figure 3.6, 5× and 10×, 48 h), relatively few suspended cells 
were observed. The results indicated that our device addressed the cell detachment issue 
and was biocompatible for HEK293 cells. 
 
Figure 3.6 HEK 293-GPR120 cells long-term cultured in well array for 48 h. Scale 
bars: 500 µm for 5 pictures, 200 µm for 10 pictures.  
3.3.3 SERS measurement 
Our previous research29 is consistent with the interpretation that FA treatment will 
increase the number of functional GRP120 receptors expressed on the cell surface and 
hence would be expected to increase the MBA SERS signal upon the binding between 
anti-GPR120 antibody conjugated on nanorods and its antigen GPR120 on the cell 
surface. While the mechanism for this increased signal has not been elucidated, the 
binding of FAs to the receptor may induce a conformational change that facilitates 
subsequent binding of the SERS probe or FAs themselves may facilitate the functional 
expression of previously quiescent receptors in the membrane. SERS has proven to 
have the ability to detect the conformation change of DNA and protein receptors by 
several groups30-33. 
The main challenge of combining PDMS microfluidics and Raman spectroscopy 
is the strong background from PDMS (Black curve, in Figure 3.7). Two dominant MBA 
specific peaks are presented at 1078 cm-1 and 1582 cm-1 (Red curve, in Figure 3.7), 
500µm 500µm 500µm 
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which do not overlap with the PDMS background signal (Cyan color highlighted zone 
in Figure 3.7). This is the major reason that the MBA was chosen as a Raman reporter 
molecule for SERS probe construction in this work. Moreover, based on Figure 3.7, the 
counts of the PMDS baseline ranged from 2000-13000 even in the area without visible 
peaks. HEK cell peaks with low counts would be hard to detect accurately in areas 
overlapping with the strong baseline. The HEK cell peaks with relatively high counts 
are marked in Figure 3.8. Peak 621 cm-1 and 1259 cm-1 are assigned to C-C twisting 
mode of phenylalanine and Amide III respectively, both are protein bands. 787 cm-1 is 
a DNA peak, it can be taken as a measure for the relative quantity of nucleic acids 
present. 1301 cm-1 and 1447 cm-1 are assigned for lipid and CH2 bending mode of 
proteins & lipids, respectively34. The peak at 1002 cm-1 represents phenylalanine. In 
most cases, the peak at 1002 cm-1 is the highest peak in a cell spectrum and shows no 
overlap with any other peaks. In order to increase the signal-to-noise ratio, 1002 cm-1 
was selected to represent a native cell peak as a comparison with the MBA peak (1078 
cm-1). In addition, as shown in Figure 3.8, the other MBA SERS peak at 1582 cm-1 was 
much weaker and overlaps with the two strong peaks Amide II (1557 cm-1) and Amide 
I (1656 cm-1) from the cells, which made it impossible to be accurately analyzed 
independently. Statistically, comparing with the control group (normal culture), the 
average counts from treatment group (treated with 60 µm linoleic acid followed by 
incubation with MBA-AuNRs-antibody) were increased from 780 (SD=204) to 2872 
(SD=2914) for 1078 cm-1, and 1202 (SD=184) to 2183 (SD=1356) for peak 1582 cm-1, 
respectively. Apparently, a larger peak increment was observed at 1078 cm-1. Taken 
together, in this study, Raman spectra were collected from a range of 950 cm-1 to 1150 
cm-1. This selected scanning range brings up with the opportunity to monitor the 
responses from native cell peak (1002 cm-1) and the SERS peak (1078 cm-1) from SERS 
probe conjugated with specific antibody to receptor GRP120. By monitoring these peak 
changes (primarily intensity changes), the influence of fatty acids on the cell itself and 
the interaction between fatty acid and its receptor GPR120 could be detected 
simultaneously in the selected scan range. 
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Figure 3.7 Raman spectra comparison, native HEK293 cell and PDMS with/without 
the presence of MBA-AuNRs-Antibody SERS probe. The spectral ranges with MBA 
peaks and without PDMS peaks are highlighted with cyan color. 
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Figure 3.8 Representative Raman spectra of HEK293-GPR120 cell culture on MgF2 
slice. Normal culture (Blue) and cultured with MBA-AuNRs-Antibody (treated with 
60 µm linoleic acid) (Red). The spectra range 950 ~ 1150 cm-1 was selected for our 
SERS measurement. Black and red shaded area are the standard deviations to the 
curve of corresponding colors (n=10). 
The last step in this approach was to examine the cell response to different 
concentrations of linoleic acid (LA) introduced to a cell culture device (Figure 3.9a). 
HEK293-GPR120 cells were seeded and induced by DOX for 48 h. Different fatty acid 
concentrations were applied to different channels of microfluidic wells (0 µM, 15 µM, 
30 µM, 45 µM, and 60 µM), the treatment time was 5 min and unbound LA was washed 
off by injection of media. After injection of MBA-AuNRs-antibody SERS probes, the 
device was put back to the incubator for 12 h before SERS measurement. Stability and 
reproducibility of the MBA SERS signal were evaluated before the SERS cell assay. 
The MBA-AuNRs were pipetted onto an MgF2 slice and let dry for 30 min. The SERS 
peaks at 1078 cm-1 were collected from 8 different spots (5 replications at each spot) 
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using a long working distance objective (50×). The result is shown in Figure 3.10, the 
counts of parallel tests from the same spot were close to each other (Figure 3.10a). 
However, large variation of counts was also observed at different collection spots 
(Figure 3.10b). The reason for different peak heights in Figure 3.10b is because that the 
SERS measurement is highly sensitive to the local environment that the incident laser 
interacts with (e.g., nanoparticle intensity, incident laser angles, and so on11-13).  
SERS measurement of the cells in response to different concentrations of LA is given 
in Figure 3.9b. Thirty-five spectra were collected from each treatment group; each 
spectrum was collected from different individual cell. Seven cells are randomly selected 
from each well (5 wells for each concentration). The baseline was removed using built-
in functions of WIRE3.4 software. The arithmetic mean value of the counts from all 
samples was used to evaluate the correlation of the MBA peak to the LA treatment 
concentration. It was found that the SERS peak intensity (at 1078 cm-1) was positively 
correlated to LA concentration, validating our previous observation that was conducted 
in culture dish29; while the heights of two peaks at 988 cm-1 and 1002 cm-1 appear 
independent of LA concentration (Figure 3.9c). The 1078 cm-1 average peak counts 
were 1549.39, 1784.20, 2035.73, 2232.12 and 3207.53 for LA treatment concentration 
0 µM, 15 µM, 30 µM, 45 µM and 60 µM, respectively. SERS intensities at 1078 cm-1 
vs. LA concentration are plotted in Figure 3.9c. A linear (R2 = 0.931) increase in 1078 
cm-1 intensity was observed with increased LA concentrations. These results also 
demonstrated the potential use of SERS to study the dynamic process of biomolecules 
in single living cells. The relative standard deviations (RSD) of sample spectra counts 
for different LA treatment groups: 0 µM, 15 µM, 30 µM, 45 µM and 60 µM, were 
15.9% 22.0% 16.9% 23.7% and 29.4% for peak 1002 cm-1 and 31.1% 40.9% 42.5% 
33.3% and 70.8% for peak 1078 cm-1. This large RSD at peak 1078 cm-1 could be 
caused by the dispersive counts distribution of the spectra collected from cell surface 
(Figure 3.9d). Notably, in the 60 µM group (Figure 3.9d), two apparent populations are 
clearly visible. It is unclear why this happened. This phenomenon could be accounted 
for in a couple of ways: the cell-to-cell variation of the in response to high 
concentrations of FA (e.g., 60 µM); or some cells expressing more GPR120 receptors 
would have a greater likelihood of being bound with anti-GPR120 SERS probes, 
leading higher counts of signal. One-way ANOVA was conducted with the confidence 
level 95% (Figure 3.11), the Raman counts of 60 µM vs 45 µM, 60 µM vs 30 µM, 60 
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µM vs 15 µM, 60 µM vs 0 µM, and 45 µM vs 0 µM were found to be significantly 
different. However, the groups, 45 µM vs 30 µM, 45 µM vs 15 µM, 30 µM vs 15 µM, 
30 µM vs 0 µM and 15 µM vs 0 µM were not significantly different. The results of non-
significant differences can be caused by the close mean value of the paired groups and 
relatively large RSD due to the non-uniform dispersive counts distribution. The 
ANOVA results also suggested the cell responses were not strong enough to distinguish 
the corresponding concentration range (0-45 µM) of LA treatments with the increment 
of 15 µM, especially, under a large RSD. The counts distribution for each sample from 
different treatment groups are demonstrated in Figure 3.9d. The sampling locations on 
cell surface were randomly selected during the SERS data collection. Although there 
was a trend that higher LA concentrations lead to higher SERS responses, the variation 
of the SERS peak intensity for the same LA treatment concentration can be appreciable 
due to the cell’s non-uniform response to LA. For example, several high counts (7000-
9000) were observed at the channel treated with 60 µM LA, on the other hand, several 
samples in each group had extremely low or even no detectable response to the 
treatment. The possible reasons could be (1) some cells were resistant to the LA 
treatment, and low or no SERS signal would be detected while focusing on anywhere 
on these cell surface. (2) Not all the GPR120 receptors on the HEK-GPR120 cells were 
activated by LA treatment, thus the active zone may be only on certain sub-regions of 
the cell surface. 
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Figure 3.9 SERS measurement setup and results (a) SERS measurement of HEK293-
GPR120 cells cultured in the microfluidic device. (b) Mean Raman spectra of HEK293-
GPR120 cells treated with different concentrations of linoleic acid (n=30-35). (c) Mean 
counts and standard deviation of HEK 293 cell Raman spectra at peak 988 cm-1, 1002 
cm-1 and 1078 cm-1 treated with different LA concentrations. Inset: relationship 
between SERS intensities at 1078 cm-1 peak and LA treatment concentration. (d) 
Counts distribution of samples with different LA treatment concentrations.  
(a) (b) 
(c) (d) 
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Figure 3.10 Stability and reproducibility of the MBA SERS, (a) MBA Spectra near 
1078 cm-1 were collected for 5 times in a raw from same spot on MgF2 substrate, (b) 
MBA Spectra near 1078 cm-1 were collected from different spots on the MgF2 slice 
(Mean values of 5 replications). 
Our results are consistent with the interpretation that the fatty acids alone do not alter 
the surface structure of the cells as noted from a lack of effect on the cell-related peaks. 
Instead, the fatty acid, as expected, appears to preferentially bind with the GPR120 
receptor. It is clear that it was possible using this approach to monitor the interaction 
between the fatty acid and its cognate receptor by assessing the SERS peak from the 
anti-GPR120 antibody conjugated SERS probe. Prior to addition of the SERS probe, 
the fatty acid binds a specific, though presently undetermined, region of the GPR120 
receptor. Anti-GPR120 antibody (which is conjugated on SERS nanoparticle surface) 
recognizes the extracellular recognition site of the GRP120 receptor. The addition of 
SERS probe and the subsequent antibody-antigen binding would lead to the 
conformation changes of fatty acid or GPR120 receptor or their complex, which, in 
(a) (b) 
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return, alters the local environment of the exposed SERS probe. The local 
environmental changes would give rise to the SERS peak changes. Simply, the more 
fatty acid molecules added, the more GPR120 receptors would be bound, thus more 
SERS probes would recognize GPR120 receptors. Thus, this would be reflected in 
higher SERS peaks. More experiments are needed in order to elucidate the specific 
mechanism of interaction. Importantly, these series of experiments represent the first 
successful simultaneously monitoring of Raman spectra of cells (1002 cm-1) and the 
receptor-fatty acid interaction (1078 cm-1) in cells using a fabricated microfluidic 
device. 
Next, it would be important to develop the ability to map the distribution of the GPR120 
receptors on HEK 293 cell surface, which would also facilitate the understanding of 
fatty acid-receptor interaction. Thus, Raman spectral mapping was employed for 
visualization of the GPR120 receptor distribution on single HEK293 cell surface 
(Figure 3.11). The mapping was conducted using HEK293-GRP120 cells cultured on 
MgF2, induced by DOX for 48 h, followed by addition of 60 µM LA for 5 min before 
incubated with SERS probe for 12 h. The blue color intensity was proportional to the 
SERS signal at 1078 cm-1 from MBA reporter molecules. Three spots (a, b and c) in 
Figure 3.11(c) were randomly selected to show the spectra at these locations. It was 
found that no SERS signal was detected at the area without cells attached (spot-c), the 
stronger color intensity (spot-a) exhibits the higher color SERS peaks (spot-b). 
Moreover, not all cells had SERS signal. These mapping results were agreed with the 
observation from Figure 3.9d (at the LA concentration of 60 µM, SERS counts varied 
between cells by cells). 
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Figure 3.11 One-way ANOVA analysis of the counts at MBA peak 1078 cm-1 with 
different LA treatment concentration, 95% confidence level (n=30-35). 
Raman spectral mapping was employed for visualization of the GPR120 receptor 
distribution on the single HEK293 cell surface (Figure 3.12). The mapping was 
conducted using HEK293-GRP120 cells cultured on MgF2, induced by DOX for 48 h, 
followed by addition of 60 µM LA for 5 min before being incubated with SERS probe 
for 12 h. The blue color intensity was proportional to the SERS signal at 1078 cm-1 
from MBA reporter molecules. Three spots (a, b and c) in Figure 3.12(c) were randomly 
selected to show the spectra at these locations. It was found that no SERS signal was 
detected at the area without cells attached (spot-c), the stronger color intensity (spot-a) 
exhibits the higher color SERS peaks (spot-b). These mapping results demonstrate that 
MBA SERS probes bound on the surface of most cells, however, the distribution of 
bound receptors was not uniform over the entire cell surface. If a spectrum sample 
collected from cell area with no bound SERS probe, no detectable SERS signal would 
be seen. If the laser spot partially covered the activated area during the spectra 
collection, the signal can be extremely low. This diverse signal variation may explain 
the observation in Figure 3.12d.  
The spectra comparison between the signals (950-1150 cm-1) acquired in RDMS 
microfluidic wells and in conventional dish culture on MgF2 slices is illustrated in 
-500 0 500 1000 1500 2000 2500
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Figure 3.13. PDMS substrate would cause a Raman laser power attenuation while laser 
travels through the top PDMS layer. The average counts of peak 1002 cm-1 and 1078 
cm-1 declined to approximately 45.9% and 56.8%, compared to those obtained from the 
cells cultured on MgF2 slice. However, the signal attenuation in device was acceptable 
(due to two well defined MBA SERS peaks), the intensity detected from PDMS device 
were still adequate for analysis. 
Our results are consistent with the interpretation that the fatty acids alone do not alter 
the surface structure of the cells as noted from a lack of effect on the cell-related peaks. 
Instead, the fatty acid, as expected, appears to preferentially bind with the GPR120 
receptor. It is clear that it was possible using this approach to monitor the interaction 
between the fatty acid and its cognate receptor by assessing the SERS peak from the 
anti-GPR120 antibody conjugated SERS probe. Prior to the addition of the SERS probe, 
the fatty acid binds a specific, though presently undetermined, region of the GPR120 
receptor. Anti-GPR120 antibody (which is conjugated on SERS nanorods surface) 
recognizes the extracellular epitope of the GRP120 receptor. The addition of the SERS 
probe and the subsequent antibody-antigen binding would lead to the conformation 
changes of fatty acid and/or GPR120 receptor or their complex, which, in return, alters 
the local environment of the exposed SERS probe. The local environmental changes 
would give rise to the SERS peak changes. Simply, the more fatty acid molecules 
added, the more GPR120 receptors would be bound, thus more SERS probes would 
recognize GPR120 receptors. Thus, this would be reflected in higher SERS peaks. More 
experiments are needed in order to elucidate the specific mechanism of interaction. 
Importantly, these series of experiments represent the first successful simultaneously 
monitoring of Raman spectra of cells (1002 cm-1) and the receptor-fatty acid interaction 
(1078 cm-1) in cells using a fabricated microfluidic device. 
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Figure 3.12 Raman mapping of the HEK293-GPR120 cells at the native cell peak 1002 
cm-1 and the SERS peak 1078 cm-1. The framed areas were selected for mapping of 
both 1002 cm-1 (a) and 1078 cm-1 (b) peaks. Combination (c) of the spectral images at 
1002 cm−1 (a) and 1078 cm−1 (b). The red (a) and blue (b) color intensities were 
positively correlated to the peak counts. Spectra from spot a, b and c (d). Scale bar: 10 
µm. The mapping spectrum scanning range was from 920 cm-1 to 1285 cm-1, 100% 
laser power, and 10 second exposure time. LA concentration: 60 µM. 
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Figure 3.13 Comparison of the peaks at 1002 cm-1 and 1078 cm-1 from HEK 293 cells 
cultured in dish (red) and in microfluidic device (black) at the FA treatment 
concentration of 60 µM. The shaded areas are the standard deviations (n=35 for device 
testing and n=25 for dish testing).  
 
3.4 Conclusion 
In this study, a PDMS integrating a concentration gradient generator (CGG) with the 
capability of delivering five concentrations of LA at a time and micro-well array cell 
culture chamber was fabricated and tested in detection of the presence of GRP120 
receptors and its interaction with fatty acid. The concentration generated in each CGG 
channel in the microfluidic device was evaluated by spectrophotometry with food dye. 
3D printed master mold was used for the fabrication of high aspect ratio micro-well cell 
950 1000 1050 1100 1150
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
C
o
u
n
ts
Raman Shift (cm-1)
 In device
 In dish
1002
1078
62 
 
 
culture array, to minimize the problem of HEK293 cell detachment under flow shear. 
The cell was cultured and induced in the device by DOX for 48 h before Raman 
measurement. MBA-AuNR-GPR120-antibody-based SERS probe was constructed and 
employed to detect the GPR120 expression on single HEK293 cell surface and the 
SERS probe also effectively avoid the interference from PDMS background signal, 
when appropriate spectral scanning range is selected. This microfluidic device for the 
first time achieves simultaneous measurement of the representative Raman peaks from 
cells and the fatty acid interaction with specific receptor. Using this device and SERS 
probe, we evaluated the dependence of the characteristic SERS peak height on the 
concentration of fatty acid (LA). It was found that the SERS peak intensities were 
positively correlated to LA treatment concentrations. The receptor distribution on the 
single cell level was also visualized by Raman mapping and the results showed that not 
all HEK293-GPR120 cells were responsive and expressed more functional GPR120 
receptors on the cell surface after LA treatment. 
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CHAPTER 4  
DEVELOPMENT OF MICROFABRICARED 
ELECTROCHEMICAL SENSING DEVICE FOR 
AQUEOUS IONS AND DNA DETECTION 
APPLICATIONS 
 
In this chapter, two PDMS-based microfluidic devices were fabricated and tested for 
water quality monitoring applications. There are two parts of this chapter accordingly: 
 
Part 4.1 - The first device is applied to detect Cd2+ and Pb2+ ions in water. The device 
consists of three electrodes system on glass substrate with a vibration motor for 
stripping and polydimethylsiloxane (PDMS) made reservoir for sample deposition. The 
motor stirring improves the detection limit and decreases deposition time. Differential 
pulse stripping voltammetry (DPSV) is used to detect Cd2+ and Pb2+ ions. Linearity is 
well defined from 10 mg/L to 80 mg/L for both ions. Detection limits for Cd2+ and Pb2+ 
ions were 0.7 mg/L and 1.2 mg/L, respectively, at 325s deposition without vibration; 
the limits were 0.11 mg/L and 0.25 mg/L at 120s deposition with vibration. The costs 
for such a device were much more affordable than the current ICP and AAS methods.  
 
Part 4.2 - The second device is to discriminate human genotype of Cryptosporidium in 
water. The device consists of 3 parts: top PI layer is gold coated on a spot in the center 
of the layer for probe DNA immobilization. The middle layer includes PDMS channels 
and reservoir for sample delivery and deposition. The bottom layer is electrodes coated 
PET sheet for signal collection. The free bases of probe strand were hybridized with 
biotin marked capture probe. Streptavidin alkaline phosphatase enzyme was incubated 
with biotin marked capture probe via biotin streptavidin conjugation and an enzymatic 
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reaction was formed for 4-aminophenyl phosphate reduction to 4-aminophenol. The 
oxidation signal was recorded using the differential pulse voltammetry (DPV) 
electrochemical method. Because of the electrode surface is clean and fresh for 
electrochemical detection, the obtained results for complementary strand shows better 
sensitivity comparing with commercial electrodes. 
 
Background 
 
Monitoring the quality of water is increasingly important as it is one of the most 
important resources and the basis of all life. A range of chemical and biological 
approaches are currently used to ensure the safety of water. The development of 
biosensors in past few decades has offered great prospect to the onsite, simplified 
and cost-effective monitoring of water quality. Biosensors can be compact, relatively 
low cost and disposable and can also allow point-of-care monitoring, thus 
eliminating the costs associated with collecting, isolating, packaging and 
transporting the sample to be analyzed as well as the large cost for operating 
traditional equipment. Currently, the biosensors for water quality monitor can be 
divided into two types based on their target analytes. The first type is for chemical 
detection, such as nutrients, pH, heavy metal, toxic organic compounds. The second 
type is for detection of microbiological pathogen. In this chapter, we introduced two 
biosensors (Chapter 4, Part 4.1 and Part 4.2), separately. One sensor from each type 
is described above.  
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PART 4.1 
MICROFABRICATED THREE-ELCETRODE ON-CHIP PDMS 
DEVICE WITH A VIBRATION MOTOR FOR STRIPPING 
VOLTAMMETRY DETECTION OF HEAVY METAL IONS 
 
4.1.1 Introduction 
 
Heavy metal ions, such as Cd2+, Pb2+ and Cu2+, cannot be metabolized in vivo, and 
they stay in the ecological system1. Due to their toxicity and cumulative behaviors, they 
are of considerable ecological hazard and detrimental effect on human health2. Atomic 
absorption spectrometry (AAS) and inductively coupled plasma mass spectrometry 
(ICP-MS), which have good precision, high sensitivity and low detection limits, are two 
typical methods to monitor concentrations of heavy metal ions in the laboratory. 
However, they are expensive and not suitable for field application because of their 
complex operations and complicated reagent preparations3, 4.  
Electrochemical methods, such as stripping voltammetry, are extensively applied for 
field measurements of heavy metal ions due to their sensitivity, selectivity, portability 
and low cost5, 6. In electrochemical detection, the working electrode often performs an 
important role because all the reactions occur on its surface. Electrodes with mercury 
film are often utilized as working electrodes in stripping voltammetry. However, due to 
the application of highly toxic mercury, new potential pollution will take place7.    
Nowadays there are a number of studies on mercury-free microfabricated electrodes, 
whose range includes new electrode material, novel structure, module package and 
disposable application8, 9. In contrast to traditional electrodes, the microfabricated 
electrodes have special advantages such as increase in mass transport, high signal-to-  
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-noise ratio, low cost, and good uniformity10. Therefore, microfabricated electrodes with 
different types, such as micro-wire electrode, metal-film electrode and screen-printed 
electrode, have been applied to detection of heavy metal ions11, 12. Among the 
microfabricated electrodes mentioned above, the electrodes with bismuth-modification 
play an important role and are recognized as one of most powerful tools in heavy metal 
ion analysis13. In brief, two main strategies are often adopted in preparing bismuth-
modified electrodes: simultaneous depositing of bismuth and heavy metal onto the 
working electrode surface (in situ bismuth-coating) and pre-coating bismuth film (ex situ 
bismuth-coating)14. By in situ bismuth-coating, impurities formed on the surface of 
working electrode can be removed with each cycle, as well as bismuth film can be 
renewed for each detection; however, this method may bring coating issues in detecting 
natural samples, and the performances of the in situ bismuth-coating may be affected by 
the properties of the samples, causing worsen in the accuracy, precision and sensitivity14, 
15. By ex situ bismuth-coating, electrodes often show better precision in measurements 
for natural samples with periodic bismuth-coating renewal or disposable application16. 
There are increasing demands for the microfabricated electrodes with bismuth-
modification or other modification methods in detection of heavy metal ions. However, 
the microfabricated electrodes in those applications still suffer from some disadvantages. 
In some measurements, traditional electrodes are often used as the reference and counter 
electrodes, so the maintenance for the traditional electrodes, especially for the liquid 
electrolyte Ag/AgCl electrode, is still needed17. Besides, typical detection limits of the 
microfabricated electrodes are about 1 - 2 µg/L, which are insufficient for the detection 
of trace heavy metal ions with less than 1 µg/L concentration18, 19. Moreover, long 
deposition time, which may be 300 - 500 s, is often required to get better signal-to-noise 
ratio and lower detection limits20.    
In this study we introduce a novel microfabricated three-electrode on-chip device 
with a vibration motor; the integration of all three electrodes contributes to simplification 
of the instrumentation; vibration produces stable convection conditions and thin 
diffusion layer for the working electrode21, 22, which help to achieve quick measurement 
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and improve the detection limits of Cd2+ and Pb2+ ions. Thermal evaporation is utilized 
to deposit gold layer with specialized shapes and connections on a glass substrate. Two 
2×2 mm square gold electrodes, which are parallel connected externally, are adopted as 
the working electrode with ex situ bismuth-coating. In this configuration, each of two 
gold working electrodes is also possible to be separated and modified with different 
coatings for detection of more ions in the future. Silver / silver chloride layer is painted 
onto a rectangular gold surface thus resulting in a solid on-chip reference electrode. A 
U-shape gold electrode is used as the counter electrode, which surrounds the reference 
electrode and provides shielding from possible electromagnetic interference. A compact 
module and an integrated measurement cell are organized by bonding a master-mold-
based polydimethylsiloxane (PDMS) cover layer onto the glass substrate. Furthermore, 
a coin-size vibration motor installed in the module provides vibration function as the 
alternate for stirring (Figure 4.1). 
 
 
Figure 4.1 Photo of the microfabricated three-electrode on-chip device. 
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4.1.2 Materials and Methods 
4.1.2.1 Reagents and materials  
 
Silver / silver chloride paste was purchased from Gwent group, United Kingdom. 
Dow Corning PDMS (Sylgard 184) and silicone adhesive were purchased from 
Krayden, Inc. (Westminster, Colorado, U.S.A). Coin-size vibration motor was 
purchased from Digikey, U.S.A. Standard solutions (1000 mg/L Zn2+, Cd2+, Pb2+ or Cu2+ 
in 2 % HNO3), acetate buffer (0.1 M, pH 4.6) and phosphate buffered saline (PBS, 0.01 
M, pH 7.4) were purchased from Fisher Scientific, U.S.A. Standard solutions (1000 
mg/L Sn2+ in 2 % HNO3, 1000 mg/L Sb3+ in 10 % HNO3) were purchased from Ultra 
Scientific, U.S.A. Potassium Ferri(III)cyanide (K3[Fe(CN)6]), potassium 
ferro(II)cyanide (K4[Fe(CN)6]), bismuth nitrate (Bi(NO3)3.5H2O), KCl and HNO3 were 
purchased from Sigma-Aldrich, USA and of guaranteed reagent (GR) grade. All 
solutions were prepared with 18 M Ohm cm deionized water from Milli-Q ultrapure 
water purification system.  
 
4.1.2.2 On-chip device fabrication  
 
Fabrication procedures for the microfabricated three-electrode on-chip device are 
presented in Figure 4.2. Firstly, a polytetrafluoroethylene (PTFE) master mold for TE 
is designed with AutoCAD software and manufactured with a computerized numerical 
control (CNC) machine. A PDMS mask is acquired by replicating from the PTFE 
master mold, exposing areas for TE process. Secondly, a 25×50×1 mm glass substrate, 
which is covered by the PDMS mask, is prepared. Chromium layer with 15 nm 
thickness is deposited onto the glass substrate as the adhesive layer with TE instrument 
(Auto E306, Edwards, United Kingdom), and then 200 nm gold layer is deposited onto 
the adhesive layer accordingly. In the next step, the PDMS mask is removed, and the 
glass substrate is rinsed with isopropyl alcohol and deionized water.  
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A PDMS cover master mold is fabricated with similar process, and a PDMS cover 
layer with 10 mm thickness is prepared. A 10×12 mm hollow area in the PDMS cover 
layer is reserved for the measurement cell, as well as the space with 10 mm diameter 
and 5 mm thickness is reserved for the vibration motor. After that, the motor is 
assembled into the PDMS cover layer. Finally, the glass substrate and the PDMS cover 
layer are bonded with oxygen plasma etching (45 s).  
 
Figure 4.2 Basic process flow for the fabrication of the on-chip device.    
 
4.1.2.3 Fabrication of Ag/AgCl reference electrode  
 
To fabricate a solid on-chip reference electrode, film painting process is introduced. 
It is important to do this step after the PDMS bonding to avoid undesirable influence 
from oxygen plasma etching. The fabrication procedures are illustrated in Figure 4.3. 
Firstly, ethanol is used to clean the electrodes in the measurement cell, and then the 
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electrodes are dried in nitrogen steam. Secondly, the area in the measurement cell is 
covered by a 0.2mm thickness PDMS mask, exposing a window for the reference 
electrode (Figure 4.3a). Then silver / silver chloride paste is painted into the window 
(Figure 4.3b). This step can be fulfilled by either a machine for surface-mount 
technology (SMT) or manual operation. After the painting step the PDMS mask is 
removed, and the device is baked at 75C (Isotemp oven, Fisher, USA) for 150 s to 
organize a solid silver / silver chloride layer. A scanning electron microscope (SEM; S-
4000, Hitachi, Japan) image of the solid silver/silver chloride layer is given in Figure 
4.3d, showing uniform microstructures. Moreover, the bare wire of the reference 
electrode in the cell is covered and protected by silicone adhesive. Finally, cyclic 
voltammetry (CV) experiments are conducted to assess the performance of the on-chip 
reference electrode.  
 
Figure 4.3 Schematic representation of the on-chip reference electrode preparation: (a) 
a PDMS mask exposes the reference electrode area, (b) silver / silver chloride film is 
painted, (c) the PDMS mask is removed and the device is baked, (d) to form a solid 
silver / silver chloride layer, whose microstructure is shown by a SEM image. 
4.1.2.4 Working electrode preparation 
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   Bismuth-coating on the working electrode is performed after reference electrode 
validation. Firstly, the electrodes, as well as the measurement cell, are rinsed with 
deionized water. After that, bismuth-coating solution, which contains 0.02 M Bi3+ and 
0.1 M KCl, is put into the measurement cell. A constant deposition potential of -0.95V 
is applied to the working electrode for 300 s. The vibration motor is disabled in the 
bismuth-coating process. Finally, the electrodes in the measurement cell are rinsed with 
deionized water and ready for further experiments.  
 
4.1.2.5 Electrochemical experiments 
 
   A commercial potentiostat analyzer (CHI-1220, CH instruments, USA) is utilized in 
all electrochemical experiments. To assess the performance of the on-chip reference 
electrode, CV experiments are performed in solution which contains 0.05 M K3[Fe(CN) 
6], 0.05 M K4[Fe(CN) 6] and 0.01 M PBS, as well as 0.1 M KCl as supporting electrolyte. 
Besides, a commercial liquid electrolyte Ag/AgCl electrode (CHI-111, CH instruments, 
USA) is used for comparison experiments to evaluate the performance of as-fabricated 
Ag/AgCl reference electrode. Moreover, the effect of vibration on electrochemical 
responses is evaluated by detecting heavy metal ions, such as Cd2+ and Pb2+ in water 
sample, with differential pulse stripping voltammetry (DPSV).  
 
4.1.2.6 ICP-MS detection of natural water samples 
 
The ion profiles of natural water samples are detected by Agilent 7700 ICP-MS in 
Utah Water Research Laboratory. 50 ml for each sample is digested using an 
Environmental Express hot block and refluxed at 115 C with 5 ml trace metal grade 
nitric acid. Once samples evaporate to 10 ml, they are cooled, and ultrapure water is 
used to fill back to 50 ml volume. Samples are filtered with a 0.45 µm plunger filter and 
then ready for ICP-MS analysis. 
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4.1.3. Results and Discussion 
4.1.3.1 Evaluation of the fabricated on-chip reference electrode 
 
CV is a popular technique which is widely used for studying electrochemical 
performance of electrodes. In the CV experiments, the counter electrode, working 
electrode (without bismuth-coating) and reference electrode in the on-chip device are 
used firstly. Ferri(III)cyanide / ferro(II)cyanide redox couple, is chosen to evaluate the 
performance of the on-chip reference electrode. The potential scan window is of -0.2 V 
- 0.4 V. Ferro (II) cyanide is oxidized to Ferri(III)cyanide in the forward scan, as well as 
Ferri(III)cyanide is reduced to ferro(II)cyanide in the backward scan. The redox peaks 
can be achieved in both forward and reverse scans. The performance of the on-chip 
reference electrode can be evaluated by the shapes and positions of the redox peaks23. A 
group of CV curves are obtained by measuring the current of the working electrode at 
different scan rates (25 mV/s, 50 mV/s, 75 mV/s and 100 mV/s).  
   Comparison CV experiments are performed accordingly by using a commercial 
liquid electrolyte Ag/AgCl electrode as well as the counter electrode and working 
electrode in the on-chip device. The comparison CV experiments are with the same 
setting for electrochemical parameters.  
 
4.1.3.2 Evaluation of the vibration function  
 
   DPSV experiments are performed for detection of Cd2+ and Pb2+ ions. Deposition 
potential is -1.0 V and scan window is -1.0 V to -0.4 V; amplitude of pulse is 25 mV; 
step potential change is 5 mV; period of pulse wave is 50 ms. Solution containing 0.1 
M acetate buffer (pH = 4.6), 50 µg/L Cd2+ and 50 µg/L Pb2+ ions is adopted in this stage. 
The above initial setting for DPSV is similar to recent studies24. The counter electrode, 
reference electrode and working electrode in the on-chip device are used. Before the 
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measurements, bismuth-coating is carried out on the surface of the gold working 
electrode. With and without vibration, the DPSV responses are recorded and compared 
to each other.  
 
Figure 4.4 DPSV current peaks for solution containing 50 µg/L Cd2+ and 50 µg/L Pb2+ 
ions (50 s deposition) vs. motor voltage (n=3).  
 
   Firstly, the vibration condition is optimized. Suggested working voltage of the motor 
is ranged from 1 V to 3 V DC. The vibrating frequencies are monitored by using an 
oscilloscope (MSO 2024A, Tektronix, USA) with a current probe in this working range, 
as well as the DPSV current peaks for 50 µg/L Cd2+ and 50 µg/L Pb2+ ions are recorded 
with 50 s deposition time (Figure 4.4). The peaks for Cd2+ ion reach saturation when the 
motor voltage is over 2.4 V, and the peaks for Pb2+ ion drop down when the motor 
voltage exceeds 2.2 V. As a result, the optimized working voltage for the motor is 
confirmed as 2.2 V. 
 
Moreover, solution containing 0.1 M acetate buffer, 5 µg/L Cd2+ and 5 µg/L Pb2+ 
ions is prepared. The detection limits of the on-chip device are calculated as three times 
76 
 
 
of the standard deviation (3σ) of the analytical results for this low concentration 
solution18. The detection limits for Cd2+ and Pb2+ ions are 0.7 µg/L and 1.2 µg/L without 
vibration (325 s deposition time), respectively; the detection limits for Cd2+ and Pb2+ 
ions can reach as low as 0.11 µg/L and 0.25 µg/L with vibration and 120 s deposition 
time, which are noticeable better than recent reports18. It can be concluded that vibration 
function brings quicker deposition, higher sensitivity and lower detection limits for 
Cd2+ and Pb2+ ions detection.  
 
4.1.3.3 Measurements for multi-concentration samples  
 
  
Figure 4.5 (a) Typical voltammograms and (b) calibration plots for the microfabricated 
three-electrode on-chip device in simultaneous detection of Cd2+ and Pb2+ ions (n=3). 
Eight solutions containing 0.1 M acetate buffer, 10 - 80 µg/L of Cd2+ and Pb2+ ions 
77 
 
 
(10 µg/L step) are prepared. DPSV experiments are with vibration and 120 s deposition 
time. Typical DPSV curves for these solutions are shown in Figure 4.5a. Current peaks 
for Cd2+ and Pb2+ ions are well defined, showing regular increment over the 
concentration range. The calibration plots of current peak versus ion concentration are 
presented in Figure 4.5b, which show that the linearity is well defined from 10 to 80 
µg/L. The calibration curves and correlation coefficients are y = 0.121x - 0.82, r = 0.996 
for Cd2+ and y = 0.192x - 0.37, r = 0.991 for Pb2+, respectively. 
 
4.1.3.4 Analysis of natural samples 
 
Measurements for natural water samples are also performed. Two natural samples 
were acquired from Logan River, Logan City, USA on 10th, March 2014. The first 
sample was from the upstream part ahead of the city. The second sample was from the 
downstream part in the city. To avoid the interference of sample background, method of 
standard additions (MSA) is introduced and executed twice. In each MSA stage, diluted 
standard solution containing 500 µg/L Cd2+ and Pb2+ ions with adequate volume is added 
into the samples, keeping 1 µg/L concentration increment for Cd2+ and Pb2+ ions. 
Current peaks for the original samples, first MSA and second MSA are recorded 
respectively, and the concentrations can be calculated according to the original peaks 
and the MSA peaks25. The data are presented in Table 4.1.1 The DPSV results meet with 
standard ICP-MS measurements with less than 15% relative error except Cd2+ 
concentration of the first sample, because it is below the detection limits of the on-chip 
device.  
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Table 4-1 Cd2+ and Pb2+ measurements for natural water samples based on DPSV and ICP-
MS  
 
(a) Sample 1 Original  
Peak 
1st MSA  
Peak 
2nd MSA 
Peak 
Calculated 
Concentration 
ICP-MS 
Concentration 
Relative 
Error 
Cd2+ Not detected N/A N/A N/A 0.04 μg/L N/A 
Pb2+ 9.8×10-8 A 2.4×10-7 A 3.7×10-7 A 0.71 μg/L 0.83 μg/L 14 % 
 
 
(b) Sample 2 Original  
Peak 
1st MSA  
Peak 
2nd MSA 
Peak 
Calculated 
Concentration 
ICP-MS 
Concentration 
Relative 
Error 
Cd2+ 9.6×10-9 A 8.7×10-8 A 1.6×10-7 A 0.13 μg/L 0.12 μg/L 8 % 
Pb2+ 1.4×10-7 A 2.8×10-7 A 4.0×10-7 A 1.04 μg/L 1.18 μg/L  12 % 
 
Sample 1 was from the upstream of Logan River. Sample 2 was from the downstream of Logan 
River. 
 
4.1.3.5 Stability and renewal procedure for the device 
 
The stability for the on-chip device is studied with solution containing 0.1 M acetate 
buffer, 50 µg/L Cd2+ and 50 µg/L Pb2+ ions. After each bismuth-coating, the device 
shows good stability in approximate 50 - 60 DPSV measurements, and the relative 
standard deviations are less than 2.4 % and 2.8 % for Cd2+ and Pb2+, respectively. After 
that, a renewal procedure is required due to the loss of bismuth-coating. During the 
renewal procedure, the bismuth film on the working electrode is removed with filter 
paper firstly; and then the device is rinsed with isopropyl alcohol and deionized water; 
finally the bismuth-coating is performed on the working electrode.    
 
The life-cycle for the on-chip device is more than 500 measurements, which is 
acceptable considering the relative low cost (less than $7 US dollars) for the device. 
After that, the gold layer for the working electrode and counter electrode may drop off 
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from the substrate. The reference electrode keeps stable and needs no special maintaince 
in the life-cycle.  
 
4.1.4 Conclusion 
In this study, we introduce a microfabricated three-electrode on-chip device with a 
vibration motor for stripping voltammetry detection of Cd2+ and Pb2+ ions in standard 
and natural water samples. The counter electrode, reference electrode and working 
electrode are fabricated in the on-chip device. A coin-size vibration motor is also 
integrated in the device, providing vibration function as the alternate for stirring to 
improve detection limits and reduce deposition time. The performance of the on-chip 
reference electrode is evaluated by CV experiments. DPSV experiments validate that 
higher current peaks, less deposition time and lower detection limits for Cd2+ and Pb2+ 
ions can be achieved synchronously from vibration. The microfabricated three-
electrode on-chip device is also used to detect Cd2+ and Pb2+ ions for both laboratorial 
standard water samples and natural water samples. The DPSV current peaks exhibit 
good linearity from 10 to 80 µg/L for Cd2+ and Pb2+ ions, respectively, in laboratorial 
standard water samples. The concentrations for natural samples are calculated based on 
MSA in DPSV measurements and compared with ICP-MS results, which validate the 
measurement reliability for the on-chip device. 
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PART 4.2  
A NOVEL THREE-DIMENSIONAL µTAS CHIP FOR ULTRA-
SELECTIVE SINGLE BASE MISMATCHED Cryptosporidium DNA 
BIOSENSOR 
 
4.2.1 Introduction 
 
Biosensor chips, especially electrochemical biosensor chips, have been dramatically 
developed in the past few decades26-28. The µTAS coupled with electrochemical 
biosensor has the advantages of both microfluidic analysis and biosensors such as fast 
analysis, powerful capability of on-chip sample pre-treatment, less consumption of 
sample and power, and portability, reduced risk of contamination, high sensitivity, 
specificity, high reliability and simple miniaturization and integration29, 30. The 
development of the µTAS electrochemical biosensors, in which both electrochemical 
cell and channel networks are integrated, has attracted an increasing attention of 
analysts. The µTAS electrochemical biosensors have exhibited great potential in the 
applications to point of care clinical analysis via either in vivo or in vitro measurements 
and in environmental monitoring31. 
 
One of the most important environmental applications of µTAS electrochemical 
biosensors is bacteria detection32, 33. The µTAS electrochemical biosensors and regular 
electrochemical biosensors have been used for the detection of Cryptosporidium as a 
killer Bactria34 35, 36. Cryptosporidium parvum and Cryptosporidium hominis are 
protozoan parasites, and they are known as the cause of the illness cryptosporidiosis in 
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animals and humans35, 36. In recent years, cryptosporidiosis has emerged as a global 
public health problem and this parasite is recognized as a common cause of 
gastroenteritis in immunocompetent individuals, and of severe illness in 
immunocompromised individuals35 37. By 2015, there are twenty-six recognized 
species of Cryptosporidium, and greater than forty distinct genotypes, however, 
approximately 90% of reported human infections involve either C. hominis, which is 
found primarily in humans, or C. parvum, which is an important zoonotic species36. In 
the developing world, persistent diarrhea, caused by agents such as Cryptosporidium, 
accounts for 30-50% of mortality for children under the age of 5, and it is estimated 
that 250-500 million cases of cryptosporidiosis occur each year38.  This evidence 
indicates that the detection and monitoring of C. parvum is very important in aquatic 
environments such as rivers and drinking waters39, 40.  
 
In this study, an electrochemical DNA biosensor was developed on a novel three-
dimensional micro total analysis system (3D µTAS) for detecting Cryptosporidium. The 
3D µTAS was comprised of two substrates as follows: (i) a substrate deposited with 
gold dot pattern, and (ii) a substrate with deposited gold electrochemical cell. Therefore, 
a new and fresh electrode surface without immobilized species was employed for 
electrochemical detection. The performance of the fabricated 3D µTAS electrochemical 
biosensor was compared with the commercial screen-printed electrode (SPE). Based on 
our best knowledge, this is the first report on the fabrication of a 3D µTAS 
electrochemical biosensor for DNA detection. The selectivity of the fabricated DNA 
biosensor was investigated through the detection of the complementary target strand in 
the presence of interfering DNA (E. coli genomic DNA). Then, the sensitivity of the 
DNA biosensor was evaluated in the presence of various base mismatched strands.  
 
4.2.2 Materials and Methods 
4.2.2.1 Materials 
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4-Aminophenyl phosphate monosodium salt (product No. ab141899) was purchased 
from Abcam (Cambridge, USA). Distilled pure water, 6-Mercapto-1-hexanol (MCH) 
(product No. 451088), magnesium chloride anhydrous (product No. M8266), trizma 
base (product No. 77861), diethanolamine (DEA) (product No. 111422), bovine serum 
albumin (BSA) (product No. A7906), streptavidin-alkaline phosphatase (product No. 
S2890), and deoxyribonucleic acid of E. coli DNA (strain B) (product No. EC11303) 
were obtained from Sigma-Aldrich (Milwaukee, USA). Commercial phosphate 
buffered saline (PBS), pH 7.4, containing monobasic potassium phosphate (product No. 
10010023), sodium chloride (product No. AM9759) and sodium phosphate (product No. 
10049215) were purchased from Thermo Fisher Scientific (USA). All solutions were 
prepared using deionized and distilled water purchased from Sigma-Aldrich. 
 
Diethanolamine buffer (pH 9.6) was made by mixing 0.1 M DEA, 1 mM MgCl2 and 
0.1 M KCl and 0.1% (W/V) BSA in distilled water and Tris buffer (pH 7.4) was 
prepared with dissolving 20 mM Trizma base and 150 mM NaCl in deionized and 
distilled water. MCH solution (1mM) was made by dissolving 0.001 g of MCH in 10 
mL distilled water.   
 
All the oligonucleotides were synthesized and purified by Eurofins MWG Operon 
(Huntsville, USA), and their sequences are listed as follows: 
 
Probe strand: 5’-SH- (CH2)6- ACG GCT CTT AGT CAT GGC TCT CTC ACC GAG 
CCG T -3’ 
Complementary Target strand: 5’- GGT GAG AGA GCC ATG ACT AA -3’ 
Single-base mismatched:          5’- GGT GAG AGA GCA ATG ACT AA-3’ 
Three-bases Mismatched:         5’- GGC GAG AGG GCA ATG ACT AA-3’ 
Five-bases Mismatched:           5’- GGC GAG AGG GCA ATG GCT AT-3’ 
Capture probe:                          5’ – biotin – ACG GCT C– 3’ 
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All of oligonucleotide solutions were prepared in PBS buffer (pH 7.4). 
 
The electrochemical measurements were performed using a BioLogic VPS-300 
multichannel potentiostat/galvanostat (Bio-Logic Science Instruments SAS, France). 
The differential Pulse voltammetry (DPV) and electrochemical impedance analysis 
(EIS) were used due to their higher sensitivity than that of other electrochemical 
detection methods. All electrochemical measurements were conducted at room 
temperature. The commercial gold SPEs and the working electrode placed in 
electrochemical cell (embedded on 3D µTAS) were used for electrochemical detections. 
The commercial SPEs (Metrohm) with a gold working electrode (4 mm diameter), 
platinum auxiliary electrode and silver as reference electrode were used. 
 
The home-made 3D µTAS electrochemical biosensor was comprised of three layers. 
The first layer was made from polyimide (PI). The gold dot (2 mm diameter) used as 
the substrate for DNA immobilization was deposited onto the PI by thermal evaporation 
system (NTE-3500, Nano-master Inc., USA).  
 
The second layer was made from PDMS (10 mm height) having suitable engraved 
channels for chemical delivery and reservoir for chemical interactions. The PDMS part 
was replicated from a designed 3D printed master mold that was manufactured by 
3Dsystem®, CA, USA. The third layer was made from polyethylene terephthalate (PET) 
sheet with gold deposited as working and auxiliary electrodes and Ag/AgCl paste 
printed as reference electrode. Figure 4.6 illustrates the fabrication process. Figure 4.7 
shows the final fabricated device. 
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Figure 4.6 The thermal evaporation gold deposition procedure and PDMS layer 
fabrication procedure. 
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Figure 4.7 The 3D µTAS electrochemical biosensor that used as detection device. (a) 
The plastic template for preparing the middle layer. (b) The layer one, electrochemical 
cells, and layer 3, gold dots. (c) The final fabricated 3D µTAS electrochemical 
biosensor. (d) The schematic structure of designed 3D µTAS electrochemical 
biosensor.  
 
(a) 
(d) 
(b) 
(c) 
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4.2.2.2 Biosensor design 
The DNA biosensor was immobilized on the gold dot surface embedded in the 3D 
µTAS and the gold working electrode of the commercial SPE with procedures as 
follows:  
 
Thiolated hairpin shape probe strand DNA 
 
Firstly, the working electrode surface and gold dot in the 3D µTAS were dropped with 
10 µL of the tiolated hairpin shape probe strand solution (0.05 µM) and a chemisorption 
could proceed for 45 min. The chemical adsorption of thiol group onto the gold surface 
occurs rapidly, and a self-assembled layer of hairpin shape probe strand produces on 
the electrode surface in a short incubation time. After three times washing with the PBS 
buffer (pH 7.4), an aqueous solution of MCH (10 µL, 1.0 mM) was placed on the hairpin 
shape probe strand immobilized working electrode and gold dot surfaces for 1 h41, and 
again they were washed with the PBS buffer (pH 7.4) three times. The immobilized 
MCH solution improves the quality and stability of the capture probe monolayer by 
preventing any unspecific interactions and blocking all unbound surface areas of the 
gold dot and gold working electrode. 
 
Hybridization processes 
 
The modified probe strands on electrode surface and gold dot were exposed to 10 µL 
of the target strand sequence solutions in the PBS buffer (pH 7.0). The assembly was 
kept at room temperature for 60 min to achieve hybridization. Then, the surfaces were 
washed with the PBS buffer (pH 7.4, three times) to remove non-specifically bound 
oligonucleotides. In the next step, the modified surfaces were dropped with 10 µL of 
the biotinylated capture probe strand sequence solution during 90 min and the surfaces 
were washed with the DEA buffer for three times (pH 9.6) as can be seen in the Scheme 
4.1. 
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Streptavidin-alkaline phosphatase enzyme labelling and electrochemical detection 
 
The formed biotinylated hybrids on the electrode surface and gold dot were incubated 
with 10 µL of the streptavidin-alkaline phosphatase enzyme (3.9 U/mL) diluted in the 
DEA buffer containing 0.1% (W/V) BSA. After 15 min incubation time, the DNA 
biosensor modified surfaces were washed with the DEA buffer (pH 9.6) for three times. 
 
For DPV measurements, the surface of DNA modified commercial SPE and gold dot 
in the 3D µTAS were covered with 60 μL of a 12 mM 4-aminophenyl phosphate 
solution prepared in the DEA buffer (pH 9.6) containing 1% (W/V) BSA (as substrate). 
The use of streptavidin-alkaline phosphatase enzyme as an electroactive label generator 
in enzymatic biosensor is very common. A DNA strand-labeled enzyme acts on 
substrates such as 4-aminophenyl phosphate, p-nitrophenyl phosphate, or 1-naphthyl 
phosphate and biocatalytically generates a redox-active product that can be detected 
using electrochemical methods. Herein, streptavidin-alkaline phosphatase 
enzymatically converts 4-aminophenyl phosphate to electroactive 4-aminophenol42-44. 
After 10 min incubation time, the DPV measurements were performed on the 
commercial SPE and the electrochemical cell embedded on 3D µTAS. The potential 
window was from -0.05 to 0.6 V. For DPV measurements, the step of potential, the 
modulation potential, and the interval time were set to 7 mV, 70 mV and 0.1 S, 
respectively.  
 
4.2.2.3 Interfering studies 
 
For interfering studies, the E. coli DNA was dissolved in the PBS buffer (pH 7.4).  
Then, it was denatured at 95 ºC for 15 min and promptly cooled down in the ice bath 
for 5 min to produce the single-strand DNA. The obtained single-strand DNA solution 
was diluted to certain concentrations in the PBS buffer (pH 7.4) and was used alone or 
88 
 
 
mixed with the complementary target solution with the certain concentrations in case.  
4.2.3 Results and Discussion 
The material PET is high temperature resistant (melting point >250℃), which 
is good for the gold coating using thermal evaporation method. The gold adhesion on 
PET was proven to be much stronger than that for glass substrate. PI also has a very 
high melting point and remains intact during the thermal evaporation. PI is a transparent 
material and the PDMS reservoir could be observed easily.  Both PET and PI are 
bendable materials. Comparing with glass and ceramic materials, PI and PET are low-
cost, easy to cut and shape. Thus, they were used as substrate to fabricate the 3D µTAS.  
 
 
Schematic 4.1 Schematic diagram for the fabrication of electrochemical DNA 
biosensor for Cryptosporidium target strand detection.  
The DNA biosensor was designed and fabricated based on Schematic 4.1. In the 
first step, the DNA biosensor response was confirmed by various control experiments. 
In this case, the DNA biosensor was designed in the absence of a hybridization or 
Gold dot 
Hairpin shape 
ssDNA probe
Biotinylated 
capture 
probe
Immobilization
Hybridization 
Streptavidin alkaline 
phosphatase enzyme 
Target 
strand 
Hybridization 
Enzymatic 
reaction
Au working 
electrode 
Au counter 
electrode
Ag/AgCl reference 
electrode 
4-Aminophenol4-Aminophenyl 
phosphate 
89 
 
 
immobilization process in each experiment. Firstly, the hairpin shape probe strand 
immobilization on the gold dot was absent and in the next experiments the hybridization 
of target and capture strands were absent, respectively. A series of control experiments 
showed that in the absence of each hybridization or immobilization process during 
DNA biosensor fabrication no DPV peak current was observed. Figure 4.8 shows that 
the interactions between all strands, including hairpin shape, target, and capture strands 
were successfully occurred during the DNA biosensor fabrication. The final DPV signal 
in Figure 4.8 is attributable to the target strand detection. 
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Figure 4.8 The DP voltammograms of the 4-aminophenyl phosphate (substrate) in 
various designs of DNA biosensor (with missing part) as control experiments. 
 
4.2.3.1 Analytical performance of the target strand detection 
 
Under the optimum experimental conditions, the dynamic range and sensitivity of the 
proposed electrochemical DNA biosensor was confirmed.  
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Figure 4.9(a) shows the DPV of the complementary target strand with different 
concentrations on the 3D µTAS. Figure 4.9(b) displays the calibration curve of the 
fabricated biosensor on the commercial SPE and 3D µTAS.  As it can be seen in Figure 
4.9, the DPV peak current was increased by increasing the target strand concentrations. 
This result agrees with the trend observed in recent publications45, 46. The calibration 
curve obtained from the electrochemical cell of the 3D µTAS exhibited a good linear 
relationship between the DPV peak currents (Figure 4.9(a)) and the target strand 
concentrations in the range from 2.5 ng/mL to 0.1 µg/mL (Figure 4.9(b)). The detection 
limit was 1.8 ng/mL, which was calculated from three times the standard deviation of 
the blank sample detection. The resulting linear equation was y = 12.844x + 0.106 with 
a correlation coefficient of 0.995. The calibration curves were rerun using the 
commercial SPEs in the same conditions as those for the fabricated 3D µTAS. It can be 
seen in Figure 4.9(a) that the calibration plot on the commercial SPE showed a lower 
linear dynamic range (from 5 ng/mL to 0.1 µg/mL), a lower calibration curve slop (y = 
0.560x + 0.329 with correlation coefficient of 0.9853) and a higher detection limit (10.6 
ng/mL) compared to those for the 3D µTAS.  
 
The improved detection limit and linear range for the 3D µTAS compared to those of 
the commercial SPEs can be attributed to employing a clean and fresh gold working 
electrode for the electrochemical detection in the fabricated 3D µTAS. In commercial 
electrodes, the electrochemical detection was performed on the working electrode 
surface that is covered by the DNA strands. In other words, the electrochemical 
detection and DNA biosensor fabrication using commercial electrode was done on the 
same surface electrode. On the other hand, the 3D µTAS DNA biosensor was fabricated 
on the gold dot that is different from the working electrode on the electrochemical cell 
part. The electrochemical detection experiments for the 3D µTAS were performed on 
a clean and fresh working electrode surface. Therefore, in each concentration of the 
target strand the DPV peak current obtained from the 3D µTAS was much higher than 
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the commercial SPE. Additionally, the base-line of DPV peaks for the 3D µTAS were 
lower than those for the commercial SPE.  
 
 
Figure 4.9 (a) The DP voltammograms obtained from the complementary target strand 
with various concentrations (from 2.5 ng/mL to 0.1 µg/mL) on the 3D µTAS. (b) 
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concentrations on the commercial SPE and 3D µTAS. The sample concentrations are 
the same for both commercial SPE and 3D µTAS. 
 
4.2.3.2 Specificity and reproducibility of the DNA biosensor 
 
The specificity of the fabricated electrochemical DNA biosensor was evaluated 
by detecting four different target DNA sequences, including the noncomplementary 
target, the single-base mismatched, the three-base mismatched and the five-base 
mismatched strand at the same condition. Figure 4.10 shows the calibration curve of 
the complementary, noncomplementary, single-base mismatched, three-base 
mismatched, and five-base mismatched strand on the 3D µTAS. As shown in Figure 
4.10, the DPV peak currents of the three-base mismatched, five-base mismatched and 
noncomplementary target strand were approximately the same in each certain 
concentration, but the single-base mismatched strand showed a different and 
distinguishable DPV peak current for each concentration. The evidence indicates that 
the DPV peak currents of the single base were slightly lower than the complementary 
strands and higher than the noncomplementary target strand, three-bases mismatched 
and five-bases mismatched strand for each certain concentration. Therefore, the single-
base mismatched strand was clearly detectable in the mentioned linear range. In 
addition, the three-bases and five-bases mismatched strand exhibited very low DPV 
peak current comparing with the complementary target strand in each certain 
concentration. Thus, the designed DNA biosensor can be successfully used for effective 
detection between the complementary, single-base mismatched, three-base mismatched, 
five-base mismatched and noncomplementary strand.  
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Figure 4.10 Calibration curve of the DPV peak currents versus complementary, non-
complementary, single-base mismatched, three-base mismatched, and five-base 
mismatched strands on the 3D µTAS. 
 
4.2.3.3 Selectivity of DNA biosensor 
 
The feasibility of the designed sensing system for practical applications was 
investigated by analyzing the mixture of interfering DNA (E. coli DNA strand) with 
and without complementary target strand. Various concentrations of an E. coli DNA 
were mixed with complementary target strand and were applied on the 3D µTAS to 
achieve this goal. Figure 4.11 shows the DPV peak currents for the complementary 
target strand DNA, mixture of the complementary target strand solution with various 
concentrations of the E. coli DNA solution. When the E. coli DNA solution was added 
onto the gold dot instead of the complementary target solution, the DPV peak current 
decrease dramatically that means no effective hybridization was occurred on gold dot 
in the presence of the E. coli DNA solution. Comparing the DPV peak current of the 
complementary target strand, the E. coli mixed solutions had lower currents. These 
lower currents were resulted from the E. coli interfering up to the concentration of 0.621 
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µg/mL. This can be attributed to the large and long strand of E. coli DNA that covered 
the gold dot surface effectively. Thus, the target strand cannot be hybridized with the 
immobilized probe strand on the gold dot surface. When the E. coli concentration was 
decreased to approximately equal or lower than the complementary target strand 
concentration, the DPV peak current increased significantly. In this condition, there was 
no interfering effect of the E. coli DNA on the obtained results. However, due to the 
presence and interfering of the E. coli DNA the standard deviation of the DPV peak 
current was higher than that of the complementary strand. Finally, the evidence 
confirms that the fabricated DNA biosensor showed an appropriate and acceptable 
selectivity even in the presence of the same concentration of a large interfering DNA 
strand such as the E. coli DNA.  
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Figure 4.11 The histogram of the DPV peak currents for the complementary target 
strand DNA (0.621 µg/mL), mixture of the complementary target strand solution (0.621 
µg/mL) with various concentrations of the E. coli DNA solution (2.5, 1.75, 1.0, 0.5 and 
0.25 µg/mL). 
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4.2.4 Conclusion 
A novel 3D µTAS electrochemical biosensor was developed for 
Cryptosporidium target strand detection, and the obtained results were compared with 
those for the commercial SPE. The results confirmed that the complementary target 
DNA can be clearly detected with very low detection limit of 1.8 ng/ml. The single-
base mismatched strand was distinguished specifically, but there was not a significant 
difference between the calibration curves of the three-base mismatched strand, five-
base mismatched strand, and no complementary DNA strand. This was ascribed to the 
non-complete hybridization between the probe strand and the mentioned strands. The 
used DNA strands were short strands and more than one mismatched base could greatly 
reduce hybridization opportunity. The detection limit of 3D µTAS was 6 times higher 
than that of the SPE electrochemical biosensor. Based on the slope of calibration curve 
the sensitivity of 3D µTAS was 23 times higher than biosensors designed on the SPE. 
These advantages are attributable to the novel designed chip that provides the clean and 
fresh working electrode surface for the electrochemical detection. Additionally, the 
interfering effect of a large and long DNA strand such as the E. coli DNA was 
investigated on DNA biosensor and no interfering effect was detected in a solution with 
approximately equal concentrations of the complementary target DNA and E. coli DNA 
mixture. The obtained evidences indicated that the novel 3D µTAS electrochemical 
biosensor has the high sensitivity and selectivity for complex probes detection, which 
has potential applications in medicinal or environmental biosensing. 
 
  
96 
 
 
References 
 
1. A. Jang, Y. Seo and P. L. Bishop, Environmental pollution 133 (1), 117-127 (2005). 
2. R. A. Goyer, Environmental Health Perspectives 104 (10), 1050-1054 (1996). 
3. D. Buzica, M. Gerboles, A. Borowiak, P. Trincherini, R. Passarella and V. Pedroni, 
Atmospheric Environment 40 (25), 4703-4710 (2006). 
4. Z. Bi, C. S. Chapman, P. Salaün and C. M. van den Berg, Electroanalysis 22 (24), 
2897-2907 (2010). 
5. R. Ouyang, Z. Zhu, C. E. Tatum, J. Q. Chambers and Z.-L. Xue, Journal of 
electroanalytical chemistry 656 (1-2), 78-84 (2011). 
6. A. Giacomino, O. Abollino, M. Malandrino and E. Mentasti, Talanta 75 (1), 266-
273 (2008). 
7. Z. Zou, A. Jang, E. MacKnight, P.-M. Wu, J. Do, P. L. Bishop and C. H. Ahn, 
Sensors and Actuators B: Chemical 134 (1), 18-24 (2008). 
8. G.-J. Lee, H. M. Lee, Y. R. Uhm, M. K. Lee and C.-K. Rhee, Electrochemistry 
Communications 10 (12), 1920-1923 (2008). 
9. S. B. Hočevar, I. Švancara, K. Vytřas and B. Ogorevc, Electrochimica Acta 51 (4), 
706-710 (2005). 
10. K. Stulík, C. Amatore, K. Holub, V. Marecek and W. Kutner, Pure and Applied 
Chemistry 72 (8), 1483-1492 (2000). 
11. G.-H. Hwang, W.-K. Han, J.-S. Park and S.-G. Kang, Sensors and Actuators B: 
Chemical 135 (1), 309-316 (2008). 
12. I. Cesarino, C. Gouveia‐Caridade, R. Pauliukaitė, E. T. Cavalheiro and C. M. Brett, 
Electroanalysis 22 (13), 1437-1445 (2010). 
13. J. Wang, J. Lu, S. B. Hocevar, P. A. Farias and B. Ogorevc, Analytical chemistry 
72 (14), 3218-3222 (2000). 
14. A. Economou, TrAC Trends in Analytical Chemistry 24 (4), 334-340 (2005). 
15. C.-H. Lien, C.-C. Hu, K.-H. Chang, Y.-D. Tsai and D. S.-H. Wang, Electrochimica 
Acta 105, 665-670 (2013). 
16. S. B. Hočevar, S. Daniele, C. Bragato and B. Ogorevc, Electrochimica Acta 53 (2), 
555-560 (2007). 
17. D. Asbahr, L. C. S. Figueiredo-Filho, F. C. Vicentini, G. G. Oliveira, O. Fatibello-
Filho and C. E. Banks, Sensors and Actuators B: Chemical 188, 334-339 (2013). 
18. Q.-M. Feng, Q. Zhang, C.-G. Shi, J.-J. Xu, N. Bao and H.-Y. Gu, Talanta 115, 235-
240 (2013). 
19. P. Sahoo, B. Panigrahy, S. Sahoo, A. Satpati, D. Li and D. Bahadur, Biosensors and 
Bioelectronics 43, 293-296 (2013). 
20. C. Kokkinos and A. Economou, Sensors and Actuators B: Chemical 192, 572-577 
(2014). 
21. V. Aumond, M. Waeles, P. Salaün, K. Gibbon-Walsh, C. M. Van den Berg, P.-M. 
Sarradin and R. D. Riso, Analytica chimica acta 753, 42-47 (2012). 
22. C. S. Chapman and C. M. van den Berg, Electroanalysis: An International Journal 
Devoted to Fundamental and Practical Aspects of Electroanalysis 19 (13), 1347-1355 
97 
 
 
(2007). 
23. A. Määttänen, U. Vanamo, P. Ihalainen, P. Pulkkinen, H. Tenhu, J. Bobacka and J. 
Peltonen, Sensors and Actuators B: Chemical 177, 153-162 (2013). 
24. Y. Wei, R. Yang, J.-H. Liu and X.-J. Huang, Electrochimica Acta 105, 218-223 
(2013). 
25. W. Zhang, H. Wan, Q. Sun, D. Ha, P. Wang, D. Kirsanov and A. Legin, 
Measurement Science and Technology 24 (4), 045801 (2013). 
26. H. Ilkhani, A. Ravalli and G. Marrazza, Chemosensors 4 (4), 23 (2016). 
27. H. Ilkhani, M. Sarparast, A. Noori, S. Z. Bathaie and M. F. Mousavi, Biosensors 
and Bioelectronics 74, 491-497 (2015). 
28. H. Ilkhani, T. Hughes, J. Li, C. J. Zhong and M. Hepel, Biosensors and 
Bioelectronics 80, 257-264 (2016). 
29. F. Qu, M. Yang and A. Rasooly, Analytical chemistry 88 (21), 10559-10565 (2016). 
30. P. Yang, J. Peng, Z. Chu, D. Jiang and W. Jin, Biosensors and Bioelectronics 92, 
709-717 (2017). 
31. J. Wang, A. Munir, Z. Li and H. S. Zhou, Talanta 81 (1-2), 63-67 (2010). 
32. N. Couniot, T. Vanzieleghem, J. Rasson, N. Van Overstraeten-Schlögel, O. 
Poncelet, J. Mahillon, L. Francis and D. Flandre, Biosensors and Bioelectronics 67, 
154-161 (2015). 
33. H. Ilkhani and S. Farhad, Analytical biochemistry (2018). 
34. G. A. Campbell and R. Mutharasan, Biosensors and Bioelectronics 23 (7), 1039-
1045 (2008). 
35. A. Dibao-Dina, J. Follet, M. Ibrahim, A. Vlandas and V. Senez, Biosensors and 
Bioelectronics 66, 69-76 (2015). 
36. A. Iqbal, M. Labib, D. Muharemagic, S. Sattar, B. R. Dixon and M. V. Berezovski, 
PloS one 10 (9), e0137455 (2015). 
37. T. Xiao, W. Hou, X. Cao, S. Wen, M. Shen and X. Shi, Biomaterials Science 1 (11), 
1172-1180 (2013). 
38. P. Bjelkmar, A. Hansen, C. Schönning, J. Bergström, M. Löfdahl, M. Lebbad, A. 
Wallensten, G. Allestam, S. Stenmark and J. Lindh, BMC public health 17 (1), 328 
(2017). 
39. S. Chen, X. Chen, L. Zhang, J. Gao and Q. Ma, ACS applied materials & interfaces 
9 (6), 5430-5436 (2017). 
40. C. K. Park, C. D. Kang and S. J. Sim, Biotechnology Journal: Healthcare Nutrition 
Technology 3 (5), 687-693 (2008). 
41. H. Ilkhani, M. Arvand, M. R. Ganjali, G. Marrazza and M. Mascini, Electroanalysis 
25 (2), 507-514 (2013). 
42. F. Berti, S. Laschi, I. Palchetti, J. S. Rossier, F. Reymond, M. Mascini and G. 
Marrazza, Talanta 77 (3), 971-978 (2009). 
43. H. Ilkhani, M. Mascini and G. Marrazza, in Sensors and Microsystems (Springer, 
2012), pp. 15-18. 
44. J. Pagan, E. Bolderson, M. Jones and K. K. Khanna, in The DNA Damage Response: 
Implications on Cancer Formation and Treatment (Springer, 2009), pp. 109-131. 
45. J. Wang, A. Shi, X. Fang, X. Han and Y. Zhang, Anal Biochem 469, 71-75 (2015). 
98 
 
 
46. F. Li, J. Peng, Q. Zheng, X. Guo, H. Tang and S. Yao, Analytical Chemistry 87 (9), 
4806-4813 (2015). 
99 
 
 
CHAPTER 5  
INKJET PRINTED µPAD FOR GLUCOSE 
COLORIMETRIC DETECTION IN ARTIFICAL URINE 
 
This article introduces a novel inkjet printing method for fabrication of microfluidic 
paper-based analytical device (μPADs) with better analytical performance for 
colorimetric measurements. Firstly, the hydrophobic boundary was created by wax 
printing on chromatography paper. Then, chitosan (CHI), 3,3',5,5'-
Tetramethylbenzidine (TMB) and enzyme mixture solvent (glucose oxidase (GOx) and 
horseradish peroxidase (HRP)) were sequentially printed in the sensing zone for 
multiple times. Polyethylene glycol (PEG6000) was mixed with the bienzymatic 
solution to act as an enzyme stabilizer and forming the printable ink. The resulting 
μPADs exhibited a linear range between color intensity and glucose concentration from 
0.025 to 0.5 mg/ml. The detectable glucose concentration is in a clinically relevant 
range from 0.01 to 4 mg/ml. The limit of detection (LOD) was achieved at 0.01 mg/ml. 
After 60-day stocking under 4°C, the color intensity at the testing zone retained over 
80% of original intensity. Furthermore, the development of this ink printing method 
also provides a point of care (POC) platform for other substances detection purposes. 
5.1 Introduction 
 
Microfluidic paper-based analytical devices (μPADs) present unique opportunities in 
the development of rapid point-of-care tests (POCTs). Multiple conventional detection 
techniques, such as colorimetric detection1-5, electrochemical detection6-9, 
fluorescence4, 10, and Surface-enhanced Raman Spectroscopy (SERS)11-13 have been 
integrated into paper-based devices for rapid POCTs. Due to its global affordability, 
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user-friendliness, portability, and rapid visual readout14, colorimetric detection could be 
the most useful technique to be coupled with μPADs. The color intensity can be 
measured by taking a photograph of the sensing zone on the μPADs using a scanner or 
smartphone15-17. 
 
In colorimetric glucose detection, glucose oxidase (GOx) and horseradish peroxidase 
(HRP) is a common enzyme pair used to catalyze the reaction between glucose and the 
chromogenic substrates5, 18-20. The GOx firstly oxidizes glucose to gluconic acid and 
hydrogen peroxide (H2O2). Then, HRP catalyzes the reaction of H2O2 with 
chromogenic substrates and exhibits a blue color. The commonly used chromogenic 
substrates for HRP include KI, TMB, DAB, ABTS, and others21.  
 
µPADs as a low-cost and portable platform for glucose assays was first proposed by the 
Whitesides group in 200722. Their device was fabricated by paper-based photo-
lithography with a measurement range of glucose concentration from 0 to 500 mM 
Whatman® chromatography paper was the most commonly used lateral flow paper 
substrate18, 19, 23. The hydrophobic barriers were constructed with many techniques such 
as photo-lithography, wax printing, hot embossing, and screen printing21. After that, the 
enzymes and substrates are always loaded onto the device manually. The limits of 
detection (LODs) with image data collected by a scanner or common digital camera is 
often reported in the literature as ranging from 0.1 to 5 mM21, 24.  
 
Although colorimetric detection provides many advantages, it also exhibits some 
drawbacks that can adversely affect the analytical performance of the μPAD. The 
washing effect2, 22, 25, uneven color development formed in the detection zones18, 26, 27, 
and enzyme/substrate loading overflow are three of the major problems. The washing 
effect is caused by the washing of the reagent and enzyme from the printed position to 
the edge of the paper substrate when the sample solution travels through the patterned 
channels. Uneven color development and overflowing are primarily caused by 
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unbalanced manual reagent loading and spreading of the fluid in porous cellulose fiber 
structure. Recent publications have achieved noticeable improvements to minimize 
these effects19, 28, 29. However, the problems remained at the visual level. 
 
In this study, we introduce a novel inkjet printing method to fabricate the paper device 
on Whatman® chromatography filter paper. This method overcomes the drawbacks 
previously described. Firstly, the nominal drop size of the nozzle is 10 pL. Generally, a 
40 µm spot can be produced with a 10 pL drop, therefore, the designed pattern could 
be printed out precisely because of the high printing resolution, and the spreading of 
liquid ink can also be minimized due to the extra low volume of each ink drop. 
Therefore, the overflowing and uneven color development issue could be addressed. 
Secondly, the application of CHI as immobilization support has been successfully 
demonstrated by other researchers for sensing studies19, 30, 31. Here, the CHI was printed 
to immobilize the enzymes (GOx and HRP) by entrapment method32 to minimize the 
washing effect.  
5.2 Materials and Methods 
5.2.1 Materials and chemicals 
Whatman® chromatography paper No.1 was purchased from GE Healthcare Life 
Sciences. Black cartridge-free ColorQube ink was purchased from Xerox. Triton X-100 
surfactant was purchased from MP Biomedicals, Inc. 3,3′,5,5′-tetramethylbenzidine 
(TMB), 2,6-dimethyl-4-heptanol, glucose oxidase from Aspergillus niger (227533 U/g, 
GOx), peroxidase from horseradish (≥250 U/mg, HRP), and chitosan powder low MW 
were purchased from Sigma-Aldrich. Phosphate-buffered saline (PBS), was used as the 
solvent.  
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5.2.2 Lateral Flow Paper Substrate 
The lateral flow sensor pattern was designed using Autodesk AutoCAD software. It 
consists of a 6 mm square testing area and a 6 mm diameter circular dropping area 
connected by a 6 mm long, 4 mm wide lateral flow column. This area is surrounded by 
a 2mm wide wax ink border, bringing the total size of the testing area plus ink border 
to a 2 mm long, 1 mm wide rectangle. The lateral flow sensor was constructed by 
printing the specified ink on the chromatography paper with a Xerox® ColorQube 8570 
printer at a resolution of 600 DPI. The sensors were then baked on a hot plate at 150° 
C for 1 min to allow the ink to penetrate the chromatography paper, creating a 
hydrophobic barrier. 
 
5.2.3 Inks 
Three liquid solutions were used in the construction of the biosensor. First, chitosan 0.2% 
v v-1 was prepared in acetic acid 0.4% v v-1 before fill into cartridge. TMB was dissolved 
in acetonitrile, then mixed acetonitrile with 2,6-dimethyl-4-heptanol at a volume ratio 
1:3. The final concentration of TMB was 20mM. The enzyme solution was prepared by 
adding 10 ml PBS, 20 µl Triton X-100, and 200 µl each of GOx (5 mg/ml) and HRP (1 
mg/ml) to a 15 ml centrifuge tube. Both solutions were stored at 4° C.  
 
5.2.4 Sensor fabrication 
2 ml of the prepared solutions were added into separate 10 pl Dimatix Materials 
Cartridges. The paper substrate was secured in a Fujifilm Dimatix DMP-2831 printer, 
and the cartridge containing the 0.2% chitosan solution was loaded and printed onto the 
6 mm square testing area on the assay at 40 volts for two layers using 16 printing 
nozzles, with a 2-minute delay between layers. The paper was allowed to dry for 5 min, 
then TMB and enzyme solution was printed onto the 6 mm square testing area at 25 
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volts for two layers using 16 printing nozzles, with a 5-minute delay between layers in 
order to ensure proper drying. Constructed sensors were covered and stored in a 
desiccator at 4° C. the whole fabrication procedure is illustrated in Figure 5.1 below. 
 
 
Figure 5.1 The flow chart of the µPAD fabrication procedure (left), a schematic 
diagram of the device for glucose detection (middle) and the paper device printing using 
DMP 2831 material printer (right) 
 
5.2.5 Artificial urine 
The artificial urine used was prepared at pH of 6.0 according to the reference22. The 
artificial urine solution was 1.1 mM lactic acid, 2.0 mm citric acid, 25 mM sodium 
bicarbonate, 170 mM urea, 2.5 mM calcium chloride, 90 mM sodium chloride, 2.0 mM 
magnesium sulfate, 10 mM sodium sulfate, 7.0 mM potassium dihydrogen phosphate, 
7.0 mM dipotassium hydrogen phosphate, and 25 mM ammonium chloride all mixed 
in Millipore water. The pH of the solution was adjusted to 6.0 through the addition of 
1.0 M hydrochloric acid. 10 ml of urine and 40 mg of glucose was added to a 15 ml 
centrifuge tube to create a 4 mg/ml glucose solution. This 4 mg/ml solution was then 
diluted to create 4 ml each of 4.0, 2.0, 1.0, 0.5, 0.25, 0.1, 0.05, 0.025 and 0.01 mg/ml 
glucose solutions, for a total of 9 glucose solutions ranging from 0.01 to 4 mg/ml. 
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5.2.6 Colorimetric detection 
15 µl of various glucose solutions were pipetted onto the circular dropping areas of the 
row of seven glucose sensors. The color change was observed and recorded after 5 min 
of the sample loading. Colorimetric measurements were performed with an office 
scanner (Epson perfection V19) using 600dpi resolution. The recorded image data were 
converted to an 8-bit gray image and inverted black and white by ImageJ software, then, 
the arithmetic mean of the gray pixel intensity within each detection zones was used to 
determine the glucose concentration. The gray value should be positively correlated to 
glucose concentration. 
 
5.2.7 Characterization 
The morphology of the chitosan and enzyme-modified cellulose paper surface was 
characterized by FEI Quanta FEG 650 Scanning Electron Microscopy (SEM). Three 
types of samples were analyzed: an untreated control sample, a pipetted sample 
(chitosan and enzymes mixture pipetted onto cellulose paper manually) and a printed 
sample (chitosan and enzymes mixture printed onto cellulose paper by ink-jet printing). 
Samples were characterized under low vacuum mode at magnification of 200 times.  
 
5.3 Results and Discussion 
5.3.1 Optimization of the ink ingredient and printing procedures  
Differing from the conventional pipette dotting method, fluids (ink) should have the 
typical physical characteristics, including relatively high viscosity and low surface 
tension to optimize the inkjet printing performance. In this case, ink needs to be 
colorless and compatible with the enzymes. Because of its low cost and printing 
feasibility, chitosan(CHI) was chosen for enzyme immobilization by the entrapment 
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method32. The chitosan solution is made at 1% in 2% acetic acid and then diluted to 
0.2% with DI water so that the viscosity of chitosan ink falls into the printable range. 
The colorimetric performance of μPADs without and with chitosan coating was 
illustrated in Figure 5.2. The cyan color bleeding can be easily observed at the μPADs 
without CHI coating. TMB was chosen as the chromogenic substrate for HRP due to its 
non-polar molecular structure and hydrophobicity. This property prevents the dye 
bleeding when in contact with aqueous solvents. For TMB substrate printing, a mixture 
of acetonitrile (25% v/v) with 2,6-dimethyl-4-heptanol(75%v/v) provides around 5.9 
cPs viscosity, suitable for printing. The solvent mixture dries in a few minutes, and the 
bi-enzyme solvent can then be printed. 0.2% (v/v) Triton X-100 was added to lower the 
surface tension of the aqueous solution. Nozzles with surface tension outside of the 
correct range were still usable, but with limited performance. To increase the viscosity 
without affecting enzymatic activity, 0.1 g/ml PEG 6000 was added to the enzyme ink. 
The final viscosity of the mixed solvent was 5.0 cPs. Another function of PEG 6000 
was to act as an enzyme stabilizer33, 34, helping to retain enzymatic activity at a low pH 
=4.0~6.0. Additional information regarding the viscosity of the mixed solvents can be 
found in Table 5-1. 
 
Figure 5.2 Optical micrographs showing the colorimetric performance of μPADs 
without and with chitosan.  
CHI+: paper-based device coated with CHI. 
CHI-: paper-based device without CHI coating. 
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Table 5-1 The viscosity of the inks used for the inkjet printing (n=3) 
Chemical solution Viscosity SD 
TMB 25mM dissolve in (DC: acetonitrile 3:1)*  5.87 ±0.05 
CHI 0.2% in 0.4% acetic acid 5.65 ±0.01 
PEG6000 0.1g/ml and 0.2% triton in PBS  5.00 ±0.02 
DI Water at 20˚C 1.03 ±0.01 
*DC= Diisobutylcarbino or 2,6-dimethyl-4-heptanol  
 
The required concentration and volumes of CHI, TMB chromogen, and bi-enzyme 
mixture were also optimized. The highest color intensity was achieved using a 0.2% 
chitosan solution and a double-layer printing at 40 volts, 25 mM TMB 2-layer printing 
at 25 volts and enzyme mixture (HRP: GOx) at 20 ug/ml:100 ug/ml (5 U/ml:22.75 U/ml) 
2-layer printing at 25 Volts. Since the drip volume for each reagent at the chosen voltage 
was approximately 10pL and the number of drips needed was given by the printer 
software, we can easily calculate the total volume for each layer of printing. The optimal 
enzyme mixture and substrate concentration were determined based on the result in 
Figure 5.3. Increasing the TMB concentration or decreasing the enzyme mixture 
concentration caused a decrease in the color intensity. Too high of an enzyme 
concentration or too low of a TMB substrate concentration led to a color change from 
cyan/blue to brown (Figure 5.3). 
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Figure 5.3 Optimizing of the TMB substrate and enzyme mixture concentration for 
µPAD printing. The glucose solution used in this test was 1 mg/ml concentration. 
 
5.3.2 SEM characterization of the paper surface  
The chitosan solution, TMB substrate, and enzymes were printed on Whatman® No.1 
cellulose paper during the device fabrication procedure. The morphology of the 
modified and unmodified cellulose paper surface was characterized by an FEI Quanta 
FEG 650 scanning electron microscope (SEM). Based on the results presented in Figure 
5.4, it is possible to observe the surface morphology differences between the modified 
groups and control group. The porous structure of cellulose on printed and pipetted 
samples was partially coated by a mixture of chitosan and enzymes in the form of a thin 
film. Theoretically, the printed layer of chitosan and enzyme thin film layer should have 
better coating uniformity. However, there was no significant difference that can be 
visually observed in Figure. 5.4b and 5.4c between the printed and pipetted samples. 
The size of cellulose fiber ranged from several µm to tens of µm (Figure 5.4d). 
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Figure 5.4 The SEM images showing the morphology of the cellulose paper surface, 
native cellulose paper (a), CHI and protein pipette coating (b) CHI and protein printing 
coating (c), and 2000× magnification at red square highlighted area (d). Scale bars: 300 
µm (a-c), 30 µm (d). 
5.3.3 Analytical Curve 
For calibration of the biosensor, one drop (15 ml) of artificial urine (0–4 mg/mL (22 
mM)) was added onto the loading zone of a μPAD, and the liquid was allowed to spread 
and travel throughout the whole zone by capillary action. Once the reaction was 
complete (5 min), the paper was scanned using an office scanner and the image was 
saved. The images were then analyzed by ImageJ to obtain the grayscale value for each 
sensing zone.  
 
According to the optical graphs presents in Figure 5.5, the visual detection associated 
with the increment on the characteristic cyan color of TMB substrate in the detection 
zones corresponds to all tested glucose concentrations. As we can see, the cyan color in 
(b) 
(c) 
(a) 
(d) 
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the sensing zone was uniformly distributed without washing effect and overflowing of 
color. Compared with previously published results, our current method was 
straightforward, low cost, and without the need of special treatment of the substrate 
such as oxidation2, incorporation of functionalized nanoparticles20, 28 or control of 
flow29. Additionally, the result also indicated uniformly printed layers with the 
appropriate mixture of CHI, TMB substrate, and enzymes. In order to show the 
repeatability of our method, the experiment was repeated for 5 times. The complete 
results can be found in Figure 5.5 
 
 
Figure 5.5 Images of the printed μPAD corresponding to glucose assays in 
concentrations ranging from 0−4.0 mg/ml 
 
The analytical performance of the printed μPADs was evaluated. According to the 
analytical curves illustrated in Figure 5.6 the intensity of the cyan color is proportional 
to glucose concentration. The assay displayed a linear profile from 0.025 to 0.5 mg/ml 
with correlation coefficient values at 0.996, but non-linear profile from overall scale 
0.01 to 4 mg/ml. The data were then linearized by comparing the mean color intensity 
and the logarithm of the glucose concentration. The correlation coefficient value (R2) 
was 0.965.  
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Figure 5.6 Analytical curves for glucose, (Y=46.94log(X)+117.51, R2=0.965) assays 
performed on µPADs (n=5) (left) and linear ranges (Y=46.13X+118.54 R2=0.996) of 
the analytical curve for glucose using inkjet printed µPAD (right) 
The limit of detection (LOD) for each bioassay was calculated based on the mean of 
the blank (Mean (Blank)) and the standard deviation for the blank (SD) (n=25). The 
formula was LOD=Mean (blank)+3SD. The LOD values achieved for glucose were 
0.0101 mg/ml (0.056 mM), 
 
The cost of inks and paper substrate has been estimated to be $30.00 USD in total and 
it has allowed the fabrication of more than 1000 μPADs with great reproducibility and 
long shelf life. The final unit cost of the μPAD was approximately $0.06 USD.  
Currently, the unit price of commercially available glucose colorimetric test strips range 
from $0.17 up to $1.00 USD or higher. 
 
In this study, we used wax and inkjet printing to fabricate the device. We then used a 
scanner and ImageJ to collect and analyze data. With this system, errors were mainly 
caused by the wetting condition of the filter paper, printer nozzle condition and printing 
alignment. Based on our observation, wetting increased background grayscale intensity, 
more wetted filter paper provided a higher background grayscale value, and less wetted 
paper led to a lower grayscale value. Since the wetting conditions at each sensing zone 
and loading zone are similar, the error may be minimized by using the formula: True 
gray value = Gray value at sensing zone – Gray value at loading zone. The nozzles of 
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the inkjet material printer can become blocked after many uses. Because of this, the 
total printing volume may be affected if nozzles become partially blocked. Theoretically, 
the entire sensing zones were analyzed to collect grayscale image data. However, due 
to imperfect alignment during printing, a small proportion of the sensing zone may not 
be printed and may influence the data acquisition after reactions. 
 
5.3.4 Shelf life testing 
 
The device shelf life was tested for a 60-day period with 5 different glucose 
concentrations (0.05, 0.1, 0.25, 0.5 and 1 (mg/ml)). The results are illustrated in Figure 
5.7 and Figure 5.8 for graphic results. Based on the results, in the first 3 days, the 
enzymatic activity decreased to 77.8%, 90.1%, 88.7%, 83.7% and 83.8% of the tested 
intensity at day 1 for glucose concentration 0.05 mg/ml, 0.1 mg/ml, 0.25 mg/ml, 0.5 
mg/ml and 1 mg/ml respectively. After day 3, the colorimetric intensity of all tested 
concentration remained stable until 2-months after printing. The change of pH and salts 
concentration during the solvent volatilization in the first 3 days could be a significant 
cause of the loss of enzymatic activity. 
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Figure 5.7 Shelf life testing of µPAD with different glucose concentrations for 
maximum of 60 days (n=3) 
 
Figure 5.8 The colorimetric results of shelf life testing (n=3), glucose range is from 
0.05-1.0 mg/ml 
 
PEG addition was reported as an efficient method to preserve enzymatic activities of 
several typical enzymes34-36. For our case, the μPADs with PEG6000 added in the ink 
has contributed to a higher color intensity at the same level of glucose concentration 
(Figure 5.9). Moreover, without adding PEG6000, the enzymes lost most of their 
function in less than 3 days (Figure 5.9).  
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Figure 5.9 µPAD fabricated using enzyme mixture inks with and without addition of 
PEG6000, the colorimetric results collected at the day of fabrication (Day1) and Day3 
(Samples were stocked at 4˚C) with different concentration of glucose (0.05 - 1 mg/ml) 
(a), the plotting of grey intensity vs glucose concentration for different experimental 
groups (b). 
(a) 
(b) 
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PEG- = device printed using ink without PEG6000  
PEG+ = device printed using ink with 0.1 g/ml PEG 6000 
 
5.3.5 Recovery experiments 
The accuracy of the µPAD devices was evaluated through recovery experiments. The 
recovery test was conducted by adding artificial urine with a standard glucose 
concentration (0.15 mg/ml, 0.75 mg/ml and 1.5 mg/ml). As can be seen in the presented 
data in Table 5-2, the µPADs recovery values varied between 102.8% and 110.1%. 10 
replicate measurements were archived for each concentration (n=10) and the more 
detailed graphs are demonstrated in Figure 5.10. Due to the standardized device 
fabrication procedures, the standard deviation was smaller than that of previously 
published results18-20, 25, and the error values were similar regardless of the sample 
glucose concentration. Since the standard deviation was a nearly fixed value in our case, 
the RSD increased while testing samples with lower glucose concentration. 
 
Table 5-2 Glucose concentration levels determined with artificial urine samples using 
inkjet printed μPADs   
Recovery test was conducted by adding three different concentrations of standard 
solution (n=10) RSD: Relative standard deviation 
 
 
Known concentration 
(mg/ml) 
Measured concentration 
(mg/ml) 
RSD (%) Recovery 
(%) 
0.150 0.161±0.019 11.9% 107.3% 
0.750 0.771±0.021 2.8% 102.8% 
1.500 1.651±0.022 1.3% 110.1% 
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Figure 5.10 The recovery test results of inkjet printed μPADs determined by 3 
different glucose concentrations of artificial urine samples (n=10) 
 
5.3.6 Comparison with the reference method 
 
Spectrophotometry was chosen as the reference method. The Glucose (HK) assay kit 
was purchased from Sigma-Aldrich®, and the ultraviolet absorbance at a wavelength 
of 340 nm was directly proportional to the sample glucose concentration. Three 
artificial urine samples with unknown glucose concentration were prepared and tested. 
The measurement results(Figure 5.11) by both μPAD (Figure 5.12) and reference 
method(Spectrophotometer) were statistically compared, the P values of one-way 
ANOVA were calculated and ranged from 0.085 to 0.504. From this, it can be concluded 
the data collected from both methodologies were not statistically different from one 
another at a confidence level of 95%. 
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Figure 5.11 Comparison of the unknown glucose concentrations in artificial urine 
samples determined by µPAD (n=5) and spectrophotometer (n=3) 
 
 
Figure 5.12 µPAD colorimetric results of 3 artificial urine samples with an unknown 
concentration of glucose (left); and the color intensity comparison of the first column 
of sample 1, 2 and 3 with calibration. 
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5.4 Conclusion 
In summary, an inkjet-printed paper-based colorimetric biosensor was developed for 
urine glucose monitoring at the point-of-care. The device was first wax printed to form 
a hydrophobic barrier. Then, CHI, enzymes, and TMB were inkjet-printed onto the 
testing zone. The surface CHI and enzyme coating was evaluated by SEM. The 
approach was successfully applied to quantify glucose in the clinically relevant range 
from 0.01 mg/ml (55 nM) to 4 mg/ml (22 mM). The limit of detection was 0.01 mg/ml 
(56 μM). This standardized printing method reduced the cost of each testing unit, 
minimized the washing effect, and improved the uniformity, accuracy, and repeatability. 
The addition of PEG6000 provided a long shelf life and enhanced analytical 
performance, allowing the visual detection of glucose at low concentrations. The device 
retained over 80% percent enzymatic activity after 2-month storage at 4°C. The 
proposed device is portable, low-cost and easy to use, providing great potential to be 
applied in point-of-care testing in the developing world. Furthermore, this printing 
method is applicable to any other enzyme/substrate system, not only glucose 
measurement. 
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CHAPTER 6  
A SMARTPHONE BASED OPTICAL PLATFORM FOR 
WHOLE BLOOD GLUCOSE COLORIMETRIC ASSAY 
 
In this work, a smartphone based optical detection platform for colorimetric analysis of 
blood glucose using a disposable paper-based device was designed, implemented and 
fully characterized. The paper-based device was fabricated by wax printing, and the 
TMB substrate and GOx/HRP bio-enzymatic system were inkjet printed as the sensing 
zone of the chromatography filter paper. The membrane filter was then laminated on 
top of the chromatography paper for blood separation and glucose in plasma penetrate 
to the sensing zone on chromatography paper resulting in a cyan color change from 
TMB substrate upon the glucose-induced GOx/HRP enzymatic reaction. The result 
color image was analyzed by an Android smartphone application using an integrated 
camera in the smartphone. To avoid the ambient light effect, a 3D printed optical 
chamber was included in this platform. With the image-processing program on the 
smartphone, the developed device was successfully applied to determine various 
glucose levels of blood from 0.05 to 4 mg/ml, which covers the range of human normal 
blood glucose concentration 0.5 to 2 mg/ml. The limit of detection (LOD) obtained 
from the developed platform was 0.05 mg/ml. The glucose concentration in blood could 
be conveniently and accurately determined using this system, and it provides great 
potential to be used as a powerful point of care (POC) diagnostic tool as well as the tool 
for diabetic patient glucose monitoring and management. 
 
6.1 Introduction 
In recent years, point-of-care testing (POCT) has been widely used in medical 
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diagnostics, food safety and environmental monitoring. Micro paper-based analytical 
device (µPAD) was first reported by Whiteside’s group for point-of-care testing for 
developing countries1. As one of the most frequently applied types of POCT device, 
the paper-based device has many advantages including affordable, specific, user-
friendly, rapid and robust, equipment free, and deliverable to end users2. The paper-
based device can be fabricated using a variety of methods. Wax printing, 
photolithography3, inkjet printing4, and wax dipping5 are the most frequently applied 
methods. The printed wax or photoresist build up hydrophobic boundaries which would 
force the hydrophilic flow surrounded by the boundaries. µPADs have been used to 
detect a variety of analytes including biochemical molecules,6-8 environmental samples9, 
10, as well as blood samples11-13. 
 
There are five main methods to detect analytes, including colorimetric14-17, 
electrochemical11, 17 chemiluminescence18, electrochemiluminescence18, and 
florescent18. However, electrical detection requires a reliable power supply and delicate 
circuitry for impedance or current measurement, and fluorescence or 
chemiluminescence method often requires the use of a charge-couple device (CCD) 
camera interfaced with an expensive fluorescence instrument, which is not ideal for 
POCT applications. Colorimetric method is most commonly used since it is simple, 
equipment free, quick to perform, and inexpensive. The colorimetric method uses a 
chemical reaction on the hydrophilic area of paper to produce a color change. The 
resulting color intensity is proportional to the concentration of the analyte. To quantify 
the analytes, a digital camera, cell phone, or scanner is typically used to record the color 
intensity19. Although colorimetric detection provides many advantages, it also exhibits 
some drawbacks that can adversely affect the analytical performance of the μPAD. 
Variation of ambient lighting condition and uneven color development in the detection 
area are two major problems. The change of ambient light would apparently influent 
the grayscale intensity of the same image. The uneven manual reagent loading and the 
mobility of the fluid in porous cellulose fiber structure can cause uneven color 
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development in the detection area. This is particularly problematic when the colored 
product concentrates at the edge of the detection zone20. 
 
For the paper-based blood colorimetric assay, detection of analytes in whole blood is 
difficult due to the chemical complexity of the matrix and the natural red background 
color of hemoglobin. Most biological samples require steps to remove cells from blood 
because cells often interfere with the analytical measurements21. As a result, 
biochemical tests are typically carried out in serum or plasma22. The paper-based blood 
separation method can be divided into two categories, lateral separation, and vertical 
separation. The lateral separation: blood cells are separated from plasma during the 
flowing phase due to the difference in flow speed of small molecular and cells. Since 
the flow is typically a horizontal flow, we name it lateral separation. Many papers were 
published regarding to this method, filter papers such VF1, VF2 and LF1 from 
Whatman® were frequently used as the materials for a lateral separation method6, 11, 14 
The vertical separation means the blood cells and plasma are separated by vertical 
flowing, The filter membrane such as Vivid™ blood separation membrane GF, GX and 
GR from Pall® were reported as an example of vertical separation method. These 
membranes are usually unidirectional filtration membranes23, 24. 
 
The use of a cell phone is more applicable for POCTs, as smartphones are portable, 
have excellent computing power, low diagnostic cost and have high-resolution cameras 
that can quantify color intensity25. Smartphone platform can be implemented for either 
electrochemical26, 27 or colorimetric readout25, 26, 28-32. The external housing unit that 
requires additional optical elements, including a light source for imaging, such as a 
light-emitting diode (LED), light diffuser, and optical chamber, providing more precise 
and accurate on-site screening of liquid analytes25, 29, 32, 33. One challenge of using 
smartphone platform for colorimetric readout is variation of the image capture related 
parameters, such as light sensitivity of the camera, exposure time and white balance 
while using a build-in auto camera, variations of these parameters would significantly 
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affect the baseline of images acquired from the sensing zone. 
 
In this work, we introduce a smartphone based optical platform for colorimetric analysis 
of blood glucose concentration using a paper-based device. This method overcomes the 
drawbacks previously described. The optical platform was 3D printed with black ABS 
plastic materials. The optical chamber with build-in LED lights stabilizes ambient 
lighting condition. The manual camera as a part of the Android application offers good 
control of exposure time, light sensitivity and white balance by enabling quantitative 
manual setting. Both optical chamber and manual camera could significantly reduce the 
variation of gray intensity baseline on the same image and hence increase of readout 
accuracy.  In order to address the color uniformity issue that is encountered by 
traditional colorimetric device fabrication, the chromogen and enzymatic system were 
inkjet printed to construct the sensing zone of the µPAD using a high-resolution 
material printer. Since the volume of the jetted ink is on a scale of nanoliters, the pattern 
for printing was also highly designable. The entire analytical system is of portability, 
high stability, high sensitivity, low diagnostic cost, and long shelf-life, meaning it offers 
great potential for clinic and POCT applications. 
 
6.2 Materials and Methods 
6.2.1 Materials and chemicals 
 
Whatman® chromatography paper No.1 was purchased from GE Healthcare Life 
Sciences. Black cartridge-free ColorQube ink was purchased from Xerox. Triton X-100 
surfactant was purchased from MP Biomedicals, Inc. 3,3′,5,5′-tetramethylbenzidine 
(TMB), 2,6-dimethyl-4-heptanol, glucose oxidase from Aspergillus niger (227533 U/g, 
GOx), peroxidase from horseradish (≥250 U/mg, HRP), and chitosan powder low MW 
were purchased from Sigma-Aldrich. Phosphate-buffered saline (PBS) was used as the 
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solvent. The GX grade Vivid™ blood separation membrane was purchased from Pall® 
Life Science, VF2 and LF1 filter papers were purchased GE Healthcare Life Science. 
 
6.2.2 Fabrication of µPAD 
 
The paper-based sensor pattern was designed using AutoCAD software (Autodesk, 
2018). A 6 mm square testing area is surrounded by a 2 mm wide wax ink border. The 
sensor was constructed by printing the wax ink on the Whatman No.1 chromatography 
filter paper with a Xerox ColorQube 8570 printer at a resolution of 600 DPI. The 
sensors were then baked on a hot plate at 150 ºC for 1 min to allow the ink to penetrate 
the chromatography paper, creating a hydrophobic barrier. The GX grade Vivid™ blood 
separation membrane purchased from Pall Life Science (NY, USA) (size: 8mm×8mm) 
was laminated on top of the filter paper. The TMB chromogen (25mM) and bio-
enzymes (GOx and HRP = 40:200 µg/ml) were inkjet printed in sensing zone the µPAD 
by Fujifilm Dimatix Material Printer DMP 2831 (Schematic 6.1). 
 
 
Schematic 6.1 Illustration of the µPAD structure 
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Sensing zone 
Wax boundary 
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6.2.3 Optical platform 
The optical platform was designed using Autodesk AutoCAD software. It consisted of 
three parts the smartphone holder (Schematic 6.2A and B), optical chamber and chip 
holder (Schematic 6.2 C). The optical chamber had a window with the diameter of 4 
cm, it can be assembled with the smartphone holder part by inserting at the even joint 
and rotating. The chip holder can be inserted to the bottom of the chamber from both 
sides. Considering the optimal focusing distance varies for different smartphones, the 
optical chamber, therefore, is designed into two hollow cylindrical parts, this design 
makes the chamber length adjustable (from 8-14 cm) by sliding the narrower one into 
a wider one, which could meet the requirement for most smartphones. The entire 
platform was printed using Fortus 250MC 3D printer (Stratasys, US). 
 
 
   
 
Schematic 6.2 The schematic of the 3D optical platform. (a) Side view of the three 
parts. (b) Bottom view of the smartphone holder. (c) Optical chamber with half 
inserted chip holder. 
 
6.2.4 Ink  
Three liquid solutions were used in the construction of the glucose biosensor. First, 
chitosan 0.2% v v-1 was prepared in acetic acid 0.4% v v-1 before fill into cartridge. 
4cm 
Battery Slot 
(a) (b) (c) 
6
cm
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TMB was dissolved in acetonitrile, then mixed acetonitrile with 2, 6-dimethyl-4-
heptanol at a volume ratio 1:3. The final concentration of TMB was 20mM. The enzyme 
solution was prepared by adding 10 ml PBS, 20 µl Triton X-100, and 200 µl each of 
GOx (5 mg/ml) and HRP (1 mg/ml) to a 15 ml centrifuge tube. Both solutions were 
stored at 4 ºC.  
6.2.5 Colorimetric detection 
25 µl of whole blood sample was pipetted onto the blood separation membrane through 
circular opening areas on the lamination layer. The color change was observed and 
recorded at the back side of the µPAD after 5 min of the sample loading (Schematic 
6.3). Colorimetric readout was performed with an in-house Android application on a 
smartphone. The recorded image data were converted to an 8-bit gray image and 
inverted black and white by the software, then, the arithmetic mean of the gray pixel 
intensity within each detection zones was used to determine the glucose concentration. 
The gray value was negatively correlated to glucose concentration. 
 
 
 
Schematic 6.3 The schematic diagram of the colorimetric detection on the paper-
based µPAD. 
 
6.2.6 Smartphone application 
Smartphone emulator Android Studio 3.2.1 was used as the software for smartphone 
application development. The Samsung Galaxy J3V Smartphone (Android version 
5min
s 
Back side Front 
side 
Front 
side 
Flip 
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8.0.0), manufactured by Samsung (Suwon, Korea), was used as the application carrier. 
The software consists of four functional modules: image acquisition, image processing, 
data analysis, and results display module (Schematic 6.4). Image acquisition module is 
for capturing image from camera or loading existing image from the photo library. The 
captured or loaded image is processed at the image processing module before it can be 
analyzed at data analysis module. Each step, the results are presented at result display 
module as feedback information. 
 
 
 
 
 
 
 
 
 
 
 
Schematic 6.4 The android application function modules 
 
6.2.7 Animal blood sample collection 
Bovine whole blood was collected from Utah State University Dairy Farm on October 
22, 2018, by following the approved Animal Care Protocol USU IACUC 10035. 
 
6.3 Results and Discussion 
Android App function modules   
Image acquisition Image processing 
  
Data analysis 
 
Results display 
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6.3.1 3D smartphone analytical platform 
Figure 6.1a illustrates the entire smartphone analytical platform that was printed with 
ABS Plus black color materials with Fortus 250MC 3D printer. The LED lights were 
inserted and fixed in the ring structure under the smartphone holder. The LED light 
voltage was set to 3V, the light reflects from the bottom of the optical chamber and 
collected by a smartphone camera. The µPAD can be inserted from both sides of the 
chip holder, only the sensing zone is exposed as valid signal collection area. The optical 
focus distance for Samsung Galaxy J3V smartphone is 80 mm. the major challenge of 
using 3D printer for construction of the platform is the poor resolution and surface 
roughness. The accuracy is 200 µm which would lead to a loss of detailed surface 
feature. In addition, the high surface roughness of the printed material was non-
negligible, this would affect the light scattering pathway in the optical chamber, and 
however, a finite element modeling analysis may be necessary to compare it with the 
ideal situation (smooth surface).  
 
   
 
Figure 6.1 Experimental step up with smartphone detection. (a) 3D printed platform 
with a smartphone for detection, (b) Bottom view of the platform with the paper-based 
device. 
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6.3.2 Smartphone application 
The smartphone application was developed for image acquisition and glucose 
concentration measurement. The user interface and operating processes are illustrated 
in Figure 6.2  
 
Button “IMAGE” is for the user to capture or load the image from the camera or from 
files. Button “RGB” is used to set the RGB ratio, and the grayscale value is calculated 
as a weighted sum of the luminance of the three-color components (R: red; G: green; 
B: blue). Button “GRAY” is to calculate and show the mean gray value of the image. 
Button “Filter” is maxed value filter to remove the effect of the light source if necessary.  
The manual camera software allows users to set light sensitivity, exposure time, white 
balance and focus distance to a fixed value so that the grayscale value from the same 
image remains consistent if use the same setting. Since the linear range across two 
orders of magnitude, from 0.025 to 0.5 mg/ml, the linear regression is used for low 
concentration samples and the logarithmic regression is used for high concentration 
samples. Parameters of regression equations are preset and changeable. 
 
 
 
(a) (b) (c) 
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Figure 6.2 The smartphone application software interface. (a) Main activity interface, 
(b) Select method to acquire the sample image. (c) self-designed manual camera user 
interface. (d) Zoom in and crop the area of interest. (e) Set RGB ratio and get gray 
value. (f) Set the type of regression and parameters to get the final glucose 
concentration. (g, h, i) third party fitting software.  
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6.3.3 Grayscale tests 
The accuracy of the Android application was first evaluated by performing a series of 
grayscale tests. A grayscale consisting of 11 grey slides was created. The grayscale slide 
was generated by defining 11 matrixes in MATLAB (R2018a), each matrix was given 
a grayscale value ranging from 0 (black) to 1 (full intensity white) with increments of 
0.1. In order to minimize the error, the matrixes were saved as images rather than 
printing out on paper and tested in a smartphone emulator in Android Studio version 
3.2.1. The grayscale is shown in Figure 6.3. The smartphone measurement results were 
completely agreed with the set value from MATLAB and the same with the results 
measured by free ImageJ software (Table 6-1). It proves that the smartphone-based 
algorithm was correct. 
 
 
 
 
Figure 6.3 The grayscale slides for smartphone-based algorithm evaluation 
 
Table 6-1 The measurement results of the grey slides (n=3) 
 
 
 
 
 
 
Slide code 1 2 3 4 5  6 7 8 9 10 
MATLAB 0 25 51 76 102 128 153 179 204 255 
ImageJ 0 25 51 76 102 128 153 179 204 255 
Smartphone 0 25 51 76 102 128 153 179 204 255 
1 2 3 4 5 6 7 8 9 10 
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6.3.4 Effect of lighting angle 
Ambient light intensity and the angle of image capture are the two major problems that 
affect the accuracy of the colorimetric reading. An optical chamber with LED light 
could address both lighting intensity and angle problems. Another method to address 
the lighting angle problem is to use filter algorithms. In this study, Max value filter and 
polynomial fitting were evaluated using MATLAB (Figure 6.4). The matrix size for the 
max filter was 25 and the fit type poly32 were applied for the polynomial fitting. Both 
methods successfully removed the light background. The Max value method also 
implants to smartphone as an optional function while the image captured outside the 
optical chamber.  
 
 
 
 
(a) 
(b) 
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Figure 6.4 The polynomial and max value filter to remove the effect of the light source. 
(a) MATLAB max value filter with matrix size 25. (b) MATLAB polynomial fitting. 
(c) A smartphone version of max value filter.  
 
6.3.5 Effect of ambient light 
Here we compared the colorimetric test results from both the smartphone-based method 
and traditional scanning method. Five different glucose concentrations (0.05, 0.1, 0.25, 
0.5 and 1 mg/ml) were used for this assay. For the smartphone-based method, the 
images captured were from both indoor and outdoor environments.  
 
The regression equations and value of R-Squares of all methods were illustrated in 
Figure 6.5, as we can see, scanning method had the best R square value (R2=0.9979) 
since the illumination situation were the same at all locations during scanning. The 
standard derivations of the smartphone-based method were much larger than the 
scanning method. The possible reasons can be the variation of the angle and distance 
between the external light source and the paper surface during the image capture. More 
(c) 
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importantly, the major difference of gray value at the same concentration point was 
caused by the variance of ambient light intensity in different environments. The scanner 
supplied the highest brightness and hence got the lowest inverted gray value in the curve. 
Given the complication of the ambient light source, re-calibration is needed if the 
location is changed while using the smartphone-based method. Providing a constant 
illumination environment would significantly improve the performance of this method. 
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Figure 6.5 Paper-based device image result collected with different methods (left), and 
Glucose analytical curves of different methods (All methods used the same sample of 
paper). 
6.3.6 Manual camera  
Figure 6.6a demonstrates two different gray values for the same µPAD sample placed 
in the optical chamber. The ambient light condition was the same for both images. An 
Auto Camera was used for this image acquisition. The camera parameters are 
uncontrollable and automatically changing every capture, as a result, the gray intensity 
of the same area varies significantly for each image capture. However, the manual 
camera could address this problem by fixing light sensitivity, exposure time and white 
brightness. As seen in Figure 6.6b, the gray intensities were much stable while using 
the manual camera for image capture.   
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Figure 6.6 The effect of exposure with different types of camera. (a) The gray intensity 
difference of two exposures of the same sample at the auto-exposure condition. (b) The 
distribution of detected gray value for the same sample with different cameras  
Eight food dye solutions with dilution ratio x2 were prepared to evaluate the analytical 
curve of smartphone method. The white balance, light sensitivity of the camera and 
exposure time were set to 7000 Kelvin, 100, and 1/60seconds, respectively. The result 
was compared with the scanner method. As shown in Figure 6.7, except for the baseline 
intensity difference caused by the different ambient light conditions, the analytical 
curves were similar to each other. It can prove that our platform system did not change 
(a) 
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the original analytical curve profile of the analyte. 
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Figure 6.7 The comparison of the analytical curve of scanner method and smartphone 
(with manual camera) method. (a) Scanner method. (b) Smartphone method. (c) 
Comparison of analytical curves of scanner method with the smartphone method using 
food dye.  
 
6.3.7 Ink optimization  
Differing from the conventional pipette dotting method, fluids (ink) used in our printing 
require the desirable physicochemical properties, including relatively high viscosity 
and low surface tension to optimize the inkjet printing performance. In this case, ink 
needs to be colorless and compatible with the enzymes. Because of its low cost and 
printing feasibility, chitosan(CHI) was chosen for enzyme immobilization by 
entrapment method34. The chitosan solution is made at 1% in 2% acetic acid and then 
diluted to 0.2% with DI water so that the viscosity of chitosan ink falls into the jettable 
range. The colorimetric performance of μPADs with and without chitosan coating is 
illustrated in Chapter 5. The cyan color bleeding can be easily observed at the μPADs 
without CHI coating. TMB was chosen as the chromogenic substrate for HRP due to its 
non-polar molecular structure and hydrophobicity. This property prevents the dye 
bleeding when in contact with aqueous solvents. For TMB substrate printing, a mixing 
of acetonitrile (25% v/v) with 2,6-dimethyl-4-heptanol(75%v/v) provides 
approximately 5.9 cPs viscosity and suitable printing performance. The solvent mixture 
dries in a few minutes, and bi-enzyme solvent can be printed. 0.2% (v/v) Triton X-100 
was added to lower the surface tension of the aqueous solution if necessary. The nozzles 
were still usable but with limited performance, if the ink surface tension did not fall 
into the correct range. To increase the viscosity without affecting enzymatic activity, 
0.1 g/ml PEG 6000 was added to the enzyme ink. The final viscosity of the mixed 
solvent was 5.0 cPs. Another function of PEG 6000 was to act as an enzyme stabilizer35, 
36. It could help remain enzyme activity at a low (pH=4.0-6.0). 
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6.3.8 Blood filtration test 
Three different types of filter paper (Vivid™ blood separation membrane, VF2 filter 
membrane, and LF1 filter membrane) were implemented for the blood filtration. The 
thickness and absorption volume of GX Vivid™, LF1 and VF2 are 330 µm and 20-30 
µl/cm2, 247 µm and 25.3 µl/cm2, and 785 µm and 86.2 µl/cm2, respectively. 
 
Although all three types of membranes were reported as a blood separation membrane, 
only GX Vivid™ membrane was successfully filtered the blood cells from vertical 
direction in our experiment (Figure 6.8). 25 µl of whole blood was even not enough to 
pass the VF2 membrane due to its large thickness. Vivid™ blood separation membrane 
is rough on the front surface and smoothes on the back surface. It can filter blood only 
when blood is loaded on the rough surface. The possible reason is because of the two-
layer structure of this membrane. On one hand, the thicker rough layer has larger pores 
allowing blood cells to settle inside the structure. In the meantime, this structure could 
prevent the problem of vertical flow blocking and would allow the small molecular 
penetrating through the whole pores structure. On the other hand, the thinner smooth 
plastic layer of the back surface has much smaller pores which could stop cells flowing 
through. The back smooth surface is located at the side of contact to the sensing zone 
and passes the analytes to the sensing surface. 
 
 
(b) (a) (c) 
(d) (e) (f) 
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Figure 6.8 The blood filtration evaluation. (a) Blood drop on the Vivid™ membrane. 
(b) Back view of the paper device with the Vivid™ membrane. (c) Dis-assembled 
device to show the filtration result. (d) Blood drop on LF1 filter paper (GE 
Healthcare®). (e) Back view of the paper device with the LF1 membrane. (f) Dis-
assembled device to show the filtration result. (g) Blood drop on VF2 filter paper. (h) 
Back view of the paper device with VF2 filter paper. 
 
6.3.9 Comparison of printing with dotting 
The inkjet printing method was introduced to minimize the color uniformity issue that 
is usually seen in paper-based analytical devices. Comparing with manual dotting 
method (Figure 6.9a), the printing method (Figure 6.9b) is high throughput and easier 
to control. In Figure 6.9a, the chromogen (TMB) and enzymes (GOx: HRP 40:200 
µg/ml) were dotted sequentially onto the sensing zone after CHI (1% in 2% acetic acid) 
coating. In Figure 6.9b, the sensing zone was printed with TMB (25mM) and enzyme 
inks (GOx: HRP 40:200 µg/ml) after the same CHI coating. Based on the results, 
printing method provides a layer with even distributed TMB and enzymes. The same 
experiment was also conducted on the whole blood sample on fully fabricated devices 
(Figure 6.9c).  
 
(g) (h) 
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Figure 6.9 Comparison of the printing method and dotting method. (a) Enzymes and 
substrate were dotted in the testing zone and tested by the use of serum. (b) Enzymes 
and substrate were printed in the testing zone and tested by serum. (c) Enzymes and 
substrate were printed in the testing zone and tested by the use of whole blood. (d) 
Enzymes and substrate were dotted testing zone and tested by the use of whole blood 
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6.3.10 Standard addition method  
Measurements for the unknown concentration serum sample were also performed. In 
order to obtain the plasma part, the sample was centrifugated at 2000 rpm for 5 min. 
Method of standard additions (MSA) is introduced and executed twice. In each MSA 
stage, a diluted standard solution containing 100 mg/mL glucose in DI water with 
adequate volume is added into the plasma samples, keeping 0.25 mg/mL concentration 
increment for glucose. first MSA and second MSA results were collected by scanner 
and data were analyzed by ImageJ (version 1.5i). The blank background gray intensity 
was 16.110±0.541, based on the equation acquire from Figure 6.10, the glucose 
concentration of the unknown blood plasma was 75.1 mg/dl. The colorimetric results 
were compared with commercial glucose meter (ACCU-CHECK® Guide, Roche) and 
spectrophotometry measurements. The result concentrations measured were 57.33 
mg/dl and 63.16 mg/dl, respectively (Table 6-2).   
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Figure 6.10 The standard addition method to calculate unknown glucose concentration 
in a serum sample. Background gray intensity for the blank sample was 16.110±0.541 
(n=3) 
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Table 6-2 Bovine blood plasma glucose measurement based on the method of 
standard addition, commercial glucose meter, and spectrophotometry (n=3). 
 
The stability and accuracy of the ACCU-CHECK® commercial glucose meter (Roche 
Diagnostics) were first evaluated by recovery experiment. The recovery test was 
conducted by adding standard glucose solution (concentration 0.10 mg/ml, 0.25 mg/ml, 
0.5 mg/ml, 0.75 mg/ml and 1.0 mg/ml). As can be seen in Table 6-3, the recovery values 
varied between 102.8% and 110.1%. Ten replicate measurements were archived for 
each concentration (n=3). According to the results in Table 6-3, the recovery rates were 
all lower than 90% starting from the addition of 0.25 mg/ml glucose to blood, which 
means the ACCU-CHECK® was likely to give a reading smaller than real value while 
measuring a plasma sample.  
 
Table 6-3 Recovery test to evaluate the commercial glucose meter. 
Recovery test was conducted by adding different concentrations of standard solution 
(n=3). RSD: Relative standard deviation 
Original 
intensity 
1st MSA 2nd MSA Calculated 
concentration 
Spectrophotometry 
concentration 
RSD 
(%) 
 ACCU-
CHECK® 
RSD 
(%) 
38.60±1.14. 41.91±0.51 46.24±0.61 75.10 63.16 2.9%  57.33 4.39% 
Sample Test 1  Test 2 Test 3 Mean RSD (%) Recovery (%) 
Blood 57 60 55 57.33 4.39% N/A 
Blood 
+0.1mg/ml 
67 65 70 67.67 3.08% 103.40% 
Blood 
+0.25mg/ml 
78 76 72 75.67 3.33% 73.36% 
Blood 
+0.5mg/ml 
98 100 103 100.33 2.51% 86.00% 
Blood 
+0.75mg/ml 
123 124 127 124.67 1.67% 89.79% 
Blood +1mg/ml 143 148 149 146.67 2.19% 89.34% 
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6.4 Conclusion 
We have developed a smartphone-based optical platform for colorimetric analysis of 
blood glucose using a disposable paper-based device. The smartphone holder, optical 
chamber and chip holder were 3D printed separately. This building block design 
improves the flexibility of updating and reduces the fabrication cost. The optical 
chamber minimizes the effect of ambient light and increases the accuracy of the 
colorimetric reading on a smartphone. An Android application was developed to collect 
and analyze the image data. As a part of the function of software, a manual camera 
which could manually set the operation parameters (such as light sensitivity of the 
camera, exposure time and white balance) was introduced. The fixation of these 
parameters would significantly stabilize the reading of different exposure environment 
for the sample image acquisition.  In order to address the color uniformity issue, the 
inkjet printing technique was implemented to replace the manual pipetting. A sensing 
layer with more uniformly distributed enzymes and substrate has been achieved. Blood 
separation membranes including VF2, LF1, and Vivid™ were evaluated by vertical 
direction blood cell filtration. Resulted shows that only Vivid™ membrane was ideal 
for vertical blood separation. The method of standard addition was performed to 
calculate a glucose concentration of unknown bovine blood sample. The results were 
compared with spectrophotometry and a commercial glucose meter (ACCU-CHECK®). 
The µPAD reading was 18.9% and 30.99% larger than results from spectrophotometry 
and commercial glucose meter, respectively. A recovery test for ACCU-CHECK® 
indicated there is a system error while using this commercial meter for a plasma sample 
assay. 
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CHAPTER 7  
RAMAN SPECTROSCOPY CHARACTERIZATION 
EXTRACELLULAR VESICLES FROM BOVINE 
PLACENTA AND PERIPHERAL BLOOD 
MONONUCLEAR CELLS 
Placenta-derived extracellular vesicles (EV) are involved in communication between the 
placenta and maternal immune cells possibly leading to a suppression of maternal T-cell 
signaling components. The ability to identify EVs in maternal blood may lead to the 
development of diagnostic and treatment tools for pregnancy complications. The objective 
of this work was to differentiate EVs from bovine placenta (trophoblast) and peripheral 
blood mononuclear cells (PBMC) by a label-free, non-invasive Raman spectroscopy 
technique. The EVs were isolated by ultracentrifugation. The dynamic light scattering 
(DLS) and scanning electron microscopy (SEM) were applied to proof the presence and 
the size distribution of EVs after the centrifugation preparation. The EV samples were 
collected from six different individual animals, three animals for each type of EV. The 
Raman peaks at 729 cm-1, 784 cm-1 and 1573 cm-1 appeared only in PBMC derived EVs, 
while the peaks 702 cm-1and 1553 cm-1 existed only in trophoblast-derived EVs. The 
discrimination of the Raman biochemical fingerprints for both trophoblast and PBMC -
derived EV samples from different animal individuals were performed by principal 
component analysis (PCA). The PCA results clearly distinguished the spectral differences 
of the two types of EVs. In addition, the PBMC-derived EVs collected from different 
animal individuals showed undistinguishable. However, the trophoblast-derived EVs from 
three placenta samples (at different gestational age/status) was distinguishable based on the 
PCA result. This research for the first time reports the Raman characteristic peaks for 
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identification of PBMC and trophoblast-derived EVs. The results also indicated Raman 
spectroscopy is a potential tool for the investigation of pregnancy complication. 
 
7.1 Introduction 
 
Extracellular vesicles (EVs) are nano-sized vesicles released by all cells in vitro as well as 
in vivo. Extracellular vesicles (EVs) are phospholipid membrane complexes that contain 
proteins, lipids, and nucleic acids. They are classified into three main categories: exosomes 
(40 – 120 nm), microvesicles (50 – 1000 nm) and 
apoptotic bodies (500 – 4,000 nm). These 
particles have different biogenesis as a 
consequence of their different sizes. The 
exosomes are formed when a late endosomal 
vesicle (multivesicular body) fuses with the 
plasma membrane and releases its vesicles in the 
extracellular space.  
 
Exosomes are packaged with signaling molecules1  (Schematic7.1), such as lipids, 
proteins, mRNAs, and miRNAs2-4, and they have been shown to regulate gene expression 
and the function of these cells5-8.  
 
As a result of their unique biogenesis, exosomes are enriched with proteins such as CD63, 
CD9, CD819. Microvesicles result from the budding of plasma membrane stimulated by 
translocation of phosphatidylserine to the outer membrane leaflet. Their formation is 
completed through actin-myosin interactions that promote the contraction of cytoskeletal 
structures. Apoptotic bodies are distinguished by the presence of organelles within the 
Schematic 7.1 Magnified schematic of a 
single exosome1 
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vesicles. They are formed due to membrane blebbing induced by signaling proteins 
involved with programmed cell death10. The role of EVs has been implicated mainly in 
cell-cell communication11, but also studied as disease biomarkers, and more recently for 
gene delivery.  
 
Pregnancy-associated exosomes were identified in humans from their involvement in 
intercellular communication between the placenta and peripheral immune cells. Placenta-
derived exosomes suppress maternal T-cell signaling components possibly leading to 
immunosuppression and promoting maternal immune tolerance to the fetus12. Some studies 
have shown that placenta-derived exosomes also have an immunomodulatory effect. For 
instance, the placental EVs carry syncytin-1 that have the ability to reduce the production 
of TNF-α and IFN- contributing to a normal pregnancy outcome9. 
 
The composition of extracellular vesicles changes with time and pregnancy status13. 
Extracellular vesicles seem to play a role in pathways of intercellular communication that 
potentially contribute to placentation, development of maternal-fetal vascular exchange14, 
15 and immune tolerance to fetal and paternal antigens16, 17. Furthermore, trophoblast-
derived EVs interact with and modulate immune cell function11. Exosomes are present at a 
low level in the circulation of non-pregnant women compared to healthy pregnant women18, 
and trophoblast-derived exosomes are present in significant amounts in the maternal 
circulation during normal pregnancy with their abundance increases in pathological 
pregnancies19. 
 
Exosomes and other EVs are difficult to characterize due to their nanoscale size and 
heterogeneity of their origin and composition. So far, there is no gold standard technique 
to isolate and determine precise physical, biochemical, and bio-molecular characteristics 
of exosome populations. The traditional strategy for EV analysis is the identification and 
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characterization of nucleic acid, protein and lipid compositions through extensive genomic, 
proteomic and lipidomic approaches. The protocols for these methods are time-consuming, 
and low-cost efficiency, which require large amount of highly concentrated EV samples 
Thus, there are needs for simpler and faster methods to analyze molecular components of 
exosomes, such as optical technologies. Although many optical methods have been used to 
analyze exosomes, most of them provide only limited biochemical information20. For 
example, fluorophore-assisted methods such as fluorescence microscopy (FM)21, 
fluorescence correlation microscopy (FCM)22, and stimulated emission depletion 
microscopy (SEDM)23 provide the biochemical information of only targeted biological 
components in the exosome and other scattering techniques such as dynamic light 
scattering (DLS)24, nanoparticle tracking analysis (NTA)25, and scattering flow cytometry 
(SFC)26 only provide limited physical information such as size distribution of the exosomes.  
 
In order to overcome the drawbacks associated with characterizing EVs by current optical 
methods, Raman spectroscopy/surface enhance Raman spectroscopy was reported as a 
non-invasive technique for classification of EVs from difference resources27-30 31, 32. Raman 
spectroscopy is a label-free technique based on inelastic scattering of laser light due to the 
interaction of photons with molecular vibrations. The Raman spectrum of inelastically 
scattered photons provides information about biochemical components of the sample. 
Raman spectra of each type of EV act as a fingerprint, which would be significant for the 
classification of EVs.  
 
In this work, Raman spectroscopy was employed for analysis of EVs isolated from PBMC 
and trophoblast. The dynamic light scattering (DLS) and scanning electron microscope 
(SEM) were applied to confirm the presence and the size distribution of EVs after the 
isolation preparation. The objective of this project was to differentiate EVs isolated from 
bovine placenta and peripheral blood mononuclear cells (PBMC) by Raman spectroscopy. 
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The long-term goals are to apply this non-invasive, label-free method to distinguish EVs 
from the serum of pregnant and non-pregnant cows to assess gestational status and the 
potential for pregnancy complications. 
7.2 Materials and Methods 
7.2.1 Materials  
SMEM and DNAse type I were purchased from Sigma-Aldrich (St Louis, MO). Penicillin, 
streptomycin, fetal bovine serum (FBS), phosphate-buffered saline (PBS) and 0.5% 
trypsin–EDTA were purchased from Life Technologies (Carlsbad, CA).  Magnesium 
Fluoride (MgF2) wafers were purchased from ALB Materials Inc. (Hendersion, NV). 
7.2.2 Cell culture and EV isolation 
Placental tissue was collected at a local abattoir, immediately transported to the laboratory 
0.06% chlorhexidine and digested for 30 min with 0.25% of trypsin and 1500 IU/ml of 
DNAse type I (Sigma-Aldrich). The cell suspensions were layered over a Percoll gradient 
(40%). The interfaces were harvested, washed in SMEM with 10% FBS. Isolated 
trophoblasts were seeded at a density of 1 x 106 cells/mL in cell culture flasks. These cells 
were cultured in EV depleted culture medium (SMEM supplemented with penicillin 50 
units/ml, streptomycin 50 μg/ml and 5% fetal bovine serum). PBMC cells were isolated by 
density gradient centrifugation (Accu-Paque, Accurate Chem. & Sci. Corp). Isolated 
PBMC cells were seeded at a density of 1 x 106 cells/mL in cell culture flasks. These cells 
were cultured in EV depleted culture medium (SMEM supplemented with penicillin 50 
units/ml, streptomycin 50 μg/ml and 5% fetal bovine serum). After 48 h of culture, cell 
culture supernatants of both cell types were collected and EVs were isolated by multiple 
centrifugation (Eppendorf Centrifuge 5810R) steps and ultracentrifugation (Beckman L7-
55) at 4C was applied (Schematic 7.2). The pellets were suspended in 200μL of PBS. 
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Three samples were collected from different animal individuals for each type of EV, we 
label these individual animals T001; T002 and T003 for Trophoblast donors, and P001; 
P002 and P003 for PBMC donors. 
 
 
Schematic 7.2 Centrifugation processing steps for EV isolation. 
 
7.2.3 Assessment of EV Isolation by DLS and SEM 
Dynamic light scattering (DynaPro NanoStar) was applied to determine the dimensional 
distribution of different types of EVs. A sample of 50 L of EVs in PBS were transferred 
to a test tube and read by the analyzer. Both trophoblast and PBMC-derived EV samples 
from three animal individuals were characterized (totally 6 samples), and for each sample, 
5 times parallel testing was performed to obtain an average distribution. The morphology 
of the EV was characterized by FEI Quanta FEG 650 Scanning Electron Microscopy 
(SEM). The EV pellet was suspended in 2% glutaraldehyde and incubated at 4°C overnight. 
This solution was ultra-centrifuged (100,000 g, 4h) and the pellet was suspended in 200 L 
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of deionized water. A sample of the fixed EVs (20 L) was transferred to a round glass 
slice and dried for 2 h at 37°C. Both trophoblast and PBMC-derived EV samples were 
analyzed then the sample was coated by gold (10 nm thickness) before SEM imaging. 
Samples were characterized under low vacuum mode at magnification of 25,000 to 200,000 
times.  
 
7.2.4 Raman spectroscopy characterization  
The Renishaw inVia Raman spectrometer connected to a Leica microscope was used for 
the cell spectra collection. A 785nm near-IR laser was equipped for Raman spectrometer.  
The 50× dry lens objective in the spectral range 600 cm-1 to 1800 cm-1 was implemented 
for the spectra collection. Silicon wafer was used for calibration before data collection 
(adjusted to 520.5±0.1 cm-1 for silicon peak). The exposure time was 10 seconds for 1 
accumulation at 100% laser power for all the cell samples. Cosmic rays in raw spectra were 
removed using “zap” function in Renishaw Wire 3.4 software. 20 L of EV samples was 
loaded on a magnesium fluoride (MgF2) optical window and dried for 1 h at 37°C before 
the spectra collection. For each type of vesicles, spectra from three independent individuals 
were collected (one optical window for each individual and totally 6 optical windows were 
employed). Approximately 35 measurements were taken on EVs attached to each MgF2 
optical window. Figure 7.1 illustrates the steps of sample preparation and experimental 
methods.  
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Figure 7.1 Schematic of steps of sample preparation and experimental methods 
7.2.5 PCA analysis 
Since Raman spectra are affected by the background noise and physical properties of the 
cell samples, mathematical processes are necessary to apply in order to reduce systematic 
noise and enhance the resolution of chemical compositions from target cells. In this study, 
Principal component analysis (PCA)33 was performed on the spectral dataset with the 
purpose of defining a new dimensional space in which the major variance in the original 
dataset can be captured and represented by only a few principal component (PC) variables 
and hence allow the most significant variables responsible for these differences to be 
identified. PCA methods were applied to extract useful information from raw dataset. 
Firstly, PCA was applied to examine the differences between the trophoblast and PBMC-
derived EVs. Secondly, the difference of the same type of EVs isolated from different 
animal individuals was also compared, three individuals of each type of EVs were 
evaluated. All algorithms were implemented in MATLAB R2017b (Mathworks Inc., 
Natick, USA). 
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7.3 Results and Discussion 
7.3.1 EV isolation  
The EVs agglomerated together after 4-hour ultra-centrifugation. Based on the results 
(Figure 7.2), the existing of EVs in the precipitation can be observed at the red circled area. 
 
Figure 7.2 The isolated EVs pellet in the centrifugal tube. 
7.3.2 DLS size measurement  
After isolation, the size of the EVs was measured by dynamic light scattering (DLS). Each 
type of EVs were collected from three animal individuals (T001; T002 and T003 for 
Trophoblast, and P001; P002 and P003 for PBMC). The PBS used for EV pellets 
resuspension was also evaluated as a control sample. The results are illustrated in Figure 
7.3. The results show that although the distribution of the EV size varied from individuals, 
EV exosomes (50 to 150 nm) were the most abundant EVs in conditioned media derived 
from trophoblast and PBMC culture. In addition, it was found that the average size of 
PBMC-derived EVs (102.3 nm) was larger than that of trophoblast-derived EVs (89.7 nm) 
based on weighted average calculation. 
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Figure 7.3 Extracellular vesicle size distribution by dynamic light scattering for 
trophoblast-derived EVs and PBMC-derived EVs from different animal individuals 
(P001(a); P002(b); P003(c); T001(d); T002(e); T003(f)) PBS used to re-suspend EVs was 
control (g) 
 
 
7.3.3 SEM morphology 
Scanning electron microscopy (SEM) was employed to directly prove the existing of EVs 
in the precipitation. The SEM morphology is illustrated in Figure 7.4. In most cases, the 
EVs presented at the form of aggregation. It was very difficult to find single discrete EVs 
under the scanning. The major reason of the aggregation could be the extremely long 
centrifugation and ultracentrifugation time. After ultracentrifugation, we noticed that the 
EV clump is visible (Figure 7.2) and it was impossible to be completely re-suspended. 
According to Figure 7.4 a and c, the dimensional distribution of either trophoblast or 
PBMC-derived EVs were close to the results measured by DLS. The diameter distributed 
from more than 10 nm to approximately 200 nm.  
 
(g) 
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Figure 7.4 The SEM morphology image of trophoblast EVs after centrifugation isolation. 
(a) The morphology of trophoblast derived EVs at 100k magnification. (b) Aggregated 
trophoblast derived EVs. (c) Scattered EVs derived from PBMC. (d) Aggregated PBMC 
derived EVs. 
7.3.4 Raman spectra  
EVs suspension was firstly loaded onto the surface of a MgF2 substrate and let dry at 37˚C 
in incubator before Raman spectra data collection. Noticeably, the dried EVs particles were 
concentrated on the edge area of the place where the EV drop was dried. The driven force 
could be the crystallization of PBS buffer solution, at the meantime, readable Raman peaks 
of EVs were only found at the edge rather than center area, which also indicated that the 
EVs were concentrated at the edge area. Because of this, our Raman spectra were all 
(a) (b) 
(c) (d) 
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collected at random place of the edge area of each of animal individual samples.  
 
Figure 7.5 illustrates the optical image of dried EV drip on MgF2. As we can see in Figure 
7.5 b and d, the dried and crystalized edge areas with and without EVs were apparently 
different, the sample with EVs suspended in PBS buffer had wider “beech” and the control 
sample with only PBS had no such “beech” like structure, when increasing the 
magnification to 50 times (Figure 7.5 c), the local structure was more like dried biological 
sample, which was significantly different comparing with crystalized PBS structure (Figure 
7.5 a)  
 
 
Figure 7.5 The optical image of dried EV drip on MgF2, the EVs was suspended in PBS 
buffer (a) the center area with crystalized PBS on MgF2, 5X magnification. (b) Edge area 
(a) 
X5 X5 
X5
0 
X5 
(b) 
(c) (d) 
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of a drip of dried EV on MgF2, 5X magnification. (c) Edge area of a drip of dried EV on 
MgF2, 50X magnification. (d) Edge area of a dried PBS buffer without EVs 
 
For this study, there are two major reasons that we use MgF2 substrates, rather than other 
materials, for Raman measurement of cell samples; 1) magnesium fluoride does not 
produce an intense background noise signal in the cell fingerprint area. 2) MgF2 has an 
extremely wide transmission Range. Windows and lenses made of this material can be used 
over the entire range of wavelengths from about 0.2 μm (vacuum ultraviolet) to around 7.0 
μm (infrared)34. Figure 7.6 compares the Raman spectra of pure MgF2, dried PBS buffer 
on MgF2 and the trophoblast-derived EV sample. According to the results, the MgF2 
background is low and smooth, the average counts were approximately 350.  Additionally, 
no peak was found between 600 cm-1-1800 cm-1. The dried PBS crystal on MgF2 elevated 
the baseline slightly by 100-200 counts, however, since both MgF2 and PBS have no 
noticeable peaks between 600 cm-1-1800 cm-1 the effect of background can be eliminated 
or minimized after baseline subtraction. 
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Figure 7.6 The Raman spectra comparison: MgF2 substrate (black), PBS buffer on MgF2 
substrate (red), and EVs derived from trophoblast cells loaded on MgF2 (blue) under 50× 
magnification at 100% laser power, 10seconds, exposure time and 1 time accumulation. 
 
After spectra collection, the baselines were subtracted before analysis. Figure 7.7 illustrates 
the Raman spectra comparison of two types of EVs, which were isolated from trophoblast 
and PBMC. The standard derivation was the highlighted gray shadow area. The spectra 
showed characteristic Raman bands of nucleic acids (720-820 cm-1), phenylalanine (1002 
cm-1), lipid and protein markers such as CH and CH2 groups (bands respectively centered 
at 1450 cm-1)35. In particular, lipids made a large contribution, which is in line with 
previously reported spectroscopic evidence29, 36, 37 Comparison of the average spectra 
revealed many spectral differences between the two EV types. The major differences in 
terms of peak intensity and peak location are highlighted by cyan color (Figure 7.7). Peaks 
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including 729 cm-1(C-C stretching, proline), 784 cm-1(DNA/RNA), 935 cm-1(C-C 
stretching mode of proline/ protein backbone), and 1573 cm-1 (Guanine, adenine/protein) 
was only found in PBMC fingerprint spectra. Peaks including 702 cm-1 (cholesterol), 960 
cm-1(calcium-phosphate stretch band (high quantities of cholesterol), and 1553 cm-1 
(Amide II) only exist in trophoblast fingerprint spectra. These peaks could be used as 
“spectral markers” for characterization. In addition, the overall intensities of the 
characteristic peaks such as 1003 cm-1 (Phenylalanine), 1250 cm-1 (Amide III) 1447 cm-1 
(CH2 bending mode of proteins & lipids) 1663 cm-1 (proteins, including collagen I) were 
found higher in PBMC spectra than trophoblast spectra. The results may imply that vesicles 
from PBMC are likely content high ratio of proteins and nucleic acids, while trophoblast-
derived vesicles may have more lipids in its encapsulation. 
600 800 1000 1200 1400 1600 1800
0
1000
2000
3000
4000
5000
600 800 1000 1200 1400 1600 1800
0
1000
2000
3000
4000
5000
C
o
u
n
ts
 PBMC
C
o
u
n
ts
Raman Shift (cm-1)
 Trophoblast
 
729 784 935 1064 
1573 
1250 
1447 
1553 702 
1002 1663 
162 
 
 
 
Figure 7.7 Raman fingerprint of EVs isolated from PBMC and trophoblast with multi-point 
baseline subtracted, the solid black line indicates the average of 30-35 spectra±1x standard 
deviation (shaded grey areas). n=30 (the spectra location and intensity differences are 
highlighted with cyan color, the peak highlighted in red only exist in PBMC-derived EVs 
and the peak highlighted in blue only exist in Trophoblast-derived EVs). 
7.3.5 PCA results  
Principal component analysis (PCA) was conducted over the baseline subtracted Raman 
spectra on the range (600-1800 cm-1). Figure 7.8 depicts the PCA-scores plot of PC1 and 
PC2 and PC1, PC2 and PC3 obtained from our analysis. In Figure 7.8 A and B, it was 
clearly seen that PCA results can distinguish the spectral differences for the two types of 
vesicles. In the PCA score plot, the first and second principal component were found to 
incorporate 50.91% and the first, second and third principal component accounted for 57.03% 
of the total variance. For the individual test of the same type of vesicles, no significant 
differences were found at both 2D and 3D level for vesicles isolated from PBMC, which 
means the components of PBMC secreted vesicles are similar regardless of the screening 
sample variation. 
 
However, the trophoblast-derived vesicles can be mostly classified to clusters at 2D level 
and clearly separated at 3D level. The biochemical components can be significantly 
different among these three animal individuals. One reasonable explanation is that 
placentas used for tissue harvesting could be at a variety of embryonic phases, which would 
have different nutrition requirement. The mean Raman spectra of trophoblastic vesicles 
from individuals were illustrated in Figure 7.9, the overall spectra intensity of Animal 1 
was much stronger than Animal 2 and 3, this could be the reason why Animal 1 was fully 
distinguished in the 2D PCA plot (Figure 7.8e). Except for the intensity difference. Few 
peak shifting was also observed in the mean spectra of Animal 1 and 2, the spectral 
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locations highlighted in Figure 7.9 with cyan color showed the peak shifting. 
 
For example, the peak 784 cm-1(phosphodiester; cytosine/DNA and RNA) only exist in 
Animal 2 and 3, the peak 1165 cm-1 (tyrosine, collagen type I)) shifted to 1155 cm-1(C-C  
&C-N stretching of proteins (also carotenoids) /Glycogen) at Animal 3, and 1553 cm-
1(tryptophan/ Amide II) shifted to 1528 cm-1(carotenoid) in Animal 2. However, in Figure 
7.10, the PBMC vesicles, besides the variation of intensities, no peak shifting was found. 
 
 
(a) (b) 
(c) (d) 
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Figure 7.8 PCA analysis of the two types of vesicles. 2D PCA plot (a) and 3D PCA plot 
(b) for trophoblast (red) and PBMC (black) derived EVs. 2D (c) and 3D (d) PCA plots of 
PBMC-derived vesicles from three different animal individuals, and 2D(e) and 3D (f) PCA 
plots of trophoblast-derived vesicles from three different animal individuals. 
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Figure 7.9 Raman fingerprint of trophoblastic vesicles with multi-point baseline subtracted, 
n=30-35. The spectra location and intensity differences are highlighted with cyan color. 
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Figure 7.10 Raman fingerprint of trophoblastic (a) and PBMC (b) vesicles with baseline 
subtracted, n=30-35. The spectra shifts are highlighted with cyan color. 
 
Bovine Serum samples were also evaluated. Two serum samples were collected from two 
cows with and without pregnancy. 20 µL of serum sample was dropped on the MgF2 optical 
window and let dry in incubator for 1 h before the Raman test. 25 spectra were collected 
from each serum sample. 
 
The mean spectra for both samples and their PCA results are shown in Figure 7.11 and 
Figure 7.12. However, since the complexity of serum components, Raman spectroscopy 
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could not specifically differentiate the types of EVs.  
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Figure 7.11 The Raman fingerprint of bovine serum from pregnant and non-pregnant 
animal individuals (n=25). 
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Figure 7.12 PCA analysis of the pregnant and non-pregnant serum samples (n=30) 
 
7.4 Conclusion 
In this study, Raman spectroscopy was employed to investigate the difference between 
trophoblast and PBMC-derived extracellular vesicles at biochemical components level. 
The EVs were isolated by 4-hour centrifugation and ultra-centrifugation. In order to prove 
the existing of EVs after centrifugation, DLS measurement and SEM imaging were applied 
to examine the diameter distribution of the particles and the morphology of the EVs 
respectively. The diameters of EVs observed under SEM were basically agreed with the 
DLS measurement results. The Raman spectra of trophoblastic and PBMC EV were 
collected from three animal individuals respectively. The peaks including 729 cm-1, 784 
cm-1 and 1573 cm-1 only appeared in PBMC EVs, while the peaks such as 702 cm-1and 
1553 cm-1 only existed in trophoblastic EVs. This finding can be further exploited and 
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potentially could be used as the criteria for classification to differentiate EVs from different 
sources. 
 
The PCA results clearly distinguished the spectral differences of the two EVs. Also, the 
trophoblastic EVs from different animal individuals could also be classified in terms of the 
variation of peak intensity and location. The placental tissue samples used for trophoblast 
cell collection were not at the same pregnancy phase may be the reason38. Due to the 
complexity of serum composition, the EVs in serum cannot be specifically characterized 
by Raman spectroscopy. 
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CHAPTER 8  
SUMMARY AND ENGINEERING VALUE 
8.1 Summary 
This dissertation mainly focuses on design and development of optical and electronic 
biosensor devices that integrated with a microfluidic system for biochemical analysis 
applications. The substrate materials for biosensor device fabrication can be of many types. 
Polydimethylsiloxane (PDMS), cellulose filter paper, glass, polyimide (PI), polyethylene 
terephthalate (PET) and MgF2 were used in this dissertation. The techniques applied for 
device fabrication include photolithography, inkjet material, printing, 3D printing, thermal 
evaporation, soft lithography and so on. The general components of a micro biosensor 
discussed in the dissertation are shown in Scheme 8.1. Each application may or may not 
include all the components.  
 
 
 
Physical/chemical sealing 
Top layer with sensing active zone 
Functional (polymer/paper based) microfluidic 
layer with patterned design 
 Bottom layer with sensing active zone 
 
Physical/chemical sealing 
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Schematic 8.1 The 3-D structure of a micro-biosensor proposed in the dissertation 
 
Research accomplishments presented in six technical chapters (chapter 2-7) can be 
summarized as follows: 
 
In Chapter 2, an MgF2-based PDMS microfluidic device was design and fabricated for 
native Raman cell fingerprint collection. Cancer cells were long-term cultured in the device 
for a compatibility test. The device has proven its usefulness in detection of cancer cells 
interaction with anti-cancer drug. The AFM cell biomechanics results from these cancer 
cells cultured in this microfluidic device agreed well with our previously published results 
that were obtained from the same type of cells cultured in traditional culture dishes. Most 
importantly, this device realizes the monitoring of cancer cells-drug interactions in 
microfluidic device in a non-invasive way with the capability of measurements in different 
time points during the culturing and minimizes the cross-contamination otherwise the dish 
culture method often occurs. This configurable microfluidic device offers a non-invasive 
and reusable tool for in vitro Raman measurement of living cells and can be potentially 
applied for anti-cancer drug screening. 
 
In Chapter 3, we developed a PDMS-based microfluidic device for detection of fatty acid 
receptor activity. The device consists of two parts: the concentration gradient generator 
(CGG) part and micro-well cell culture chamber part. The CGG could deliver five 
concentrations of fatty acid simultaneously. The 3D printed master mold was used for the 
fabrication of 3D high aspect ratio micro-well cell culture array. Due to the poor adhesive 
ability of HEK 293 cells, high aspect ratio well array could minimize the cell detachment 
under flow shear by seeding HEK293 into the deep wells. Since characteristic peak of 
MBA and PDMS does not overlay, MBA-AuNR-GPR120-antibody-based SERS probe 
was implemented to avoid the background from PDMS. HEK 293 cells response to fatty 
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acid (LA) were evaluated by the monitoring of SERS peak heights over various LA 
concentrations. It was found that the peak heights of SERS peak were proportional to LA 
treatment concentration. It was also noticed that not all HEK293-GPR120 cells were 
responsive and expressed more functional GPR120 receptors on cell surface after LA 
treatment. 
 
In Chapter 4, we described two PDMS-based MEMS devices for water quality monitoring 
applications. The first device was developed for detection Cd2+ and Pb2+ ions in water. The 
device consists of three electrodes system on glass substrate with a vibration motor for 
stripping and polydimethylsiloxane (PDMS) made reservoir for sample deposition. The Au 
electrodes were thermal deposit on glass substrate, and the PDMS reservoir was replicated 
from a 3D printed master mold. The motor stirring improves the detection limit and 
decreases deposition time. Detection limits for Cd2+ and Pb2+ ions were 0.7 mg/L and 1.2 
mg/L, respectively, at 325 s deposition without vibration; the limits were 0.11 mg/L and 
0.25 mg/L at 120 s deposition with vibration. The costs for such a device were much more 
affordable than the current ICP and AAS methods. The second device was to characterize 
human genotype of Cryptosporidium in water. This novel 3D device, comprising three 
layers, was fabricated to achieve better result comparing the commercial SPE. The first 
layer consisted a circular gold coated area (gold dot) in the center of a PI sheet and the third 
layer consisted of a common homemade screen-printed electrode (SPE). The second layer 
was included in PDMS channels and reservoir for sample delivery. The biosensor was 
fabricated on the gold dot of the first layer and electrochemical signal was recorded using 
the differential pulse voltammetry (DPV) and Impedance methods on the third layer and 
the results were compared with biosensor fabricated on commercial SPE. The specificity 
of prepared DNA sensor was conducted by using non-complementary, single, three and 
five mismatches strands and the potential of the biosensor in discriminating single 
mismatch detection was experimentally appraised. The results on our 3D device show a 
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great improvement of sensitivity compared with reported results obtained on commercial 
electrodes. 
 
In Chapter 5, we introduced an inkjet printed paper-based colorimetric biosensor for Urine 
glucose monitoring. Wax printing was first applied to build up a hydrophobic boundary, 
then, CHI, enzymes, and TMB were inkjet-printed to the testing zone. The surface CHI 
and enzyme coating was evaluated by SEM. The paper-based device was successfully 
applied to quantify glucose in the clinically relevant range from 0.01 mg/ml (55 nM) to 4 
mg/ml (22 mM) with the limit of detection of 0.01 mg/ml (56 μM). A shelf life testing was 
also conducted after 2-month storage at 4°C, the device retained over 80% color intensity 
after the enzymatic reaction. This standardized inkjet printing method reduced the cost of 
each testing unit, minimized the washing effect, and improved the uniformity, accuracy 
and result repeatability, which provide great potential for point of care application. 
 
In Chapter 6, we developed a smartphone-based optical platform for whole blood glucose 
assay using a paper-based microdevice. We developed a smartphone application for image 
data processing and result readout. We designed and 3D printed an optical platform to 
avoid the ambient light effect. We developed a manual camera system that can 
conveniently adjust exposure time, ISO and white balance to stabilize the readout results 
for the same sample. We designed and fabricated a disposable paper-based device with 
blood cell filtration function and colorimetric sensing function. The method of standard 
addition was performed to calculate a glucose concentration of unknown bovine blood 
sample. The results were compared with spectrophotometry and a commercial glucose 
meter (ACCU-CHECK®).  
 
In Chapter 7, we firstly, isolated the trophoblastic and PBMC extracellular vesicles by 
multiple time centrifugation and ultracentrifugation. Secondly, we employed the dynamic 
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light scattering (DLS), and scanning electron microscopy (SEM) to proof the presence and 
the size distribution of EVs after the centrifugation preparation. Then, we collected the 
Raman spectra of two types of EVs from 6 different animals (3 individual for each EV 
type). At last, the discrimination of the biochemical fingerprints for both trophoblast and 
PBMC derived EV samples were also performed by PCA. These results paved the way for 
new non-invasive diagnosis and classification of cell types by using EVS as biomarkers. 
 
8.2 Engineering Value 
8.2.1 Three-dimensional µTAS chip for single base mismatching  
In Chapter 4, a novel µTAS chip was demonstrated for Cryptosporidium DNA detection.  
The biosensor consisted of three layers. The first PI layer is a one-time use disposable layer. 
The third PET layer can be used for many times. In order to reuse the chip, the whole device 
was sealed by mechanical pressure rather than chemical bonding. Gold adhesion on PET 
and PI was much stronger than that for glass substrate. PI and PET are low-cost, bendable, 
easy to cut and shape. Thus, they were used as substrate to fabricate the 3D µTAS. The 
detection limit of 3D µTAS was 10 times higher than that of the SPE electrochemical 
biosensor. Over 50 chips can be fabricated at a time with a proper Al mask for gold 
evaporation, and the cost for each was less than 1 dollar. Our results indicated that the novel 
3D µTAS chip has a high sensitivity and selectivity for complex probes detection, which 
has the potential to be a commercialized product in medicinal or environmental sensing 
field. 
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8.2.2 Standardized µPAD manufacture method for massive production  
In Chapter 5, we introduced a novel inkjet printing method for glucose assay. The 
procedures for printing was standardized, which could efficiently control the stability and 
repeatability of each batch of products. The time need for each unit printing is less than 2 
seconds. Over 200 chips can be printed under 5 min. The cost of inks and paper substrate 
has been estimated to be $30 USD in total and it has allowed the fabrication of more than 
1000 μPADs with great reproducibility and long shelf life. The final unit cost of the μPAD 
was approximately $0.06 USD. Currently, the unit price of commercially available glucose 
colorimetric test strips range from $0.17 up to $1.00 USD or higher. The device retained 
over 80% percent enzymatic activity after 2-month storage at 4°C, which indicates the 
method is of repeatable, high stability on testing result low-cost, fast fabrication, long shelf 
life. The development of this printing method provides a platform for massive industry 
manufacture of paper-based colorimetric devices. 
 
8.3 Future Direction 
8.3.1 The combination of electrochemical measurement with colorimetric 
measurement 
In this dissertation, I included initial studies that used paper-based microfluidic device for 
colorimetric glucose measurement. For the paper device fabrication, we used Fuji DMP 
2831 material printer. I also included another study that used MEMS devices for water 
quality monitoring by electrochemical method. The future plan is a combination of MEMS, 
electrochemical readout with paper-based device with colorimetric readout. The DMP 2831 
printer could also print conductive silver/gold inks, which allow us to combine the 
microelectrodes system and enzymatic color reaction onto the same sensing zone. The 
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basic steps are listed below: 
Step 1: Wax printing to build up hydrophobic boundary on a paper substrate. 
Step 2: DMP material printer to pint enzymes/substrates at sensing zone for chemical 
reactions that would be used for both colorimetric readout and electron transfer. 
Step 3: print conductive inks to build up two or three electrode systems for 
electrochemical readout. 
The completed µTAS would be a paper-based device with both electrochemical and 
colorimetric readouts. Colorimetric method does not require any extra equipment, the result 
can be read out directly through a smartphone application, and it can be used for normal 
concentration range of blood glucose sample. On the other hand, the electrochemical 
method needs an adaptor to connect with a smartphone, and usually it has lower LOD and 
higher sensitivity. This combination of electrochemical and colorimetric techniques allows 
the detection of a broad range of glucose concentration samples from various bio-fluids, 
such as sweat, tear, and urine. 
8.3.2 Noninvasive glucose monitoring 
Another direction is noninvasive glucose monitoring. Diabetes patient must regularly 
measure their blood glucose concentration and to decide how much medication to use. 
Currently, this blood glucose monitoring is generally completed at home using an invasive 
method (finger prick blood glucose meter). Although high accuracy, this invasive test can 
be messy and suffering, as a result of it, many patients are not monitoring as frequently as 
they are supposed to be. Researchers have performed numerous studies regarding 
noninvasive blood glucose monitoring1-3. However, currently, noninvasive glucose 
monitoring does not satisfy our demand due to its uncertain measurement accuracy and 
weak blood glucose correlation. Optical method like infrared is easily influenced by 
interference from background substrate4. The indirect method such as impedance and 
Raman spectroscopy were lack of glucose specificity5, 6. Using body fluid such as sweat, 
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saliva, and tear for blood glucose measurement was not accurate since the glucose is 10 to 
100 times diluted in those fluid7-9. A simple, pain-free, non-invasive method would make 
improvement in diabetes care but still, need optimized sensor design. 
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